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SUMMARY XIII
Summary
In budding yeast the microtubule organising centre (MTOC) is represented by a multi­
layered structure called the spindle pole body (SPB) which stays embedded in the 
nuclear envelope throughout the cell cycle (Byers and Goetsch, 1975). The outer and 
inner plaque of the SPB are involved in the attachment of nuclear and cytoplasmic 
microtubules, a function provided by the ytubulin complex. The central plaque 
anchors the SPB in the nuclear envelope and extends into the half-bridge. The half­
bridge is a specialised structure of the nuclear envelope which is essential for the cell 
cycle dependent duplication of the SPB (Byers and Goetsch, 1975). In early Gi-phase 
of the cell cycle a precursor of the new SPB, the so-called satellite, develops at the 
distal end of the half-bridge (Byers and Goetsch, 1975). It mainly consists of 
components of the central/outer plaque (Adams and Kilmartin, 1999). After ‘Start’ of 
the cell cycle, the satellite enlarges into a duplication plaque which is inserted into the 
nuclear envelope (Adams and Kilmartin, 1999; Byers and Goetsch, 1975). The inner 
plaque is most likely to be assembled onto the inserted duplication plaque from the 
nuclear side by attachment of the inner plaque component Spell Op. to the central 
plaque component Spc29p (Adams and Kilmartin, 1999; Elliott et al., 1999; Pereira et 
a l, 1998). Proper duplication of the SPB is a prerequisite for the formation of a 
functional mitotic spindle, and therefore the segregation of chromosomes and 
successful mitosis.
In this study, Bbplp is described as a novel SPB component. BBP1 was first identified 
as a high gene dosage suppresser of mutants in SPC29 (S. Elliott, published in 
Schramm et a l, 2000), a gene coding for a component of the central plaque. Bbplp 
was shown to localise to the SPB by fluorescence microscopy. In more detail, Bbplp is 
present at the central plaque periphery as revealed by immunolabelling microscopy. 
Here, Bbplp interacts with Spc29p as further indicated by two-hybrid experiments and 
in vitro binding (S. Elliott, published in Schramm et a l, 2000). In addition, Bbplp 
interacts with the half-bridge component Karlp in the yeast two-hybrid system. Via 
these interactions, Bbplp may connect the central plaque to the half-bridge. High gene 
dosage of SPC34, coding for a SPB component of unknown function, and SPC42,
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coding for a component of the central plaque rescued specific mutant alleles of BBP1, 
indicating further interactions of Bbplp with SPB components. The known two-hybrid 
interaction between Bbplp and Bfrlp (Xue et al., 1996) was tested and repeated, but a 
direct interaction between the two proteins could not be established. Bfrlp is localised 
in the cytoplasm and might be enriched at the nuclear envelope, indicating a local 
proximity of Bfrlp to Bbplp. Recent studies showed, that Bfrlp might be part of the 
Scpl60p/Pablp complex which is found at polyribosomes (Lang and Fridovich-Keil, 
2000).
Furthermore, Bbplp was shown to form a complex with Mps2p. Mps2p was identified 
by MALDI-MS in the affinity precipitate of Bbplp-ProA. Mps2p co-precipitates with 
Bbplp-3HA by immunoprecipitation and vice versa, Bbplp co-precipitates with 
Mps2p-3HA. Both proteins also interact in the yeast two-hybrid system. High gene 
dosage of MPS2 can suppress all known mutant alleles of BBP1. However, BBP1 is a 
high gene dosage suppresser of mps2-2 and mps2-42, but not mps2-l. Like Bbplp, 
Mps2p is a component of the SPB which is localised at the central plaque periphery as 
shown by fluorescence microscopy and immunolabelling electron microscopy. 
Analysis of mutants in BBP1 at the restrictive temperature revealed that they are 
defective in late steps of SPB duplication, like the proper insertion of the duplication 
plaque and the subsequent formation of the inner plaque. Failure in SPB duplication 
resulted in spindle formation and chromosome segregation defects. Bbpl-1 cells 
displayed a typical G2 arrest. An almost identical phenotype was observed before for 
mutants in MPS2 (Winey et al., 1991). The functional similarity of Bbplp and Mps2p 
led to the hypothesis that the Bbplp/Mps2p complex functions in SPB duplication. In 
addition, the growth defect of bbpl and mps2 cells can be rescued by the deletion of 
POM152, a gene coding for a nuclear pore component. Interestingly, deletion of 
POM152 rescues mutants in NDC1 (Chial et al., 1998), which are also defective in the 
insertion of the duplication plaque (Winey et al., 1993).
BBP1 is an essential gene (Xue et al., 1996; this study), but cells lacking MPS2 are 
partially viable and can grow very slowly (Munoz-Centeno et al., 1999; this study). 
Cells lacking MPS2 display various abnormal phenotypes including multiple bud 
formation, unsuccessful chromosome segregation and abnormal SPB content. In a
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suppresser screen SMY2 was identified as unique high gene dosage suppresser of 
Amps2 cells. SMY2 is the homologue of the fission yeast MPD2 which is a high gene 
dosage suppresser of CDC7 (Cullen et al., 2000), the budding yeast homologue of 
CDC15. In budding yeast high gene dosage of SMY2 is known to rescue mutants in 
M Y02  (Lillie and Brown, 1994), coding for the yeast class V unconventional myosin 2. 
In addition, the mps2-42 allele is rescued by high gene dosage of HSC82 coding for 
one of the two budding yeast HSP90 chaperones. Hsp90p was shown to be a core 
component of the drosophila centrosome and it is required at different stages in the 
centrosome cycle (Lange et al., 2000).
In addition to the Bbplp/Mps2p complex another novel complex consisting of Spc24p, 
Spc25p and Ndc80p was isolated (Janke et al., in press). Spc24p was enriched in 
precipitates of Ndc80p-6HA and Ndc80p co-precipitated with Spc24p-3HA. 
Furthermore, Spc24p co-precipitated with Spc25p-3HA. The direct interaction of the 
proteins was supported by the earlier finding that SPC24 interacts with SPC25 and 
NDC80 in in the yeast two-hybrid system (Cho et al., 1998). Recent studies in our 
laboratory showed that Spc24p, Spc25p and Ndc80p are part of a larger complex which 
associates with kinetochores (Janke et al., in press).
INTRODUCTION 1
1. Introduction
1.1 Events in the S. cerevsiae cell cycle
Saccharomyces cerevisiae also called budding yeast or baker’s yeast, is an organism 
mainly specialised on proliferation. The single cell organism propagates through 
budding of daughter cells from the body of mother cells. The high proliferation rate of 
budding yeast is a welcome feature for the food industry, which utilises the yeast 
metabolism, as well as for researchers studying budding yeast as a model system for 
eukaryotic cells. For proliferation, the cell and its constituents have to be duplicated 
and duplicated organelles and chromosomes have to be separated before the 
completion of cell division. The set of processes required for the duplication and 
segregation of cell constituents and for the division into mother and daughter cells is 
called the cell cycle. The cell cycle can be divided into four different periods, Gi- (Gap 
1), S- (synthesis), G2 - (Gap 2) and M-phase (mitosis) (Alberts et al., 1994) (Figure 1). 
In early Gi, environmental conditions, mainly growth conditions, are critical for the 
commitment of budding yeast cells to the cell cycle. If nutrient conditions are 
sufficient, cells proceed through the cell cycle. However, if nutrients are limited, cells 
enter a quiescent state (haploid cells) or form spores (diploid cells) and persevere until 
conditions improve. In addition, haploid cells exposed to mating pheromone arrest in 
Gi, differentiate and finally mate (Lew et al., 1997; Pringle and Hartwell, 1981). Cells, 
which have proceeded past a decision point or period called ‘Start’ do not have any 
alternative but continue through the cell cycle (Pringle and Hartwell, 1981). At the 
Gi/S transition several processes are initiated nearly simultaneously (Figure 2). The 
duplication of the spindle pole body (SPB), the yeast microtubule organising centre 
(MTOC) starts. The process of bud formation begins at the designated bud site. 
Furthermore, DNA replication is initiated, although this process might be slightly 
delayed in comparison to the other two. G2 - and M-phase are not clearly divided in the 
budding yeast cell cycle (Lew et a l, 1997). The nuclear envelope does not breakdown 
as observed in higher eukaryotes. Condensation of chromosomes occurs but single 
chromosomes cannot be observed by light microscopy (Gordon, 1977).
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Figure 1: The S. cerevisiae cell cycle. The budding yeast cell cycle is divided in four 
phases termed Gi (Gap 1), S (Synthesis), G2 (Gap 2) and M (Mitosis; Alberts et al., 1994). 
During a period in Gi defined as ‘Start’ cells commit to the cell cycle (Pringle and Hartwell, 
1981). In early Gi, prior to ‘Start’, cells enter into a quiescent state or start sporulation if 
nutrients are limited. If haploid cells arc exposed to mating phcromone in early Gi they 
initiate the mating program. The transition from G2 to M is not well defined in budding 
yeast. Cytokinesis takes place after mitosis. The duration of the budding yeast cell cycle 
is approximately 2 h.
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It is assumed that DNA replication is completed before the assembly of the short 
bipolar spindle (Byers and Goetsch, 1975; Kilmartin and Adams, 1984). In mitosis the 
spindle is positioned in the mother bud axis. The chromosomes are being separated in 
anaphase and in late anaphase each cell contains one SPB and a set of chromosomes. 
The cell cycle is completed by cell division (cytokinesis) and a new cycle can start.
1.2 Cell cycle regulation and cell cycle checkpoints in 
S. cerevisiae
The various processes involved in cell duplication are initiated at certain time points 
throughout the cell cycle in an exact order. Proper co-ordination of processes is 
monitored so that for example, chromosome segregation can not occur before 
completion of chromosome replication. While the cell cycle timing is provided by 
cyclins and cyclin dependent kinases (CDKs), the cell cycle progression is monitored 
by various checkpoints.
CDKs are inactive as monomers and require complex formation with regulatory 
proteins called cyclins for their activation (Morgan, 1995). CDK/cyclin complexes can 
regulate processes by phosphorylation including regulation of the CDK/cyclin 
complexes themselves by auto-regulatory feed back loops. The main CDK in
S. cerevisiae is Cdc28p (Nasmyth, 1993; Reed, 1992). Cdc28p levels are constant 
throughout the cell cycle (Wittenberg and Reed, 1988) but levels of almost all cyclins 
fluctuate, thereby regulating Cdc28p activity. Cyclin fluctuation is achieved by 
transcriptional regulation (Epstein and Cross, 1992; Schwob and Nasmyth, 1993; 
Wittenberg et al., 1990) and degradation (Seufert et al., 1995; Willems et al., 1996). In 
addition, kinase activity is regulated by activation/inactivation of CDK inhibitors. The 
degradation of cyclins and CDK inhibitors is initiated by ubiquitination by the 
anaphase promoting complex (APC) (Page and Hieter, 1999) or by the Skplp-cullin-F- 
box (SCF) (Feldman et al., 1997; Skowyra et al., 1997). The ubiquitin label is 
recognised by the proteasome which is responsible for the degradation of poly- 
ubiquitinated proteins (Voges etal., 1999; Zwickl etal., 1999).
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Most conditional lethal cdc28 alleles cause an arrest of the cell cycle at ‘Start’ in Gi 
(Reed, 1980) before DNA replication or bud initiation. Other mutants block nuclear 
division and cytokinesis (Piggott et al., 1982) or show a mixed arrest in Gi and G2 
(Zarzov et al., 1997). According to their function throughout the cell cycle, cyclins can 
be divided in Gi (Clnlp, Cln2p, Cln3p), S-phase (Clb5p, Clb6p) and mitotic cyclins 
(Clblp, Clb2p, Clb3p, Clb4p). Gi cyclin/Cdc28p complexes trigger DNA replication 
and bud formation in Gi (Figure 2A) (Dirick et al., 1995; Stuart and Wittenberg,
1995). Gi cyclin/Cdc28p complexes are also necessary for SPB duplication to continue 
but early stages of duplication like the formation of the satellite are independent of 
Cdc28p activity since some mutants in CDC28 arrest in the cell cycle with a single 
SPB already containing a satellite. The signal to initiate SPB duplication is therefore 
active before the Cdc28p/Start point. The S-phase cyclin/Cdc28p complexes are 
probably also involved in initiating DNA replication and in addition, in sustaining 
DNA replication in S-phase (Figure 2A) (Schwob and Nasmyth, 1993). The mitotic or 
B-type cyclins (Clblp-Clb4p) form complexes with Cdc28p to promote various 
processes (Figure 2A). Clb3p and Clb4p cyclins are responsible for promoting SPB 
separation (Fitch et al., 1992; Richardson et al., 1992). Clblp and Clb2p are essential 
for anaphase onset (Richardson et al., 1992; Surana et al., 1991). In complex with 
Cdc28p they trigger the reorganisation of the actin cytoskeleton leading to the isotropic 
switch in bud growth (see 1.3.2) (Lew and Reed, 1993). If cells lack Clblp and Clb2p 
the isotropic switch does not occur and cells form elongated tubular buds. Destruction 
of the mitotic cyclins is necessary for events that lead to exit from mitosis (King et al.,
1996).
Completion of events triggered by cyclin/Cdc28p complexes is monitored by so called 
checkpoints. Checkpoints are signalling pathways that act to delay cell cycle 
progression when perturbations prevent the completion of certain cell cycle events 
(Hartwell and Weinert, 1989). So far, checkpoint pathways have been found to control 
DNA replication, DNA damage, spindle assembly/positioning and cell morphogenesis. 
The spindle checkpoint is the most relevant to this study and it will be discussed in 
more detail.
Figure 2: Key events in the S. cerevisiae cell cycle. (A) Cell cycle regulation by cyclins 
and the cyclin dependent kinase Cdc28p. Complex formation between cyclins and 
Cdc28p initiates steps of the cell cycle. Arrows indicate initiation. T-bar indicates 
inhibition. (B) The chromosomes in the cell cylce. In late Gi after ‘Start’ chromosomes 
are being replicated. Sister chromatids are separated during mitosis. (C) The SPB and 
the microtubule cytoskeleton in the cell cycle. In early G,, cells contain one SPB 
(square) nucleating nuclear and cytoplasmic microtubules (lines). The satellite (circle) 
forms at the end of the half-bridge in G, (Byers and Goetsch, 1975; Vallen et al., 1992; 
Donaldson and Kilmartin, 1996). At this time point cytoplasmic microtubules attach to 
the half-bridge (Pereira et al., 1999). When a small bud has formed, SPBs are 
duplicated and the nuclear microtubules of both SPBs interdigitate at sharp angles 
(O’Toole et al., 1999). SPB separation is initiated by Clb3/4p-Cdc28p. A short spindle 
is formed in G2. Spindle positioning is mediated by the cytoplasmic microtubules 
respectively (Jacobs et al., 1988). Elongation of spindle microtubules indicates mitosis. 
SPBs are pushed (Hoyt et al., 1992; Roof et al., 1992) and pulled (Eshel et al., 1993; Li 
et al., 1993) apart by motor proteins acting on microtubules. (D) The actin cytoskeleton 
in the cell cycle. The actin cytoskeleton transports the secretory vesicles to sites of 
growth (arrows). Changes in the localisation of actin cables (lines) and cortical actin 
patches (circles) during bud formation and cytokinesis are indicated. The isotropic 
switch in bud growth occurs at S/G2. (E) The cell cycle time scale. See Figure 1 for 
more detailed description.
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Figure 2\ Sec facing page for figure legend.
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The spindle checkpoint was first defined in budding yeast. Seven genes were identified 
whose deletion resulted in failure of cells to arrest in the cell cycle after microtubule 
depolymerisation (Hoyt et al., 1991; Li and Murray, 1991; Weiss and Winey, 1996). 
The majority of these genes (MAD1, MAD2, MAD3, BUB1, BUB3 and MPS1) codes 
for proteins which function in the spindle assembly checkpoint that senses failure of 
kinetochore microtubule attachment (Pangilinan and Spencer, 1996; Weiss and Winey,
1996). The other gene identified, BUB2, encodes a protein involved in the spindle 
checkpoint that monitors spindle positioning (Bloecher et al., 2000; Pereira et al., 
2000; Wang et al., 2000).
The spindle assembly checkpoint (Figure 3A) is activated by kinetochores which are 
not attached to spindle microtubules. Two theories exist for the generation of a signal 
activating the checkpoint (Li and Nicklas, 1995; Li and Nicklas, 1997). Firstly, 
unattached kinetochores per se could trigger the checkpoint. Secondly, the absence of 
tension at unattached kinetochores could be transformed into a chemical signal 
resulting in checkpoint activation. This yet unknown signal triggers a signalling 
cascade involving Mpslp, Bublp, Bub3p and the Mad proteins. The complex 
signalling cascade is only partially understood. It is known that Mpslp phosphorylates 
Madlp in a BUB1, BUB3 and MAD2 dependent manner (Farr and Hoyt, 1998). 
Furthermore, Bublp can also activate the checkpoint but it does not function through 
phosphorylation of Madlp. The target of the cascade is most likely the APC/CCdc20p 
complex. Cdc20p is the activator of the APC (Visintin et al., 1997), a mulitsubunit 
ubiquitin ligase, which ubiquitinates Pdslp (securin) and thereby targets it for 
destruction by the proteasome (Cohen-Fix et al., 1996). Before anaphase, Pdslp forms 
a complex with Epslp (separin) keeping Epslp in an inactive form (Ciosk et al., 1998). 
Degradation of Pdslp results in activation of Esplp which induces cleavage of Scclp 
(cohesin) (Uhlmann and Nasmyth, 1998), a protein required for cohesion between 
sister chromatids during S phase (Michaelis et al., 1997). As consequence, sister 
chromatid separation can occur. Binding of the Madlp, Mad2p, Mad3p proteins to 
Cdc20p was shown in vivo (Hwang et al., 1998). Furthermore, binding of Mad2p to 
Cdc20p-APC inhibits its ubiquitination activity (Fang et al., 1998). The current model 
is that after checkpoint activation Madlp, Mad2p, Mad3p form a complex with
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Cdc20p-APC, thereby inhibiting the ubiquitination activity of the APC and therefore 
degradation of Pdslp and sister chromatid separation.
The spindle positioning checkpoint (Figure 3B) monitors spindle alignment in the 
mother bud axis. Bub2p and Bfalp both localise to the cytoplasmic side of the SPB 
and form a two component GAP (GTPase-activating protein) (Pereira et al., 2000). 
Here Temlp interacts with these two proteins in early mitosis (Pereira et al., 2000). If 
one SPB enters the bud, Temlp comes in contact with its putative GEF (GDP/GTP 
exchange factor), Ltelp which is localised in the bud cortex (Bardin et al., 2000; 
Pereira et al., 2000). Temlp is converted into its GTP-bound form which activates the 
mitotic exit network (MEN). The components of the MEN (Cdc5p, Cdcl5p, Dbf2p, 
Dbf20p, Moblp) trigger the destruction of B-type cyclins via the release of Cdcl4p 
from the nucleolus (Shou et al., 1999; Visintin et al., 1999). Cdcl4p promotes exit 
from mitosis in two ways. Firstly, it dephosphorylates Hctlp/Cdhlp which activates 
the APC, the ubiquitin-ligase responsible for destruction of Clb2p (Jaspersen et al., 
1999). Secondly, Cdcl4p promotes the accumulation of the cyclin dependent kinase 
inhibitor Siclp by activation of the transcription factor Swi5p and by preventing Siclp 
degradation through Siclp dephosphorylation (Visintin et al., 1998). Thus, proper 
spindle alignment allows exit from mitosis due to destruction of Clb2p. If the SPB 
does not enter the bud as a result of failure in spindle alignment, the signalling cascade 
is not activated and exit from mitosis does not take place.
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Figure 3: The spindle checkpoints. (A) The spindle assembly checkpoint. Unattached chromosomes 
activate the spindle checkpoint and delay the onset o f  anaphase. The checkpoint prevents the 
activation of the APC and therefore, the ubiquitination o f  Pdslp. As consequence, Epslp remains 
inactive and sister chromatids are not separated. (B) The spindle positioning checkpoint and 
signalling leading to exit from mitosis. When the mitotic spindle is properly positioned, one SPB 
(green) can enter the bud and Tem lp can get in contact with its putative GEF (Ltel p) resulting 
in the active GTP-bound form o f  Tern l p. Tern l p-GTP initiates the indicated signalling cascade 
for exit from mitosis. Abnormal spindle positioning prevents contact o f  Tern l p with Ltel p and 
Tern l p remains inactive.
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1.3 Functions of the cytoskeleton throughout the cell cycle
The cytoskeleton is a dynamic network of fibres, which fulfils functions throughout the 
cell cycle. It can be divided into microfilaments, microtubules and intermediate 
filaments. The morphology and function of microfilaments and microtubules will be 
discussed here for the budding yeast S. cerevisiae only, thus excluding functions of the 
cytoskeleton observed in higher eukaryotes like cell motility and intercellular contacts. 
Functions of the cytoskeleton in meiosis are omitted and the specialised microtubules 
of the centrosome of higher eukaryotes are mentioned in paragraph 1.4.1.
1.3.1 The microtubule cytoskeleton in the cell cycle
Microtubules are hollow cylinders of 25 nm in diameter which are made out of 
protofilaments consisting of hetero-dimers of a- and |3-tubulin. The organisation of 
protofilaments and their arrangement in a cylinder result in the polarised structure of 
microtubules. The microtubule minus-end is formed by a-tubulin and the plus-end by 
P-tubulin. It has been shown for higher eukaryotes that micro tubules nucleate at the 
MTOC with the minus-end and attach to chromosomes with the plus-end (Kellogg et 
al., 1994). In budding yeast, nuclear microtubules nucleate at the inner plaque and 
cytoplasmic microtubules at the outer plaque (see 1.4.2 and 1.4.4) and at the half­
bridge of the SPB (see 1.4.2.2.5) (Byers, 1981a; Pereira et al., 1999; Snyder, 1994; 
Winey and Byers, 1993) which is a one-sided extension of the SPB (see 1.4.2). In 
budding yeast, the nuclear microtubules stay attached to the 16 chromosomes (haploid 
cell) throughout the cell cycle (O'Toole et al., 1999).
In early Gi of the cell cycle, cells contain one SPB and attached nuclear and 
cytoplasmic microtubules show an aster like distribution (Figure 2C). Cytoplasmic 
microtubules can also be seen attached to the bridge structure in Gi and when bud 
formation has started, they are orientated into the bud (Figure 2C). After SPB 
duplication, both SPBs are still connected with each other via the bridge structure. At 
this stage, nuclear microtubules from both SPBs interdigitate at sharp angles (O'Toole 
et al., 1999) (Figure 2C). After cleavage of the bridge, the SPBs move to opposite sites 
of the nuclear envelope and a bipolar spindle is formed (Figure 2C). The spindle
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consists of a core of long microtubules and various short microtubules (O'Toole et al.,
1999). The cytoplasmic microtubules are essential for the positioning of the spindle 
within the cell along the mother bud axis (Jacobs et al., 1988). Since the nuclear 
envelope does not break down in yeast during mitosis the entire nucleus moves during 
the positioning of the spindle (nuclear migration) mediated by microtubules. Proper 
spindle positioning ensures the separation of chromosomes into the daughter cell. 
During spindle and nuclear positioning in the mother bud neck, the spindle stays 
relatively short. Afterwards the spindle elongates and this event determines anaphase. 
The chromosomes are being separated in anaphase and spindle breakdown probably 
coincides with cytokinesis.
Microtubules function together with various motor proteins. In S. cerevisiae the 
kinesin-related gene products (Cin8p, Kipl-3p and Kar3p) and the dynein Dynlp 
assist with spindle function (Carminati and Stearns, 1997; Cottingham and Hoyt, 1997; 
DeZwaan et al., 1997; Li et al., 1993). For example, Cin8p and Kiplp promote sliding 
of nuclear microtubules to push SPBs apart while dynein functions on cytoplasmic 
micro tubules to create pulling forces. Taken together, micro tubules are responsible for 
the movement of chromosomes and nuclear migration.
1.3.2 The actin cytoskeleton in the cell cycle
Microfilaments are actin polymers (filamentous actin, F-actin) which interact with 
actin-binding proteins to form a functional actin cytoskeleton. In budding yeast 
polymerised actin has been visualised by fluorescence microscopy and immunoelectron 
microscopy as actin fibres and as cortical actin patches (Adams and Pringle, 1984; 
Kilmartin and Adams, 1984; Mulholland et al., 1994; Pringle et al., 1989). Cortical 
actin patches are bundles of actin fibres associated with invaginations of the plasma 
membrane (Mulholland et al., 1994). They are highly mobile but appear to be limited 
in their movement to the area in which they are found (Doyle and Botstein, 1996; 
Waddle et al., 1996). The rate-limiting step in the polymerisation of filamentous actin 
from globular actin (G-actin) is the actin trimer formation (Cooper et al., 1983; 
Tobacman and Korn, 1983). Polymerisation of monomeric actin into filaments is not 
energy dependent but ATP-bound actin can polymerise faster than ADP-bound actin
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(Engel et a l, 1977). The actin nucleator might be the Arp2/3-complex which is 
conserved in eukaryotes (Kelleher et al., 1995; Machesky et al., 1994; Welch et al., 
1997a, b). The Arp2/3p hetero-dimer interacts with actin (Kelleher et al., 1995) and the 
complex stimulates filament nucleation (Mullins et al., 1998).
In S. cerevisiae, the actin cytoskeleton is involved in various aspects of bud formation. 
Bud formation is localised growth that depends on polarised secretion. The actin 
cytoskeleton functions in bud site selection, polarised movement of secretion vesicles 
to the bud region and possibly in secretion itself (Dunn and Shortle, 1990; Novick and 
Botstein, 1985; Shortle et al., 1984). Furthermore, actin is involved in organelle 
movement and positioning (Drubin et al., 1993), nuclear migration, nuclear division 
and cytokinesis (Palmer et al., 1992). More recent work shows a role for actin in early 
spindle positioning in budding yeast (Beach et al., 2000; Theesfeld et al., 1999; Yin et 
al., 2000). In addition to these functions, actin is also involved in endocytosis 
(Benedetti et al., 1994; Holtzman et al., 1993; Kubler and Riezman, 1993). 
Transformation and response of the actin cytoskeletion can be triggered by intracellular 
signals (cyclin/Cdc28p complexes) or by extracellular signals, such as changes in 
osmolarity or nutrient availability. Another extracellular signal, mating pheromone, 
results in polarised organisation of the actin cytoskeleton for the formation of the 
mating projectile, the shmoo (Chowdhury et al., 1992; Kron and Gow, 1995; Read et 
a l, 1992).
The organisation of the actin cytoskeleton in budding yeast undergoes changes which 
are cell cycle dependent (Adams and Pringle, 1984; Kilmartin and Adams, 1984) 
(Figure 2D). In early Gi of the cell cycle cortical actin patches and cables are evenly 
distributed and ‘randomly’ orientated at the inner the cell surface (Mulholland et a l, 
1994). As shown in microscopy studies most actin fibres run along the inner surface of 
cells and do hardly extend into the cytoplasm (Botstein et a l, 1997). After Start of the 
cell cycle, a concentration of actin patches at the bud site can be observed with actin 
cables oriented towards the bud site (Kilmartin and Adams, 1984; Li et a l, 1995). In 
early bud phase (Gi/S transition), actin patches localise at the bud tip were bud growth 
predominantly takes place. When the bud reaches a certain size, actin patches distribute 
over the whole bud surface and isotropic bud growth occurs (Farkas et a l, 1974; Tkacz
INTRODUCTION 12
and Lampen, 1972). During cytokineses actin patches form a contractile ring in the bud 
neck from which cables emanate. Here, cell division will take place.
Myosins are motor proteins which interact with actin filaments to provide translocation 
of actin cables and movement along actin cables. Myosins are divided in different 
subclasses according to similarities in motor and tail domains. Budding yeast has five 
myosins. The S. cerevisiae conventional myosin Myolp (class II) is mainly involved in 
cell separation (Rodriguez and Paterson, 1990; Sweeney et al., 1991; Watts et al.,
1987). The four unconventional myosins of budding yeast all belong to the class I and 
V myosins. The class V myosins are actin based motor proteins which are involved in 
polarised growth throughout different organisms (Mercer et al., 1991; Prekeris and 
Terrian, 1997; Provance et al., 1996). The yeast class V Myo2p motor protein, is an 
essential protein required for polarised growth, transport of secretory vesicles 
(Govindan et al., 1995) and spindle orientation (Beach et al., 2000; Yin et al., 2000). 
In mutants, the normal actin localisation in the bud is disturbed and secretory vesicles 
accumulate in the mother cell (Johnston et al., 1991). Loss of Myo2p function finally 
results in ceasation of budding (Govindan et al., 1995; Reck-Peterson et al., 2000). 
Some mutant cells also show defects in spindle orientation (Beach et al., 2000; Yin et 
al., 2000). In these cells myo2p fails to provide the polarisation of Kar9p at the bud 
cortex. In wild type cells Kar9p moves via binding to Myo2p to the bud cortex and 
captures microtubules through interaction with the microtubule-binding protein Bimlp 
thereby orientating the spindle. Mutants in MY02  can be rescued by high gene dosage 
of SMY1 and SMY2 (Lillie and Brown, 1994). SMY1 is one of the six kinesin-related 
proteins in yeast and the only one that does not assist with spindle functions. Instead, 
Smylp is involved in polarised cell growth (Lillie and Brown, 1994; Lillie and Brown,
1998). Smylp and Myo2p co-localise and the two proteins interact in their putative 
cargo-carrying domains (Beningo et al., 2000). Deletion of SMY1 does not result in 
spindle orientation defects (Yin et al., 2000) and the relevance of this interaction of an 
actin motor with a putative microtubule motor is unknown. The other multi-copy 
suppresser, SMY2, is a novel non-essential gene. High gene dosage of SMY2 can also 
suppress mutations in other genes. These are for example, mutations in genes coding 
for proteins involved in vesicular transport (SEC22, BET1, SEC 16) and in transcription
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(SPT15) (Lillie and Brown, 1994). The fission yeast homologue of SMY2 is MPD2 
which was isolated in a high gene dosage suppresser screen of fission yeast cdc7 
mutants (Cullen et al., 2000). The budding yeast homologue of CDC7, CDC15, is part 
of the mitotic exit network (see 1.2) and localises to the budding yeast SPB (Xu et al.,
2000). Furthermore, Myo2p binds to calmodulin and the two proteins co-localise 
throughout the cell cycle (Brockerhoff et al., 1994) and are found in regions with high 
concentrations of cortical actin patches. However, they do not co-localise with the 
cortical actin patches (Brockerhoff et al., 1994).
The performance of the actin cytoskeleton is tightly regulated to ensure rearrangements 
during the cell cycle at the right time. The timing of bud emergence is triggered by the 
cyclin dependent kinase CDC28 (Lew and Reed, 1993, 1995) and requires complex 
formation with the CLN Gi cyclins (Figure 2A). The organisation of the actin 
cytoskeleton is mediated by the Rho-like GTPases in signalling pathways in response 
to these intracellular stimuli and also to extracellular growth signals (Tapon and Hall, 
1997; Van Aelst and D'Souza-Schorey, 1997).
1.4 Microtubule organising centres
Microtubule organising centres (MTOCs) are a group of morphologically different 
organelles that are analogous in function. As mentioned above, they serve as focus 
points for microtubules and provide functions in mitosis necessary for successful cell 
duplication (see 1.4.4). Historically, the different types of MTOCs were named 
according to their morphology. The MTOC of animal cells was discovered by the cell 
biologists Boveri and van Beneden in the 19th century (Boveri, 1900). They observed a 
structure in the centre of the cells they studied from which fibres emanated. This 
organelle was named the ‘centrosome’. The centrosome duplicated prior to mitosis and 
associated with the spindle poles. Theodor Boveri at first believed he found the 
‘material of inheritance’ but later realised that he discovered one of the key players in 
partitioning this material now known as chromosomes. The functional equivalent of 
the centrosome in yeast is called the spindle pole body (SPB) and was discovered as a 
‘fibre apparatus’ by Robinow and Marak in 1966. The SPB is structurally different 
from the centrosome. While the centrosome consists of a pair of centrioles and
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pericentriolar material (see 1.4.1), the SPB is a multi-layered disk-like structure (see 
1.4.2.1). The SPB does not contain a structure related to the centriole (see 1.4.1). 
However, it seems that microtubule organisation at both MTOCs is mediated by 
homologous proteins which are part of a complex called the gammasome or y-tubulin 
ring complex in animal cells and the y-tubulin complex in yeast (see 1.4.3 and 1.4.4). 
Although SPBs and centrosomes are very different in structure, more homologous 
proteins have been discovered and these are discussed in 1.4.3. The centrosome and the 
SPB of budding yeast are so far the best-characterised MTOCs. The third type of 
MTOC is the basal body which is structurally very similar to the centriole. Basal 
bodies are found at the plasma membrane and they nucleate the assembly of flagella 
and cilia. In most land plants, microtubule nucleation proteins are not associated with a 
defined structure such as the centrosome (Vaughn and Harper, 1998). Therefore, no 
conventional centralised MTOC can be defined.
Although lately, there has been some controversy about the role of the MTOCs (see
1.4.4) the main function remains the nucleation and organisation of microtubules (see
1.4.4). MTOCs are being studied in a variety of organisms. This study specialises on 
the SPB of the yeast Saccharomyces cerevisiae, but for comparison, the animal 
centrosome is discussed in more detail. In addition, significant homologies to or 
differences in MTOCs of organisms are described.
1.4.1 The centrosome
The animal centrosome is about 1 pm3 in size and is made up by around 100 proteins. 
Some of those proteins require microtubules to be localised at the centrosome others 
localise independently. Some proteins stay at the centrosome throughout the cell cycle 
and others appear at a particular time and then dissociate or are degraded. The 
centrosome can be divided into two structurally different parts, a pair of centrioles and 
the centrioles surrounding pericentriolar material (Figure 4A). Presumably, the pair of 
centrioles serves as scaffold on which the pericentriolar material assembles.
Each centriole consists of a cylindrical array of nine triplets of microtubules which are 
connected with each other. These specialised microtubules are very stable which might
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be due to post-translational modification such as poly-glutamylation (Bobinnec et al.,
1998). It has been shown in the algae Chlamydomonas that delta-tubulin is required for 
the triplet structure because without delta-tubulin cells are only able to produce 
microtubule doublets (Dutcher and Trabuco, 1998). The two centrioles differ in 
appearance with the older centriole displaying spoke like appendages at the end distal 
to its partner (Lange and Gull, 1996; Paintrand et al., 1992). Both centrioles are linked 
together at the proximal end by specialised fibres. These fibres allow mobility, since 
one centriole moves around in a certain radius in a cell cycle dependent manner while 
its partner seems to be mainly stationary (Piel et al., 2000). An additional protein of 
centrioles is centrin, a homologue of the budding yeast Cdc31p and it is found in the 
lumen of centrioles (Paoletti et al., 1996).
The basic element of the pericentriolar material is a network of 12-15 nm filaments 
which other components associate with. Localisation of proteins can be cell cycle 
dependent and therefore, the pericentriolar material changes during the cell cycle 
reaching a peak at metaphase to anaphase transition with the low point at telophase in 
most cells. Microtubule nucleation functions are carried out by components of the 
pericentriolar material while centrioles do not seem to be directly involved in this 
process (Moudjou et al., 1996; Tassin et al., 1998). However, this traditional model is 
being debated lately. The main protein-complex necessary for the nucleation process is 
the y-tubulin ring complex (see 1.4.4) which contains y-tubulin and a variety of 
associated proteins. Another protein, which localises to the pericentriolar material is 
pericentrin, a large 220 kd protein (Doxsey et al., 1994). Pericentrin forms a complex 
with y-tubulin which assembles into a organised lattice (Dictenberg et al., 1998). 
Recently, a pool of Hsp83, a member of the highly conserved Hsp90 family, was found 
to localise to Drosophila centrosomes throughout the cell cycle (Lange et al., 2000). 
Hsp90 function was shown to be necessary for centrosome separation and maturation 
as well as spindle formation and chromosome segregation (Lange et al., 2000).
Figure 4\ Microtubule organising centres. (A) Cartoon of the centrosome. The 
centrosome consists of two centrioles (violet and green) which are linked by fibres (red) 
and of the pericentriolar material (grey). The mature ‘mother’ centriole (blue) has 
spoke-like appendages (pink) near its distal end. Microtubules (blue) are nucleated by 
the pericentriolar material. ‘Reprinted from Current biology, Vol. 9, Urbani and 
Steams, The centrosome, page No. R315, copyright (1999), with permission from 
Elsevier Sciences.’ (B) Electron micrograph of isolated S. cerevisiae SPBs connected 
via a mitotic spindle. The outer (OP), central (CP) and inner (IP) plaque are indicated. 
(C) 2.3 nm tomographic slice of a budding yeast cell. The SPB (Cl) is a multi-layered 
structure which is embedded in the nuclear envelope (NE). Microtubules (MT) can be 
seen attached to the inner plaque (IP). A hook-like structure (H) is visible at the side of 
the central plaque The half-bridge (HB) forms a one-sided extension of the SPB. The 
half-bridge (C2) is a specialisation of the nuclear envelope and consists of five distinct 
layers (see arrowheads). ‘Reprinted from Molecular Biology of the Cell, (1999, volume 
10, 2017-2031), with permission by the American Society for Cell Biology.’ CP: 
central plaque, H: hook, HB: half-bridge, IL: intermediate layer, IP: inner plaque, MT: 
microtubules, NE: nuclear envelope, OP: outer plaque.
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Figure 4. See facing page for figure legend.
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1.4.2 The spindle pole body (SPB)
1.4.2.1 Morphology of the SPB
The SPB of S. cerevisiae is organised in distinct layers (Byers and Goetsch, 1974) 
which are connected to each other. The vertical extension, through the layers, remains 
constant but the horizontal size of the SPB can differ. In haploid cells the SPB is about 
half the size (horizontally) compared to the SPB of diploid cells. This change in size 
might be explained by the necessity of the diploid SPB to nucleate twice as many 
microtubules to connect the doubled number of chromosomes. The nomenclature of 
the different layers was introduced by Bullitt et al. (1997) who proposed that the SPB 
consists of five distinct layers (Figures 4B and 5). Recent studies using high-voltage 
electron tomography by O’Toole et al. (1999) support this model. The layers are 
defined as follows. The first distinct layer on the cytoplasmic site is termed outer 
plaque (OP) and is the site of cytoplasmic microtubule attachment. The following 
structures are the first intermediate layer (IL1) and the electron dense second 
intermediate layer (IL2). The central very electron dense layer which is at level with 
the nuclear envelope is called the central plaque (CP). The central plaque might be 
connected to the nuclear envelope with a hook-like structure, discovered by O’Toole et 
al. (1999). So far no components of the hook-like extension of the central plaque have 
been identified. On the nuclear side of the SPB the inner plaque (IP) is formed by the 
capped microtubule ends and here, the nuclear microtubules are anchored to the SPB. 
Horizontal sections through the layers show that IL2 contains a crystalline hexagonal 
lattice which is most likely a densely packed crystal of Spc42p (Bullitt et al., 1997). 
Molecules in the central plaque section seem less spaced than in IL2. The other layers 
do not show ordered packing by high-voltage electron tomography (O'Toole et al.,
1999).
The SPB has a one-sided extension which is distinct from the nuclear envelope. This 
structure is called the half-bridge or if it connects the duplicated SPBs, the bridge. 
O’Toole et al. (1999) propose that the half-bridge consists of at least five distinct 
layers (Figure 4C) of which layer 2 is continuous with layer 5 and layer 3 is 
continuous with layer 4. Layer 1 lies at the cytoplasmic face of the bridge and does not
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appear to be continuous with any of the other layers (Figure 4C). Layer 1 connects the 
bridge structure to the SPB via its interaction with a region between the central plaque 
and IL2 at the edge of the SPB. Cytoplasmic microtubules can be seen attached to the 
half-bridge in special stages of the cell cycle (see 1.4.2.2.5). At the end of the bridge, 
distal to the SPB a small structure forms in Gi/S which is called the satellite, the 
precursor of the new SPB (see 1.4.2.2.6).
1.4.2.2 Components of the SPB
1.4.2.2.1 Proteins forming inner and central regions of the SPB
Rout and Kilmartin (1990) identified three SPB components by raising a bank of 
monoclonal antibodies against an enriched SPB fraction. One of the proteins was 
110 kD in size and it could be localised to the inner plaque of the SPB by 
immunolabelling EM using the original antibody from the screen (Rout and Kilmartin, 
1990). The gene coding for the 110 kD protein, now named SPC110 (spindle pole body 
component of 110 kD) is essential, but deletion of only the predicted coiled-coil 
domain of the protein is viable. Interestingly, deletion of the coiled-coil region results 
in a change in size of the inner plaque. The coiled-coil domain is non-essential but it is 
proposed that it provides flexibility of the inner plaque necessary for microtubule 
attachment (Kilmartin et al., 1993) (Figure 5).
SpcllOp was re-discovered later in two screens designed to identify calmodulin 
interacting proteins. Calmodulin is a ubiquitous eukaryotic Ca2+-binding protein which 
is involved in cell signalling. One of these screens was aimed to search for proteins 
which compensate mutants in calmodulin (Geier et al., 1996). The other screened an 
expression bank for calmodulin-binding proteins (Mirzayan et al., 1992). SpcllOp 
indeed contains a calmodulin binding site in its C-terminus (Stirling et al., 1994) and 
mutations in the binding site, prevent calmodulin binding in vitro and SpcllOp 
function in vivo (Geier et al., 1996; Kilmartin et al., 1993; Kilmartin and Goh, 1996; 
Stirling et al., 1994,1996).
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Figure  5: Molecular model o f  the S. cerevisiae  SPB. The SPB is a mulit-layered 
structure consisting o f  outer plaque, intermediate layer I (IL1), intermediate layer 2 
(IL2), central plaque and inner plaque. The SPB is embedded in the nuclear envelope 
throughout the cell cycle via the central plaque. Microtubules attach to the outer and 
inner plaque and in G, to the half-bridge. The half-bridge is a one-sided extension o f  the 
SPB and is a specialisation of the nuclear envelope. The precursor o f  the new SPB 
occurs in late G, at the distal end of the half-bridge (Byers and Goetsch, 1974; Byers et 
al., 1978; Byers, 1981a, 1981b). The y-tubulin complex consisting of Tub4p, Spc97p and 
Spc98p functions in the nucleation of microtubules (Sobel and Snyder, 1995; Geissler et 
a l ., 1996; Marschall et a l ., 1996; Knop and Schiebel, 1997; Knop et a t ., 1997) and is 
localised at the outer and inner plaque (Rout and Kilmartin, 1990; Spang et al., 1996a; 
Knop et al., 1997). The y-tubulin complex is connected to the central plaque via 
Spcl I Op and Spc72p (Kilmartin and Goh, 1996; Knop and Schiebel, 1997; Knop et al., 
1997; Chen et al., 1998). The amino-terminus o f  Spc72p interacts with Spc97p and 
Spc98p (Knop and Schiebel, 1998). The carboxy-terminus o f  S pc llO p  including the 
calmodulin binding site is located near the central plaque (Geiser et al., 1993; Stirling et 
al., 1994; Spang et al., 1996a) while the amino-terminus interacts with the y-tubulin 
complex in the nucleoplasm (Spang et al., 1996a; Knop and Schiebel, 1997). 
Spc94p/N udlp  and Cnm 67p form the intermidiate layer I (Adams and Kilmartin, 1999; 
Elliott et al., 1999). Spc42p is the main portein of the intermediate layer 2 (Bullitt et al.,
1997) and Spc29p binds to Spc42p and to the C-terminus o f  S pc llO p  (Adams and 
Kilmartin, 1999; Elliott et al., 1999). Kar l p  and Cdc31p are components of the half­
bridge (Rose and Fink, 1987; Span g e t  al., 1993, 1995).
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The SPC110 mutants fail to form a functional mitotic spindle (Kilmartin and Goh,
1996). Mutants in calmodulin are also unable to organise spindle microtubules and the 
majority of mutant cells arrests at the restrictive temperature containing only one SPB 
(Sun et al., 1992). Calmodulin is localised at the central region of the SPB as shown by 
electron microscopy (Spang et al., 1996a; Sundberg et al., 1996) (Figure 5). This 
localisation is consistent with the interaction of calmodulin with the C-terminus of 
SpcllOp which is localised in the central plaque region while the N-terminal domain 
of SpcllOp extends into the inner plaque (Kilmartin and Goh, 1996; Spang et al., 
1996a; Sundberg et al., 1996).
Two-hybrid experiments showed that the C-terminus of SpcllOp additionally interacts 
with Spc42p, a component of the intermediate layer 2, while the N-terminus of 
SpcllOp does not (Adams and Kilmartin, 1999). These findings were confirmed by the 
affinity precipitation of a complex containing mainly ProA-SpcllOp, Spc42p, 
calmodulin and Spc29p (Elliott et al., 1999; Knop and Schiebel, 1997). Analysing this 
complex, Elliott et al. (1999) showed that Spc29p interacts with the N-terminus of 
Spc42p and with the C-terminus of SpcllOp in the yeast two-hybrid system. 
Furthermore, mutants in SPC29 are lethal when combined with cmdl-1, spcllO-2 or 
spc42-9 demonstrating that the proteins are functionally related. Thus, the C-terminal 
domain of SpcllOp interacts with calmodulin and Spc29p. Presumably those proteins 
mediate the interaction of SpcllOp with the N-terminus of Spc42p in the central region 
of the SPB (Figure 5). Inner and central regions of the SPB are therefore ‘polar’ in their 
organisation and the lateral extension is determined by interacting proteins.
Spc42p is like SpcllOp predicted to be a coiled-coil protein. The putative coiled-coil 
domain of Spc42p is located in the central region of the protein and is essential for 
protein function (Donaldson and Kilmartin, 1996). Electron micrographs of cells 
overexpressing the protein show a large polymeric disc structure which extends from 
the side of the central region of the SPB along the cytoplasmic face of the nuclear 
envelope (Bullitt et al., 1997; Donaldson and Kilmartin, 1996). This layer is composed 
entirely of phosphorylated Spc42p (Bullitt et al., 1997). The lateral extension proposes 
that it is a bilayer (Bullitt et al., 1997; Donaldson and Kilmartin, 1996) but it is 
assumed that this is an effect of overexpression and only a single layer of Spc42p
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forms the intermediate layer 2 (Bullitt et al., 1997). Electron microscopy of frozen 
preparations of the Spc42p structure revealed that it contains a crystalline array with 
hexagonal symmetry proposing a highly organised pattern for Spc42p (Bullitt et al.,
1997). Bullitt et al. (1997) concluded from their findings that Spc42p has the ability of 
self-assembly. Furthermore, that the Spc42p layer is the base structure of the SPB on 
which other layers of the SPB are added on in the fashion of crystal like self-assembly. 
However, this model does not offer an explanation for the size control of the SPB. If 
the size of the Spc42p lattice determines the size of the SPB how is the lattice itself 
controlled?
All interactions described above for SpcllOp involve the C-terminus of the protein. A 
synthetical lethal screen to identify mutations that enhance the phenotype of 
temperature sensitive spcl 10 mutants identified mutations in the SPC97 and SPC98 
genes. Mutations in SPC97 affect both N-and C-terminal spcl 10 alleles, while 
mutations in SPC98 are only synthetical lethal with mutations in the N-terminal 
SPC110. SpcllOp interacts weakly with Spc97p and strongly with Spc98p in the two- 
hybrid system (Nguyen et al., 1998). Spc97p and Spc98p and are part of the y-tubulin 
complex (Geissler et al., 1996; Knop and Schiebel, 1997) which is proposed to play a 
role in microtubule nucleation (see 1.4.4). A direct interaction of SpcllOp with the 
yeast y-tubulin Tub4p has not been shown. Therefore, SpcllOp via its interactions with 
Spc97p and Spc98p tethers y-tubulin to the inner plaque. A functional inner plaque 
provides the basis for nuclear microtubule attachment and proper spindle formation.
1.4.2.2.2 Components of the outer plaque
Elliot et al. (1999) observed a small fraction of Cnm67p in an affinity precipitate of 
SpcllOp-ProA. Two-hybrid analysis showed two interactions for Cnm67p. The C- 
terminus of Cnm67p binds to the C-terminus of Spc42p (Adams and Kilmartin, 1999; 
Elliott et al., 1999) and the N-terminus of Cnm67p interacts with Spc94/Nudlp in the 
two-hybrid system (Elliott et al., 1999). Cnm67p was first identified to be a component 
of the SPB by Brachat et al. (1998) who determined the localisation of the GFP-tagged 
protein at the outer plaque (Figure 5). Further analysis of the gene revealed that 
mutants are defective in spindle orientation and nuclear migration resulting in the
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formation of multi-nucleate and anucleate cells (Brachat et al., 1998). Spc94p/Nudlp 
is a component of the outer plaque (Wigge et al., 1998) (Figure 5) and it is essential. 
Mutants in SPC94/NUD1 are unable to exit from mitosis and cells arrest with a large 
bud (Adams and Kilmartin, 1999).
Another component of the outer plaque is Spc72p (Figure 5). In contrast to CNM67, 
SPC72 is essential in some but not all strain backgrounds (Knop and Schiebel, 1998; 
Soues and Adams, 1998). Deletion of SPC72 in a W303 strain in which the gene is 
non-essential results in abnormal spindle positioning and aberrant nuclear migration. 
This phenotype was the result of a lack of cytoplasmic microtubules nucleated by the 
outer plaque. The spc72 mutant cells do not arrest in the cell cycle, they break through 
the chromosome segregation block and undergo cytokinesis. This results in aploid and 
polyploid cells containing multiple SPBs (Soues and Adams, 1998).
The microtubule nucleation defect of the outer plaque in these mutants can be 
explained by the following interactions of Spc72p with other SPB components. Firstly, 
Spc72p interacts with Spc97p and Spc98p in the yeast two-hybrid system. Both 
proteins as mentioned above, are part of the yeast y-tubulin complex, a protein 
complex involved in the nucleation of microtubules at the MTOCs throughout different 
species (see 1.4.3 and 1.4.4). Spc72p also shows a positive result in the two-hybrid 
system with the yeast y-tubulin as bait, if Spc97p and Spc98p are co-overexpressed. All 
four proteins can be immunoprecipitated using anti-HA antibodies against the HA- 
epitope tag of Spc72p (Knop and Schiebel, 1998). This shows that Spc72p interacts 
with the y-tubulin complex at the outer plaque and it is therefore analogous in function 
to SpcllOp at the inner plaque (see 1.2.2.1).
Furthermore, Spc72p interacts with Stu2p. These two proteins associate in the yeast 
two-hybrid system and can be co-immunoprecipitated (Chen et al., 1998). Stu2p is a 
component of the SPB but it also localises to microtubules. It is able to bind 
microtubules in vitro and might therefore be involved in attachment, organisation and 
dynamics of microtubule ends at the SPB (Wang and Huffaker, 1997).
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1.4.2.2.3 Components which associate with SPBs and centromeres
Wigge et al. (1998) identified a protein named Ndc80p/Tid3p by MALDI-MS analysis 
of enriched SPBs fractions. This protein was identical to the 80 kD component 
discovered by Rout and Kilmartin (1990) in an early experiment using a monoclonal 
antibody approach. Ndc80p is localised close to SPBs as seen by immunoelectron 
microscopy (Rout and Kilmartin, 1990) and its localisation at the SPB does not change 
throughout the cell cycle (Wigge et al., 1998). In addition, Ndc80p was detected at 
early short spindles by fluorescence microscopy (Wigge et al., 1998). In anaphase 
cells, speckles of Ndc80p appear which might be at the positions of centromere DNA 
(Zheng et al., 1999). It is also in anaphase that mutants in NDC80 display defects. The 
SPB in these mutants is duplicated properly and the two SPBs are connected via a 
mitotic spindle but the chromatin can be seen mainly associated with only one SPB 
which remains in the mother cell. Therefore anaphase cells have large buds which 
contain one SPB but no or little DNA (Wigge et al., 1998). Ndc80p was shown to be 
related to the human HEC protein with 26 % identity at the N-terminus and 36 % 
identity at the C-terminus (Wigge et al., 1998). The human HEC protein localises to 
the kinetochore (Chen et al., 1997a) a specialised region of the chromosome involved 
in microtubule attachment. Furthermore, the protein is probably involved in the 
regulation of proteasome-mediated degradation of mitotic cyclins (Chen et al., 1997b). 
Due to the homology of Ndc80p with the centromere protein HEC and its mutant 
phenotype, Ndc80p might also have functions at the yeast kinetochore. This 
assumption is also supported by the speckled localisation of Ndc80p in anaphase which 
might represent kinetochore staining. Kinetochores are known to cluster in vicinity of 
the SPB probably through microtubule-kinetochore interactions (Goh and Kilmartin, 
1993; Goshima and Yanagida, 2000; Hyland et al., 1999). Taken together, Ndc80p 
could qualify as a shared component of SPBs and centromeres (Wigge et al., 1998; 
Zheng et al., 1999).
As another genetic interaction, ndc80 is conditional lethal with ctfl9  (Hyland et al.,
1999). Ctfl9p is possibly another shared component of SPBs and centromeres because 
Ctfl9p localises to nuclear face of the SPB and it interacts with CEN DNA of the
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centromeres (Hyland et al., 1999). Ctfl9  mutants also display a severe chromosome 
missegregation phenotype (Hyland et al., 1999).
1.4.2.2.4 Components which are shared by SPBs and nuclear pores
There are various hints that connections between SPBs and nuclear pore complexes 
(NPCs) exist. Nuclear pores are multi-protein complexes in the nuclear envelope which 
mediate nucleocytoplasmic transport. The best example for a shared component is 
Ndclp, a transmembrane protein of the nuclear envelope which localises to both NPCs 
and SPBs. Co-localisation of Ndclp with the nuclear pore component Nup49p and the 
SPB component Spc42p showed the localisation of Ndclp at both organelles by 
immunofluorescence (Chial et al., 1998). In detail studies of Ndclp by 
immunoelectron microscopy revealed that Ndclp localises to regions of NPCs and 
SPBs which are in contact with the nuclear envelope (Chial et al., 1998). The NDC1 
gene was first discovered in a screen for cell cycle mutants (Moir et al., 1982). Ndcl-1 
mutant cells fail to separate the chromosomes in mitosis but this does not result in a 
block of the cell cycle (Thomas and Botstein, 1986). It was shown, that the 
chromosome segregation defect is due to the failure of ndcl mutant cells to properly 
duplicate their SPBs. SPB duplication occurs but the new SPB is not inserted in 
nuclear envelope and the parental SPB organises a monopolar spindle (Winey et al., 
1993). Although SPB duplication is impaired in ndcl mutants, NPCs are functionally 
normal in these cells (Chial et al., 1998). Yeast cells are very sensitive to altered gene 
dosage of NDC1 which results in aneuploid and polyploid cells (Chial et al., 1999). 
The NDC1 gene has a homologue in fission yeast (Schizosaccharomyces pombe) which 
is called Cutll+. In fission yeast, the SPB is not constantly anchored in the nuclear 
envelope like the budding yeast SPB but it must be embedded in the nuclear envelope 
to organise the spindle in mitosis. C utllp  localises to mitotic SPBs in fission yeast and 
it is required for the cell cycle-dependent SPB anchoring in the nuclear envelope and 
therefore, for the formation of the bipolar spindle. C utllp  was also shown to associate 
with NPCs (West et al., 1998). Analogue to the function of C utllp  it was proposed 
that Ndclp functions in the insertion of organelles into the nuclear envelope (Chial et 
al., 1998).
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Interestingly, the deletion of the gene coding for the non-essential nucleoporin, 
Poml52p, suppresses the SPB duplication defect of ndcl mutants (Chial et al., 1998). 
The mechanism by which this takes place is as yet unknown. Poml52p, a 
transmembrane protein, forms part of the peripheral membrane ring of the nuclear pore 
(Strambio-de-Castillia et al., 1995; Wozniak et al., 1994) and it was proposed that its 
localisation at the nuclear pore coincides with that of Ndclp (Rout et al., 2000). 
Poml52p, was also identified by MALDI analysis of isolated SPBs (Wigge et al., 
1998) but like two more nuclear pore components (Nic96p, Nup85p) identified in this 
experiment, Poml52p was classified as contaminant.
A SPB component recently discovered to be present at nuclear pores is the budding 
yeast centrin, Cdc31p (see 14.2.2.5). Centrin is a ubiquitous component of MTOCs 
(see 1.4.3). In budding yeast, Cdc31p is localised at the half-bridge and it is involved in 
SPB duplication (see 1.4.2.2.5). Rout et a l (2000) identified Cdc31p by MALDI 
analysis of highly enriched nuclear pore complexes but they were unable to localise 
Cdc31p at nuclear pores because Cdc31p-ProA fusion proteins were non-functional. 
Therefore, the assumption that Cdc31p is a true component of nuclear pores is based 
on co-enrichment of Cdc31p with Poml52p in nuclear envelope preparations and on 
co-fractionation of Cdc31p with the known nuclear pore components Nic96p and 
Nupl59p (Rout et al., 2000).
1.4.2.2.5 Proteins of the bridge structure
So far, only two permanent components of the bridge structure, Karlp and Cdc31p are 
known. Both proteins were localised to the half-bridge by electron microscopy (Spang 
et al., 1993, 1995). The genes coding for the two half-bridge components were firstly 
identified in genetic screens which determined the role of the proteins based upon the 
consequences of loss of their function. Mutants in KAR1 were isolated due to the loss 
of nuclear fusion (karyogamy) during mating (Conde and Fink, 1976) and Karlp 
indeed contains a domain that is essential for karyogamy. Another part of the protein is 
required for SPB localisation and association with the other half-bridge component 
Cdc31p (Biggins and Rose, 1994; Spang et al., 1995; Vallen et al., 1992a, b). CDC31 
was identified in a screen for cell division mutants (Pringle and Hartwell, 1981). Cells
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lacking Karlp or Cdc31p block cell cycle progression and arrest with an enlarged 
single SPB with an indistinct half-bridge and no satellite (Byers, 1981b). The function 
of Karlp and Cdc31p is therefore required for early steps in SPB duplication (see
1.4.5.2.2).
In addition to its function in SPB duplication, Cdc31p is involved in morphogenesis 
and cell integrity. This function is fulfilled via an interaction with Kiclp (Sullivan et 
al., 1998), an essential protein kinase that phosphorylates substrates in a Cdc31p- 
dependent manner. Most likely, this interaction does not take place at the half-bridge 
since Cdc31p can also be found in the cytoplasm (Biggins and Rose, 1994). KIC1 
mutants have no SPB duplication defect but mutations in the kinase domain of Kiclp 
result in abnormal bud morphology, unusual actin distribution and cell lysis (Sullivan 
et al., 1998). Certain cdc31 alleles also show defects other than in SPB duplication. 
These mutants have an elongated bud morphology and they display cell wall defects 
leading to cell lysis (Sullivan et al., 1998).
Other components of the half-bridge are the outer plaque component Spc72p and the y- 
tubulin complex. However, their localisation at the half-bridge is temporary and cell 
cycle dependent. In Gi of the cell cycle cytoplasmic microtubules emanate from the 
half-bridge (Byers and Goetsch, 1975) in addition to outer plaque organised 
cytoplasmic microtubules. For the nucleation of microtubules at the half-bridge Spc72p 
and the y-tubulin complex associate with the half-bridge in Gi. The N-terminal domain 
of Spc72p interacts with the C-terminal domain of Karlp in vitro and vivo thereby, 
targeting the y-tubulin complex to the half-bridge (Pereira et al., 1999).
1.4.2.2.6 Components of the satellite
The satellite it a small globular structure which appears at the end of the half bridge in 
Gi of the cell cycle. The satellite reassembles the precursor of the new SPB. In initial 
steps of duplication it enlarges into a duplication plaque which is then inserted into the 
nuclear envelope. Adams and Kilmartin (1999) tested which known SPB components 
associate with the satellite and the duplication plaque by immunolabelling electron 
microscopy of cells expressing GFP- fusions of SPC42, NUD1, CNM67, SPC29 and
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SPC110. Spc42p, Nudlp, Cnm67p were found at both satellite and duplication plaque, 
while Spc29p could only be clearly detected at the satellite. SpcllOp instead, is not 
associated with any of both structures. Therefore, proteins (Spc42p, Nudlp, Cnm67p) 
which also localise to the cytoplasmic side of the SPB seem to dominate the early 
structures of SPB duplication. The SpcllOp protein which mainly composes the inner 
plaque of the SPB, might therefore localise to the ‘new’ SPB from the nuclear side at a 
later stage, possibly after insertion of the duplication plaque into the nuclear envelope 
(Adams and Kilmartin, 1999).
1.4.2.2.7 Further proteins associated with SPBs
In an experiment using MALDI analysis of enriched SPBs fractions Wigge et a l 
(1998) confirmed existing SPB components and identified several novel SPB 
associated proteins. Of those proteins identified, many have not yet been characterised 
in more detail but they will be mentioned here for completeness. One of the 
components isolated is Spc34p. It localises to the SPB and all along the mitotic spindle 
by immunofluorescence and immunolabelling electron microscopy (Wigge et al.,
1998). Spc34p interacts in the yeast two-hybrid system with Spcl9p (Uetz et al.,
2000), another component identified in the MALDI-MS experiment (Wigge et al.,
1998). Spcl9p displays the same localisation as Spc34p (Wigge et al., 1998). In 
addition to its interaction with Spc34p, Spcl9p interacts with the ribosomal protein 
Rpn5p and Ndc80p/Tid3p (a shared component of SPBs and kinetochores, see
1.4.2.2.3), in the yeast two-hybrid system (Uetz et al., 2000). Two more SPB 
components, Spc24p and Spc25p, firstly isolated by Wigge et al. (1998) show an 
interaction in the yeast two-hybrid system with each other (Winzeler et a l, 1999). 
Spc24p also interacts genetically with P rpllp , a pre-mRNA splicing factor, Ssk22p, a 
MAP kinase kinase, Ste50p a protein involved in spore wall formation and Firlp, a 
protein involved in mRNA processing (Cho et al., 1998). The relevance of these 
genetic interactions is not yet proven. Finally Spcl05p, a potential trans-membrane 
protein, also localises to the SPB region. It is mainly concentrated at one side of the 
SPB with the gold staining on the cytoplasmic as well as on the nuclear face of the 
nuclear envelope (Wigge et al., 1998).
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1.4.3 Homologous proteins of MTOCs
Various components of the budding yeast SPB have homologues in other organisms. 
Several examples have been mentioned throughout the text and will be summarised 
here.
Centrin/caltractin is a ubiquitous component of MTOCs and it was originally identified 
in basal body of Chlamydomonas reinhardtii (Huang et al., 1988; Salisbury et al.,
1988). The yeast centrin, Cdc31p (Baum et al., 1986a; Errabolu et al., 1994; Spang et 
al., 1993) is most closely related to the human HsCEN3 more than to the other two 
human centrins HsCENl and HsCEN2 (Middendorp et al., 1997; Salisbury, 1995). All 
human centrin isoforms are located in the distal lumen of centrioles (Middendorp et 
al., 1997) while Cdc31p localises to the half-bridge. Centrin 3, as Cdc31p, has a role in 
centrosome reproduction since injection of recombinant HsCen3p or of RNA encoding 
HsCen3p in one blastomere of two-cell stage Xenopus laevis embryos results in under­
cleavage and inhibition of centrosome duplications (Middendorp et al., 2000). 
HsCEN3 does not complement mutations or deletion of CDC31 in S. cerevisiae, but 
specifically blocks SPB duplication which indicates that the human protein acts as a 
dominant negative form of CDC31.
Another MTOC component conserved from yeast to humans is y-tubulin (see 1.4.4). 
The S. cerevisiae y-tubulin gene TUB4 has 35 -  40 % homology to other y-tubulins. 
Two other components of the y-tubulin complex are highly conserved proteins. The 
yeast SPC97 (Knop et al., 1997) and SPC98 (Geissler et al., 1996 ;Rout and Kilmartin,
1990) genes have homologues in higher eukaryotes (Martin et al., 1998; Murphy et al., 
1998; Tassin et al., 1998). Spc97p is homologous to the human hGCP2 and the 
Drosophila Dgrip84 while Spc98p is homologous to HSSc98/hGCP3 in humans and 
Xgripl09 in Xenopus and Dgripl09 in Drosophila. This is an example for a protein 
complex conserved during MTOC evolution.
The budding yeast Ndc80p (see 1.4.2.2.3) has 45 % similarity with human HEC 
protein (Wigge et al., 1998). HEC is localised at centromeres but not at MTOCs. 
Functionally expressed in yeast, human HEC protein localises to the nucleus (Zheng et
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al., 1999) and Ndc80p can be functionally replaced with human HEC protein when 
expressed under the NDC80 promotor (Zheng et al., 1999).
Furthermore, NDC1 (see 1.4.2.2.4) is homologous to the S. pombe CUT11. Both 
proteins are proposed to function in insertion of the SPB into the nuclear envelope.
1.4.4 The function of MTOCs
The main function of MTOCs is proposed, as the name already suggests, to be the 
nucleation and the organisation of microtubules. There has been some controversy 
about the role of MTOCs in cell division in higher eukaryotes because it was shown 
that bipolar spindles form in the absence of centrosomes. The microtubules forming 
those spindles originate from chromosomes and self-organise into mitotic spindles 
(Waters and Salmon, 1997). Consequently, centrosomes do not seem to be required for 
spindle formation. This was also shown in the fly Sciara coprophila. Unfertilised fly 
oocytes which do not harbour centrosomes can develop parthenogenetically. Nuclear 
division of these oocytes takes place via chromosome organised bipolar spindles (de 
Saint Phalle and Sullivan, 1998). These findings argue against the role of the MTOC as 
the unique microtubule organiser of the cell. However, the spindles of the fly oocytes 
are not properly orientated in the cell and cytoplasmic microtubules are not observed to 
connect to the spindle poles. Cytoplasmic microtubules are normally required for the 
spindle orientation and they are usually nucleated by MTOCs. Chlamydomonas 
rheinhardtii spindles which have developed without MTOCs, also show random 
spindle positioning in relation to the cleavage furrow (Ehler et al., 1995). This shows 
that MTOCs are required at spindle poles to nucleate astral microtubules thereby 
ensuring proper spindle positioning and therefore functional cell division.
The best candidate for the universal microtubule nucleator of MTOCs is y-tubulin. y- 
tubulin is a conserved component of all MTOCs (Stearns et al., 1991; Zheng et al.,
1991) (see 1.4.3). y-tubulin was first identified in a screen for suppression of the A. 
nidulans benA33 p-tubulin mutation. The p-tubulin mutant displays hyper stable 
microtubules which are overcome by mutation of y-tubulin (Oakley and Oakley, 1989). 
The requirement of y-tubulin for microtubule nucleation was proven by Joshi et al.
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(1993) who showed that injection of anti-y-tubulin antibodies blocks micro tubule 
nucleation in mammalian cells. Mutations in y-tubulin result in disruption of MTOC 
function of A. nidulans, S. pombe, S. cerevisiae and D. melanogaster (Horio et al., 
1991; Martin et al., 1997; Spang et al., 1996b; Sunkel et al., 1995). In budding yeast, 
conditional lethal mutants in the y-tubulin gene TUB4 have disorganised non­
functional spindles with less than the normal amount of MTs (Sobel and Snyder, 1995; 
Spang et al., 1996b).
The y-tubulin complex was first identified in Xenopus egg extract and here it includes 
a-and p-tubulin and proteins of 195, 133, 109, 75 kD (Zheng et al., 1995). In the 
Xenopus centrosomes, part of the complex is organised in an open ring structure with a 
25-28 nm diameter (Zheng et al., 1995). These characteristic ring structures were also 
isolated from Drosophila pericentriolar material (Moritz et al., 1995a, b). In yeast, the 
y-tubulin complex does not display a ring like structure. This might be due to its small 
size (6S compared to 25 S in embryonic and somatic cells). While the y-tubulin ring 
complex consists of at least five different proteins, the yeast complex most likely 
contains two molecules of the yeast y-tubulin Tub4p and one molecule of Spc97p and 
Spc98p each (Knop and Schiebel, 1997). Spc97p and Spc98p were identified in yeast 
and have now been cloned in Drosophila, Xenopus and humans (see 1.4.3).
The yeast Tub4p localises to the inner and outer plaque structures of the SPB by 
immunoelectron microscopy (Spang et al., 1996b) and so do Spc97p and Spc98p 
(Knop and Schiebel, 1997; Rout and Kilmartin, 1990). At the outer plaque, the y- 
tubulin complex binds to Spc72p which connects to the central plaque via 
spc94p/Nudlp and Cnm67p (see 1.4.2.2.2). At the inner plaque, SpcllOp connects the 
y-tubulin complex to the central plaque (see 1.4.2.2.1). At the outer plaque the y- 
tubulin complex nucleates cytoplasmic microtubules and at the inner plaque nuclear 
microtubules. In yeast microtubule minus ends appear rounded in the electron 
micrograph (Pereira and Schiebel, 1997). Such capped microtubule ends have now also 
been described in vertebrates (Rodionov et al., 1999; Wiese and Zheng, 2000).
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Since no direct interaction between y-tubulin and a-or |3-tubulin has been shown, 
nucleation models are still theoretical. In yeast the y-tubulin complex is supposed to 
interact with microtubule minus ends possibly with the help of the microtubule binding 
protein Stu2p (Saunders, 1999). For microtubule nucleation by the y-tubulin ring 
complex of higher eukaryotes two models exist. The ring/helix nucleation model by 
Oakley (1992) and Zheng et al. (1995) suggests, that y-tubulin forms a helical ring on 
which microtubules assembles by direct interaction of a-tubulin with y-tubulin. The 
protofilament model by Erickson and Stoffler (1996) proposes that a- and |3-tubulin 
subunits would interact with a y-tubulin filament, a - and p-tubulin will assemble into 
the form of a sheet which than curves up into a cylindrical microtubule. The second 
model takes into account that a- and p-tubulin form sheets in vivo and that minus ends 
of microtubules are free for dynamic instability.
Recently, functions of the budding yeast MTOC in cell cycle regulation have been 
proposed (Bardin et al., 2000; Pereira et al., 2000). As described in 1.2, proteins of the 
spindle positioning checkpoint (Bub2p, Bfalp, Temlp) localise to the SPB in a cell 
cycle dependent manner and positioning of one SPB in the bud is necessary to allow 
exit from mitosis. If defects in the spindle positioning occur and the SPB does not 
reach the bud, cell cycle progression is inhibited. Further data suggest that other cell 
cycle proteins like Cdcl5p, Cdc5p etc. also localise to the SPB. Taken together, the 
SPB might play a central role in cell cycle regulation.
1.4.5 Duplication of MTOCs
In mitosis, every cell needs two functional MTOCs to form the poles of the mitotic 
spindle, to help with the positioning of the spindle in the cell and to assist with the 
separation of the chromosomes. Since each cell inherits only one MTOC, the MTOC 
has to be duplicated before mitosis. The duplication must be tightly regulated that only 
one duplication event occurs per cell cycle and that finally two functional MTOCs 
exist at the right time and in the right place.
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1.4.5.1 Duplication of centrosomes
In Gi of the animal cell cycle each cell harbours one centrosome consisting of a pair of 
centrioles with the surrounding pericentriolar material. At approximately the same time 
as DNA duplication, this is at the Gi to S transition, centrosome duplication starts. 
Firstly, centrioles move apart and once separated new centrioles grow orthogonal to the 
original ones. In early G2 the duplicated centrosomes can be observed side by side and 
each contains a complete pair of centrioles (Chretien et al., 1997). This process of 
centrosome duplication is called semiconservative since each resulting centrosome 
posses one new and one old centriole (Kochanski and Borisy, 1990). The theory exists 
that the pre-existing centriole is the nucleator. This is the case for typical somatic cells 
which must have an existing centriole to create a new centriole. But it is also known, 
that some animal and plant cells form basal bodies and centrioles de novo therefore 
new centrioles are not strictly templated by existing ones. In late G2 and mitosis, the 
duplicated centrioles move to opposite sides of the nuclear envelope. The migration of 
the centrosomes is dependent on kinesin microtubule motor proteins. When the nuclear 
envelope brakes down microtubles attach to chromosomes and after mitosis is 
completed, cytokinesis takes place.
1.4.5.2 Duplication of the budding yeast SPB
1.4.5.2.1 Duplication process
The duplication of the S. cerevisiae SPB begins in Gi of the cell cycle with the 
formation of the satellite. The satellite is detectable by electron microscopy as a small 
electron dense structure on the cytoplasmic face of the half-bridge. It is always located 
at the side of the half-bridge distal to the existing SPB (Byers, 1981a; Byers and 
Goetsch, 1974). The structure of the satellite is either spherical in haploid cells or 
plaque-like in tetraploid cells (Adams and Kilmartin, 1999). It is mainly a small copy 
of the cytoplasmic/central core of the existing SPB (Adams and Kilmartin, 1999) (see 
1.4.2.2.6). The satellite sits on top of the half-bridge but both structures are closely 
associated (O'Toole et al., 1999). At this stage the precursor of the new SPB is not 
inserted in the nuclear envelope which is consistent with the finding that the satellite
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does not contain SpcllOp (see 1.4.2.2.6) and does not nucleate nuclear microtubules 
(Adams and Kilmartin, 1999).
The appearance of the satellite is the first morphological marker for the beginning of 
SPB duplication. When the small bud emerges, SPBs have already been duplicated but 
they are usually still connected by the bridge. In Gi-phase, the satellite enlarges and 
forms the duplication plaque which still contains the cytoplasmic SPB components 
described in 1.4.2.2.6 (Adams and Kilmartin, 1999) but not the nuclear SpcllOp 
protein. Although, there might be other components present which have not yet been 
identified. At this stage, an elongation of the half-bridge under the duplication plaque 
occurs but the cytoplasmic phase of the half-bridge seems to stay constant (Adams and 
Kilmartin, 1999). The half-bridge layers are supposed to fuse at the distal end and here, 
a nuclear pore like structure is often present (Adams and Kilmartin, 1999). How the 
duplication plaque inserts into the nuclear envelope is not clarified. Two hypotheses 
exist. One model is that the half-bridge which is supposed to be extended under the 
duplication plaque retracts and reduces itself to its normal size thereby allowing 
nuclear components to assemble onto the duplication plaque from the nuclear side. The 
other theory suggests that the retraction of the half-bridge is passive and that SpcllOp 
assembles onto the duplication plaque from the fusion point of the half-bridge (Adams 
and Kilmartin, 1999).
After insertion of the duplication plaque into the nuclear envelope two side-by-side 
SPBs connected via the bridge can be observed (Byers, 1981a). Now nuclear 
microtubules are nucleated from both SPBs and these interdigitate at sharp angles 
(O'Toole et al., 1999). When the SPBs move apart the bipolar spindle forms and it 
consists of numerous short and some long microtubules (O'Toole et al., 1999). A 
question that still has to be answered is whether the bridge is cleaved in the middle and 
equally distributed or whether the bridge is cleaved at the side, leaving one SPB 
without a bridge structure.
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1 .4 .5 .2.2 Proteins involved in SPB duplication
Several proteins are known to be involved in the SPB duplication process. Their 
identification is mainly the result of mutant analysis. The different proteins can be 
categorised for requirement in early, intermediate or late stages of duplication 
according to the mutant phenotype.
A protein that functions at early and late stages of SPB duplication is the dual specific 
kinase Mpslp. However, most conditional lethal mutants in MPS1 display defects in 
early SPB duplication. Cells arrest with a single SPB that connects to an enlarged half­
bridge. These mutant cells do not show any satellite formation (Winey et al., 1991). 
The mpsl-737 mutant shows defects in a later stage of duplication. Mutant cells are 
able to initially form satellites but most cells arrest containing only one single SPB 
with a reduced half-bridge. In some of these cells an additional small SPB-like 
structure is observed (Schutz and Winey, 1998). This SPB is unable to nucleate 
microtubules and can not function in spindle formation. Taken together, Mpslp is 
involved in multiple steps of duplication.
The same duplication defect as in ‘early’ MPS1 mutants was observed in mutants of 
the heat shock transcription factor HSF1. In hsfl mutants, the SPB is unduplicated and 
the half-bridge is enlarged (Zarzov et al., 1997). It is unknown whether this is due to a 
direct function of Hsflp at the SPB or if it is an effect of the lack of HSP/HSC82 
expression observed in the hsfl mutants (Zarzov et al., 1997).
The yeast centrin Cdc31p and its half-bridge localiser Karlp (see 1.4.2.2.5) are both 
required at the same time point early in SPB duplication (Rose and Fink, 1987a). 
Mutants in CDC31 and KAR1, do not form a satellite but cause enlargement of the 
existing SPB (Baum et al., 1986a). Mutants in KAR1 can be rescued by overexpression 
of CDC31 (Salisbury, 1995) and its mutated form cdc31-16 which makes cells KAR1 
independent (Vallen et al., 1994). Mutants in KAR1 can also be rescued by high gene 
dosage of DSK2. This suppression is specific for SPB duplication and the additional 
karyogamy defect is not suppressed. Dsk2p is a nonessential ubiquitin-like protein
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which has not been detected at the SPB (Biggins et al., 1996). High gene dosage of 
DSK2 is also sufficient to rescue the complete deletion of KAR1 (Biggins et al., 1996).
Another gene product that functions early in SPB duplication is Rpt4p/Pcslp. It is a 
protein of the 19 S regulatory particle of the proteasome (Glickman et al., 1998) also 
called the proteasome cap subunit (McDonald and Byers, 1997). The proteasome is 
required for degradation of ubiquitinated proteins throughout the cell cycle, including 
degradation of cyclins (see 1.2). Conditional lethal mutants of RPT4/PCS1 arrest as 
large budded cells in G2 of the cell cycle with only one SPB which nucleates a 
monopolar spindle (McDonald and Byers, 1997). DNA duplication and bud formation 
is not effected in these mutants. Fully functional Rpt4p-GFP localises to the nuclear 
envelope and ER (endoplasmic reticulum) throughout the cell cycle where the main 
proteasomal activity takes place. Taken together, Rpt4p a component of the 
proteasome might be involved in degradation of proteins required for SPB duplication 
(McDonald and Byers, 1997).
The central plaque component Spc42p is also required for proper SPB duplication. It 
seems to function at an intermediate stage of the duplication process because mutants 
in SPC42 have a single SPB with disordered material associated with the cytoplasmic 
site of the half-bridge. This might indicate that the enlargement of the satellite into the 
duplication plaque is compromised in these mutants (Donaldson and Kilmartin, 1996).
The following proteins are involved in late events in SPB duplication and mutants 
show similar phenotypes to the Tate’ MPS1 mutant allele mpsl-737. Mutants in MPS2 
were isolated in the same screen as MPS1 mutants, a screen for cells containing 
monopolar spindles (Winey et al., 1991). The defect in these MPS2 monopolar spindle 
mutants can be explained by incomplete SPB duplication. Mutant cells which 
temporarily arrest in G2 contain the original SPB organising a monopolar spindle and 
in some cases a small SPB-like structure. The small SPB resides on the cytoplasmic 
face of the nuclear envelope and only nucleates cytoplasmic microtubules (Winey et 
al., 1991). The lack of nuclear microtubules might be the consequence of the 
incomplete insertion of the new SPB into the nuclear envelope and its lack of the inner 
plaque structure (Winey et al., 1991). Similar phenotypic features are observed in
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mutants in NDC1 (see 1.4.2.2.4). These mutants start to duplicate the SPB but the 
duplicated SPB is not inserted into the nuclear envelope (Winey et al., 1993). The 
original SPB organises a monopolar spindle which connects to all chromosomes 
(Winey et al., 1993). The mutant cells undergo asymmetric segregation with all 
chromosomes located at one pole (Thomas and Botstein, 1986). It was proposed that 
Mps2 and Ndclp function in insertion of the duplication plaque into the nuclear 
envelope.
CDC37 was originally identified in a screen for mutants that arrest at Start in Gi (Reed, 
1980). The cdc37-l mutants arrest as unbudded cells in Gi and remain mating 
pheromone responsive (Reed, 1980). Interestingly, SPB duplication proceeds past Start 
and cells have side-by-side SPBs at the arrested stage (Schutz et al., 1997). The new 
SPB is incomplete since it lacks outer plaque material. Further hints that Cdc37p is 
involved in SPB duplication come from genetic experiments. CDC37 is a high gene 
dosage suppresser of mpsl -1 mutants which show an early SPB duplication defect and 
mpsl and cdc37 are co-lethal (Schutz et al., 1997). Mutants in CDC37 cause the loss of 
Mpslp kinase activity but the level of Mpslp in the cells remains constant (Schutz et 
al., 1997). The mammalian homologue of Cdc37p is a subunit of the Hsp90 chaperone 
complex which associates with several protein kinases (Stepanova et al., 1996).
The SPB component Spc29p is required in late SPB duplication (Adams and 
Kilmartin, 1999; Elliott et al., 1999). Mutant cells in late Gi of the cell cycle contain 
two SPBs but one of those SPBs is smaller in size. The SPBs nucleate spindle 
microtubules but the spindle is asymmetric with the smaller SPB nucleating less 
microtubules (Adams and Kilmartin, 1999). However, later in the cell cycle mainly one 
SPB per cell is observed by immunofluorescence and only about 20 % of mutant cells 
still show a second SPB signal. It is therefore assumed that the smaller SPB 
disintegrates in the majority of mutant cells (Adams and Kilmartin, 1999; Elliott et al., 
1999).
INTRODUCTION 37
1.4.5.2.3 Involvement of the PKC1 MAP kinase pathway in SPB duplication
Khalfan et al. (2000) searched for high copy suppressers of the double deletion mutant 
Adsk2 Arad23 which is defective in early steps of SPB duplication. As expected they 
found that high gene dosage of CDC31 overcomes the defect as shown before by 
Biggins et al. (1996). In addition, they identified two genes of the PKC1-pathway, 
SLG1/WSC1 and PKC1 itself, that can suppress the deletion mutant. The PKC1- 
pathway is a MAP kinase signalling pathway involved in numerous cell processes 
including cell wall integrity and bud emergence at the Gi/S transition (Gray et al., 
1997; Marini et al., 1996; Mazzoni et al., 1993; Zarzov et al., 1996). One of the 
proteins identified in the suppresser screen, Slglp, functions as a plasma membrane 
protein that signals Pkclp via the small GTPase Rholp (Jacoby et al., 1998; Verna et 
al., 1997). Pkclp the other protein identified by Khalfan et al. (2000) activates the 
subsequent MAP kinase module consisting of Bcklp, Mkklp/ Mkk2p and Mpklp (Irie 
et al., 1993; Lee et al., 1993; Lee and Levin, 1992). In addition, high gene dosage of 
SLG1 and PKC1 partially suppresses the karl-Al 7 and cdc31-2 mutants which are also 
known to show SPB duplication defects (see 1.4.5.2.2). The downstream components 
BCK1 and MPK1 were also able to suppress the defects of the karl-A17 strain. Further 
genetic studies revealed that mutants in SPC110 coding for a inner plaque component 
can be suppressed by high-copy number of PKC1 and SLG1 (Khalfan et al., 2000). The 
Spcl10-220 mutation leads to defective SPB assembly because of reduced interaction 
between SpcllOp and calmodulin (Sundberg et al., 1996). Therefore, PKC1, SLG1, 
MPK1 and BCK1, all of which are genes coding for components of the MAP kinase 
cascade, show genetic interactions with genes coding for proteins involved in SPB 
duplication.
1.4.5.3 Similarities of MTOC duplication in different organisms
The duplication process of the budding yeast SPB has often been described as template 
mechanism. The template would be the satellite on which the other SPB components 
assemble. Although, there is no structural evidence, the template mechanism has also 
been proposed for centriole duplication. This is based on the finding that the 
procentriole always assembles at a set distance of about 70 nm from the proximal end
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of the existing centriole. The occurrence of the procentriole in a set location led to the 
suggestion that a template structure might be attached to the existing centriole in this 
place (Rattner and Phillips, 1973; Robbins et al., 1968).
The duplication process of the fission yeast SPB shows some similarities to the 
duplication of the budding yeast SPB. In fission yeast, the new SPB assembles on the 
end of a bridge structure attached to the existing SPB (Ding et al., 1997). This is 
analogous to the assembly of the satellite and the duplication plaque at the end of the 
half-bridge in budding yeast. However, it appears that the new fission yeast SPB uses 
the existing SPB as a source for building material since the ‘old’ SPBs decreases in 
size while the new one grows. This has not been observed in budding yeast cells where 
the established SPB stays mainly constant in size throughout the cell cycle. The 
budding yeast SPB is embedded in the nuclear envelope throughout the cell cycle 
(Byers, 1981a) and the new SPB is inserted into the nuclear envelope during 
duplication. The fission yeast SPB resides just outside the nuclear envelope apart from 
mitosis. In mitosis the fission yeast SPBs have to insert into the nuclear envelope to 
form the spindle poles since there is no nuclear envelope breakdown. Therefore, fission 
yeast inserts completely duplicated SPBs into a fenestration of the nuclear envelope 
while budding yeast inserts the duplication plaque into the nuclear envelope. So far 
only one of the components involved in the insertion process has been identified but 
this component is homologue in both organisms. This is the fission yeast C utllp  and 
its budding yeast homologue Ndclp (see 1.4.2.2.4).
An indication that certain steps of MTOC duplication might be conserved in all 
organisms comes from the finding that centrin is a common component of all MTOCs. 
Mutants in the budding yeast centrin, CDC31, block formation of the satellite and lead 
to enlargement of the remaining unduplicated SPB (see 1.5.2.2) (Baum et al., 1986b; 
Byers, 1981b; Schild et al., 1981). The Chlamydomonas reinhardtii centrin/caltractin 
which is found in basal bodies, is essential for accurate basal body duplication and 
separation (Taillon et al., 1992) and for microtubule severing (Sanders and Salisbury, 
1989, 1994). Another example is the centrin of the green alga Spermatozopsis similis 
which localises to fibres connecting the new probasal body to the existing basal body 
(Lechtreck et al., 1999). Centrin 3 which is the closest relative to the budding yeast
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Cdc31p out of the three human centrins has a role in centrosome reproduction. This 
was shown in an experiment by Middendorp et al. (2000) who showed that injection of 
recombinant HsCen3p or of RNA encoding HsCen3p into one blastomere of two-cell 
stage Xenopus laevis embryos resulted in inhibition of centrosome duplication.
1.5 Aim of thesis: characterisation of Bbplp
In our laboratory, a screen for high gene dosage suppressers of conditional lethal 
mutants in SPC98 resulted in the identification of BBP1 (S. Geissler, unpublished 
data). BBP1 was also isolated in our laboratory in a two-hybrid screen for interacting 
proteins of the SPB component Spc29p (Schramm et al., 2000).
BBP1 had been identified before in a two-hybrid screen for proteins interacting with 
BFR1 (Xue et al., 1996). BFR1 itself was isolated as a high-gene dosage suppresser of 
Brefeldin A induced lethality (Jackson and Kepes, 1994). The drug Brefeldin A causes 
the disassembly of the Golgi complex due to inhibition of the small G protein Arflp 
(Peyroche et al., 1999). High gene dosage of BFR1 was also shown to rescue mutants 
in SEC17 (Jackson and Kepes, 1994). The gene product of SEC17 is involved in 
vesicle targeting and/or fusion (Clary et al., 1990; Griff et al., 1992). More recently, 
Bfrlp was shown to be part of the polyribosome-mRNP complex (Lang and Fridovich- 
Keil, 2000) where it associates with the mRNP complex protein Sep 160 and the poly 
(A)-binding protein Pablp.
Xue et al. (1996) investigated the effect of depletion of BBP1. They constructed a bbpl 
deletion strain which contained wild type BBP1 under the GAL promoter. The strain 
was incubated on glucose medium to deplete Bbplp, and the cells continued to grow 
for 16 h to 18 h. FACS analysis showed that some cells increased in ploidy after 16 h. 
Immunofluorescence revealed that spindle formation was defective in these cells since 
duplicated SPBs were not connected via a spindle.
The genetic interactions of BBP1 with genes coding for the known SPB components 
Spc98p and Spc29p indicated a potential function of Bbplp at the SPB. Furthermore, 
the spindle defect of cells depleted of BBP1 suggested an implication of Bbplp in the
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formation of a functional spindle, one of the main tasks of SPBs. Taken together, 
Bbplp was a promising candidate for a novel SPB component with functions in 
mitosis. In this study, this theory was followed up in different experiments. The 
localisation of Bbplp potentially at the SPB was to be determined by fluorescence 
microscopy and immunoelectron microscopy. In addition, interactions of Bbplp with 
known SPB components were to be tested by two-hybrid and suppression analysis. To 
identify novel interactors of Bbplp, affinity precipitates of Bbplp were analysed by 
MALDI-MS. If these experiments were to show that Bbplp is a SPB component, the 
cellular function of Bbplp was to be determined by overexpression experiments and by 
analysis of conditional lethal mutants. Finally, a molecular model of the SPB including 
Bbplp was to be proposed.
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2. Materials and Methods
2.1 Materials
2.1.1 Chemicals
All chemicals were purchased from Sigma (Dorset, UK), Merck (Darmstadt, 
Germany), Gibco (Paisley, UK) or Fisher Scientific (Loughborough, UK), unless 
specified otherwise.
2.1.2 Buffers
Frequently used buffers are listed here. All buffers were prepared with double distilled 
water. Some buffers were autoclaved (121 °C, 2.0 bar) as indicated.
Blotting-buffer: 48 mM Tris
39 mM glycine 
0.037 % (w/v) SDS 
20 % (v/v) methanol
HU-buffer: 200 mM Tris-HCl (pH 6.8)
8.0 M urea
5 % (w/v) SDS 
0.1 mM EDTA
15.0 mg/ml DTT
0.1 % (w/v) bromophenol blue (Roth, Karlsruhe, 
Germany)
Laemmli-buffer: 25 mM Tris
192 mM glycine 
0.1 % (w/v) SDS
PBS: 50 mM NaP04
150 mM NaCl 
pH 7.5 
autoclaved
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Qiagen buffer 1: 20 mM Tris-HCl (pH 8.0)
10 mM EDTA (pH 8.0) 
100 pg/ml RNAse
Qiagen buffer 2: 200 mM NaOH
1 % (w/v) SDS
Qiagen buffer 3: 3.0 M potassium acetate
6 x loading buffer DNA: 0.25 % (w/v) bromophenol blue (Roth, Karlsruhe,
Germany)
0.25 % (w/v) xylene cyanole FF
15 % (w/v) Ficoll 400 (Pharmacia, Uppsala, Sweden)
Stripping buffer: 62.5 mM Tris (pH 6.7)
2 % (w/v) SDS
100 mM p-mercaptoethanol
50 x TAE buffer: 2.0 M Tris-acetic acid (pH 7.7)
50 mM EDTA 
autoclaved
10 x TBS: 25 mM Tris-HCl (pH 7.5)
150 mM NaCl 
autoclaved
TBS-T: 1 x TBS
0.1 % (v/v) Tween 20 
pH 7.5
2.1.3 Enzymes
Restriction enzymes were purchased from New England Biolabs (Beverly, USA), 
Roche (Lewes, UK), Pharmacia (Uppsala, Sweden) and Gibco (Paisley, UK).
Taq DNA polymerase was purchased from Perkin Elmer, Wellesley, USA (Amplitaq) 
or Eurogentec, Southampton, UK (Goldstar). Vent polymerase was obtained from New 
England Biolabs (Beverly, USA).
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Klenow enzyme and alkaline phosphatase were purchased from Roche (Lewes, UK).
RNAse A and DNAse I, were purchased from Sigma (Dorset, UK).
Gluculase was obtained from NEN (Boston, USA), zymolyase from Seikagaku 
Corporation (Tokyo, Japan) and mutanase (Novozym 234) was a gift from Novo 
Nordisk (Copenhagen, Denmark).
2.1.4 Kits
Big Dye™ squencing kit 
ECL™
Qiaex™
Qiagen™ Plasmid Midi Kit
2.1.5 Standards
2.1.5.1 DNA standards
The size of DNA-fragments on agarose gels was determined with the 1 kb DNA 
extension ladder from Gibco (Paisley, UK). This standard consists of fragments with a 
size of 40 kb, 20 kb, 15 kb, 10 kb, 8,144 bp, 5,090 bp, 4,072 bp, 3,054 bp, 2,036 bp, 
1,636 bp, 1,018 bp and 506 bp.
2.1.5.2 Protein standards
For the determination of molecular weights of proteins on SDS polyacrylamide gels 
(PAGE), the SDS-PAGE broad range standard from BioRad (Hemel Hempstead, UK) 
was used. This standard consists of myosin (200,000 D), p-galactosidase (116,250 D), 
phosphorylase B (97,400 D), serum albumin (66,200 D), ovalbumin (45,000 D), 
carbonic anhydrase (31,000 D), trypsin inhibitor (21,500 D), lysozyme (14,400 D) and 
aprotinin (6,500 D).
Applied Biosystems (Warrington, UK) 
Amersham Pharmacia (Uppsala, Sweden) 
Qiagen, (Hilden, Germany)
Qiagen (Hilden, Germany)
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2.1.6 Primer
A and B primers for the amplification of yeast genes were designed to anneal about 
300 bp upstream of start and 300 bp downstream of stop. Two-hybrid primers were 
constructed to be ‘in frame’ and to include a start or a stop codon. Sequencing primers 
were constructed according to the specific application. For the cloning of inserts, 
restriction sites were constructed in the oligonucleotides.
SI- and S2-primers were used for the deletion of yeast genes. S2- and S3-primer pairs 
were suitable for C-terminal epitope tagging of yeast genes. S1-, S2- and S3-primers 
for the amplification of pYM modules (Knop et al., 1999) were constructed as follows:
All S-primers contain firstly, chromosomal sequences for homologous recombination 
and secondly, nucleotide sequences for the amplification of the pYM modules. SI 
(forward) primers contain 50 bases of the gene-specific sequence upstream from the 
start codon including the start codon plus 5’CGTACGCTGCAGGTCGAC3’ for the 
amplification of the pYM modules. S2 (reverse) primers contain 50 bases of the gene- 
specific sequence downstream from stop including the stop codon plus 
5’ATCGATGAATTCGAGCTCG3’ sequence for the amplification of the pYM 
modules. S3 (forward) primers are identical to the 50 bases of the gene-specific 
sequence upstream of the stop codon not including the stop codon and contain the 
5’CGTACGCTGCAGGTCGAC3’ sequence for amplification of the module.
Table I : Primers
Name Sequence Description
B B Pl-A cgggatccGTCCTCAGTATCATTATTAACAATG (BamH V)
BBP1-A2 cgggatccGGAGCCGGGTA A AGCGCGCATG (BamH D
BBP1-B tccgctcgagACAGCI'CGTG I'l GAGTGATG (Xho n
BBP1-2H1 ceggatccetATGAATCAGGAAGACAACACG (BamH H
BBP1-2H2 cgggatccgtatgGATAGACAATTACTATGTCCGGG (BamH I/artificial start")
BBP1-2H3 tccectcgagctaCAGGTCrCTACTGTTCAAGTC (Xho I/artificial stop")
BBP1-M1 GACCCGTTTTTGTGTCGCTCG
BBP1-M2 AGAGACAATTTCGCGTTGCACC
BBP1-PCR5’ CTCTTGG AACAATAGCGGTC
BBP1-PCR3’ CTTCGATCATGGCACCC
BBP1-PCR3’2 GTCCGGTATGATTACTGACGGCAGGACTAC
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Table I  continued
B B Pl -SEQ5' -3545 CTGGTCTGGATTCAACGCTCCATAGGAAG 
BBP1 -SEQ3'-4316 CGGATAGTCTTTGCTTCAATGTTTG
B B P l-SI  
BBP1-S2  
BBP1-S3
GTCAATCrTCGAAGGAGCATAGAGGCGAATGACTACrGAACAATGcgtacgctgcaggtcgac
AGAGTCGTAACrGTTATTTCCATTGTGGAATGGAGTCCTGTCCTAatcgatgaattcgagctcg
AGAAAAGATACTTCTGCTGGTTCGAATATnTTTCAACAGGACAAcgtacgctgcaggtcgac
BFR1-A
BFR1-B
BFR1-2H1
BFR1-S1
BFR1-S2
BFR1-S3
cgggatccCGTAAGCGTGGCTACTGCATTG
tccgctcgagCAGGTGCAATGTCCCACGCCTTC
cgggatccgtATGTCCTCCCAACAACACAAG
(BamH. II 
(XhoD  
(BamH D
TATCAACGTAATAGCATATTTTCTAACAACACAGCCATTGCCATGcgtacgctgcaggtcgac
AAAAGATTGAAAGAACAGGAAGAGTCrGAAAAAGATAAAGAAAATcgtacgctgcaggtcgac
MPS2-A cgggatccCTTGTGTAAATGCCTTCACGGG
M PS2-B tccgctcgagCAACGCTGCCACGCACATTATTTTG
MPS2-2H1 cgggatccglATGAGTAACGGTGCGTTTGATGC
MPS2-2H2 tccgctcgagTTAAATGCCGAATACTCTACTATATGCG
MPS2-2H3 cgggatccgtatgGTATATGCTCATGACACACCATCC
MPS2-2H4 tccgctcgagttaCCATATGTTGGAGGGAACCGCGGA
MPS2-GFP cgggatccATGAGTAACGGTGCGTTTGATGC
MPS2-M1 GTTCCTATGAGCTTCGATTGCC
MPS2-M2 GGACACCTGCCAGTAAAGCGAAACAG
M PS2-S1 GAAAGAAAGCTTTACAAACAATTCTGTCnTGACAACGTAAGTATGcgtacgctgcaggtcgac
M PS2-S2 TATTTTCACTGTGTATGAAGTGGCACGGTGCAAAGGCCAAGGnTAatcgatgaattcgagctcg
MPS2-S3 CAAATGCCAATGTGGATGACGCATATAGTAGAGTATTCGGCATTcgtacgctgcaggtcgac
(BamH D 
(Xho II 
(BamH D 
(Xho n
(BamH I/artificial start) 
(Xho I/artificial stop) 
(BamH II
POM152-A gcgggatccCTGGTATTATAGAAATAGAGTTTC (BamH II
POM152-B tcccccggggCGGATAGGTCATTGAGCCAATTTC (Sm al)
POM152-2H1 gcgggatccgtATGGAGCACAGATATAACGTG (BamH D
POM152-S1 TAGATTTATCATACCAGATACGTTTATCAGGAGGCTTGTATAATGcgtacgctgcaggtcgac
POM 152-S2 TATTGCGGGAAAGAAAAATTTCATCAGACnTCrTGTAATATTTAatcgatgaattcgagctcg
POM152-S3 ACAGATGCTTATTGTTTTGCCAAAAATGATCri'l'rri'lCAATAACcgtacgctgcaggtcgac
SEC66-A cgggatccCGATATCAGTAGTATAGG (BamH II
SEC66-B tccgctcgagGTGAGCAAGAAGAAGGGTAGAAAACAC (Xho D
SMY2-A
SM Y2-B
aaaactgcagGGTAGGTGATGACGTCCACAGCAA
tcccccgggGAATTTGTCATTATCTGCGTT
(Pst D 
(Sma II
UMP1-A
UMP2-B
cgggatccTTCAATCCATTCTGTGTTCCC
tccgctcgagTGCGGACTATATAGGACACTA
(BamH II 
(Xho n
Capital letters indicate nucleotide sequences homologue to the chromosomal DNA sequence. Artificially 
created restriction sites are underlined.
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2.1.7 Plasmids
Table II: Plasmids
Name Description Source or reference
p415 -ADH p415 containing AD H  promotor (Mumberg et al., 1995)
p425-GAL1 p425 containing GAL1 promotor (Mumberg et al., 1994)
pAcrn two-hybrid vector: pRS425 containing GAL4-HA (Durfee et al., 1993)
pALl pET28c containing M PS21'307 A. Camasses
pBG2A pRS425 containing DSK2 B. Geier
pC Sl pGEX-5X-l containing B B Pl this study
pCS7 pGEX-5X-l containing B B P l1'237 this study
pCS8 pGEX-5X-l containing B B P l202'385 this study
pCS9 p425-GAL7 containing B B Pl this study
pCS14 pRS425 containing BBPl this study
pCS15 pRS315 containing BBPl this study
pCS16 pRS316 containing BBPl this study
pCS17 pRS414 containing BBPl this study
pCS51 pRS304 containing bbpl-1 this study
pCS52 pRS304 containing bbpl -3 this study
pCS53 pRS304 containing b b p l-2 this study
pCS55 pEG202 containing BFR1 this study
pCS58 pACTII containing BFR1 this study
pCS61 pACTII containing MPS2i'307 this study
pCS71 pRS315 containing MPS2 this study
pCS72 pRS425 containing MPS2 this study
pCS78 pRS316 containing MPS2 this study
pCS84 p415 -ADH containing BFR1 this study
pCS85 Y epl3  clone 61 containing UMP1, SEC66 and SMY2 this study
pCS86 pRS425 containing SEC66 this study
pCS88 pRS425 containing UMP1 this study
pCS91 pRS425 containing SMY2 this study
pEG202 two-hybrid vector: 2 pm , ///53-vector with LexA DNA-binding domain (Gyuris et al., 1993)
pET28c E. coli expression vector containing His6 under control o f the T7 promotor Novagen, Madison, USA
pFL44 2 pm, URA3-based yeast-E. coli shuttle vector C. Mann
pFL44-HSCl pFL44 containing HSC82 C. Mann
pFL44-HSFlS pFL44 containing MPS2 C. Mann
pGEX-5X-l E. coli expression vector containing GST under control o f the lacZ promotor Pharmacia, Uppsala, Sweden
pGPl p414-GAL1 containing SPC98 G. Pereira
pLysS E. coli expression vector containing gene coding for T7 lysozyme (Studier, 1991)
pMM5 two-hybrid vector: pRS423 containing GAL1-LexA-Myc M. Knop
pMM6 two-hybrid vector: pRS425 containing GAL1-GAL4-HA M. Knop
p M K ll pRS425 containing SPC97 (Knop et al., 1997)
pMK15 pACT 11 containing SPC97 (Knop et al., 1997)
pMK16 pEG202 containing SPC97 (Knop et al., 1997)
pMK26 pRS414containing SPC97 M. Knop
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Table II continued
Name Description Source or reference
pMK51 p414-GAZJ containing SPC 97 M. Knop
pRS304 TRP1 -based yeast integration vector (Sikorski and Hieter, 1989)
pRS305 LEU2-ba&zd yeast integration vector (Sikorski and Hieter, 1989)
pRS315 CEN6, LEU2-based yeast-£. coli shuttle vector (Sikorski and Hieter, 1989)
pRS316 CEN6, URA3-based yeast-E. coli shuttle vector (Sikorski and Hieter, 1989)
pRS414 CEN6, TRP1 -based yeast-E1. coli shuttle vector (Sikorski and Hieter, 1989)
pRS423 2 pm, HIS3-based yeast-£. coli shuttle vector (Christianson et al., 1992)
pRS425 2 pm, LEU2-based yeast-£. coli shuttle vector (Christianson et al., 1992)
pRS426 2 pm, URA3-based yeast-£. coli shuttle vector (Christianson et al., 1992)
pSE3 pRS425 containing SPC29 (Elliott et al., 1999)
pSElO pRS425 containing SPC34 S. Elliott
pSE17 pRS425 containing SPC42 S. Elliott
pSE63 pMM5 containing SPC29 S. Elliott
pSE64 pMM6 containing SPC29 S. Elliott
pSE65 pMM5 containing BBP1 S. Elliott
pSE66 pMM6 containing BBP1 S. Elliott
pSE67 pMM5 containing M PS2i~301 S. Elliott
pSE68 pMM6 containing MPS21'307 S. Elliott
pSE69 pMM5 containing CDC31 S. Elliott
pSE70 pMM6 containing CDC31 S. Elliott
pSE71 pMM5 containing KAR1 -ETM S. Elliott
pSE72 pMM6 containing KAR1-ATM S. Elliott
pSE83 pMM5 containing cdc31-16 S. Elliott
pSE84 pMM6 containing cdc31-16 S. Elliott
pSG21 pEG202 containing TUB4 S. Geissler
pSG26 pACT II containing SPC98 S. Geissler
pSG46 pACT II containing TUB4 S. Geissler
pSG56 pEG202 containing SPC98 S. Geissler
pSM39 pRS315 containing KAR1 E. Schiebel
pSM234 pRS425 containing CDC31 E. Schiebel
pSM271 pRS425 containing SPC98 E. Schiebel
pSM292 pRS426 containing CMD1 E. Schiebel
pSM347 pRS426 containing TUB4 E. Schiebel
pSM375 pRS414 containing SPC98 E. Schiebel
pSM458 pRS426 containing SPC72 E. Schiebel
pSM535 pRS425 containing SPC19 E. Schiebel
pSM538 pRS425 containing SPC25 E. Schiebel
pSM541 pRS425 containing SPC24 E. Schiebel
pSM544 pRS425 containing SPC105 E. Schiebel
pSM553 pRS425 containing TUB1 E. Schiebel
pSM554 pRS425 containing RBL2 E. Schiebel
pSM568 pRS425 containing CNM67 E. Schiebel
pSM603 pRS425 containing STU2 E. Schiebel
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Table II continued
Name Description Source or reference
pSM733 pRS305 containing mps2-2 E. Schiebel
pSM734 pRS305 containing mps2-42 E. Schiebel
pSM740 pRS315 containing SPC42-GFP-kanMX6 E. Schiebel
pSM743 pRS426 containing MPS2 E. Schiebel
pSM751 pRS426 containing BBP1 E. Schiebel
pSM782 pRS315 containing SPC110-GFP-kanMX6 E. Schiebel
pY M l pFA6a-kanMX6 containing 3HA (Knop et al., 1999)
pYM4 pFA6a-kanMX6 containing 3Myc (Knop et al., 1999)
pYM5 pFA6a-His3MX6 containing 3Myc (Knop et al., 1999)
pYM6 pFA6a-&/77?Picontaining 9Myc (Knop et al., 1999)
pYM8 pFA6a-kanMX6 containing TEV-ProA-7HIS (Knop et al., 1999)
pYM12 pFA6a-kanMX6 containing yEGFP (Knop et al., 1999)
Y E pl3 2 pm, LEU2-based yeast-E. coli shuttle vector (Broach et al., 1979)
2 A.BE. coli strains
Plasmids listed above were transformed (see 2.2.8.5.1) and amplified in either of the 
following strains:
DH5a deoR endAl gyrA96 hsdR17(T^m{) recAl relAl supE44 thi-1
A(lacZYA-argFV169) §80hlacZAM15 F’ X"; Clontech, Palo Alto, 
USA
SURE el4  (McrA) A(mcrCB-hsdSMR-mrr)171 endAl supE44 thi-1
gyrA96 relAl lac recB recJ sbcC umuCv.Tn5 (Kanr) uvrC [F’ 
proAB laclqZA(M15 Tn 10 (Tetr)]; Stratagene, La Jolla, USA
BL21 (DE3) pLysS E. coli B F" dcm ompT /wd5(rp"mp") gal (DE3) [pLysS Camr)a; 
Stratagene, La Jolla, USA
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2.1.9 Yeast strains
Table I I I : Yeast strains
Name Genotvne-construction Source or reference
ALYl MATa ura3-52 lys2-801 ade2-101 trp l  A63 his3A200 leu2Al Amps2::HIS3MX4 pCS78 A. Camasses
CJY16 MAT a ura3-52 lys2-801 ade2-101 trp l  A63 his3A200 leu2Al SPC24-3HA-kanMX6 C. Janke
CMY677 ura3-52 lys2-801 ade2-101 trp l  A63 leu2M  cdc28-109 C. Mann
CMY936 ura3-52 lys2-801 ade2-101 trp l  A63 leu2Al h sfl-82 C. Mann
ESM357 M ATa ura3-52 his3A200 leu2Al E. Schiebel
ESM400 M A Taura3-52 tr p lA63 leu2Al m psl-1 E. Schiebel
ESM401 M ATa ura3-52 his3A200 m ps2-l (Elliott et al., 1999)
ESM527 MATa ura.3-52 lys2-801 ade2-101 trp lA 63  his3A200 leu2Al spc29-2 (Elliott e ta l., 1999)
ESM480 MATa ura3-52 lys2-801 ade2-101 t r p lA63 his3A200 leu2Al SPC25-3HA-kanMX6 E. Schiebel
ESM578 MATa ura3-52 lys2-801 ade2-101 t r p lA63 his3A200 leu2Al spc29-3 (Elliott et al., 1999)
ESM780 MATa ura3-52 lys2-801 ade2-101 t r p lA63 his3A200 leu2Al Amps2::HIS3MX4 pCS78 E. Schiebel
ESM786 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2A l::pSU 133 mps2::HIS3MX4 E. Schiebel
ESM787 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 /eu2Ai.vpSM 734 mps2::HIS3MX4 E. Schiebel
ESM834 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al Asstl::URA3
NDC80-6HA -klTRPl E. Schiebel
SGY37 MATa ura3-52::URA3-lexA-op-LacZ trp l his3 leu2 (Geissler et al., 1996)
YAS8 MATa ura3-52 lys2-801 ade2-101 t r p lA63 his3A200 leu2Al Asstl::URA3 (Spang et al., 1995)
YCS1 MATala ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al BBPl/Abbpl::HIS3M X4 this study
YCS3 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al BBP1 -3HA-kanMX6 this study
YCS4 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al BBPl-ProA-kanMX6 this study
YCS5 MATa ura3-52 lys2-801 ade2-101 tr p lA63 his3A200 leu2Al BBPl-3Myc-kanMX6 this study
YCS6 MATa ura3-52 his3A200 leu2Al BBP1-GFP- kanMX6 this study
YCS17 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al A b b p l::HIS3MX4 pCS16 this study
YCS18 M ATa ura3-52 his3A200 leu2Al pCS9 this study
YCS47 MATa ura3-52 lys2-801 ade2-101 t r p lA63 his3A200 leu2Al BBPl-9M YC-klTRPl this study
YCS50 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al BFRl-9M YC-klTRPl this study
YCS53 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al BFR1 -3/£4-kanMX6 this study
YCS56 M ATala ura3-52 lys2-801 ade2-101 tr p lA63 his3A200 leu2Al BFRHAbiil::HIS3MX4 this study
YCS64 MATa ura3-52 lys2-801 ade2-101 trp7A63::pCS51 his3A200 leu2Al A bbpl ::HIS3MX4 this study
YCS65 MATa uro3-52 lys2-801 ade2-101 frp7A63::pCS51 his3A200 leu2Al A b b p l::HIS3MX4 this study
YCS66 MATa ura3-52 lys2-801 ade2-101 trp l A63::pCS53 his3A200 leu2Al A bbp l:.HIS3MX4 this study
YCS67 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al Abfrl::HIS3MX4 this study
YCS70 MATa ura3-52 lys2-801 ade2-101 rrp7A63::pCS51 his3A200 leu2Al A bbpl ::HIS3MX4
Asstl::URA3 this study
YCS72 MATa ura3-52 lys2-801 ade2-101 trp l A63::pCS53 his3A200 leu2Al A bbp l::HIS3MX4
Asstl::URA3 this study
YCS75 M ATala ura3-52 lys2-801 ade2-101 trp lA 63 his3A200 leu2Al MPS2/Amps2::HIS3MX4 this study
YCS78 MATa ura3-52 his3A200 leu2Al MPS2-GFP-kanMX6 this study
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Table I I I  continued
Name Genotvoe-construction Source or reference
YCS84 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al BBPl-3Myc-kanMX6
MPS2-3HA-HIS3MX6 this study
YCS88 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al MPS2-3HA-kanMX6 this study
YCS94 MATa ura3-52 lys2-801 ade2-101 trp l  A63 his3A200 leu2Al Amps2::HIS3MX4 this study
YCS108 MATa ura3-52 lys2-801 ade2-101 tr p lA63 his3A200 leu2Al POM152-6HA-klTRPl this study
YCS109 MATa ura3-52 lys2-801 ade2-101  frp7A63::pCS51 his3A200 leu2Al A bbp l:.HIS3MX4
pSM740 this study
YCS110 MATa ura3-52 lys2-801 ade2-101 trp l A63::pCS51 his3A200 leu2Al A bbpl:.HIS3MX4
pSM782 this study
YCS111 MATa ura3-52 lys2-801 ade2-101 tr p lA63 his3A200 /eu2Ai.vpSM734 mps2::HIS3MX4
POM152::kanMX6 this study
Y CS112-1 MATa ura3-52 lys2-801 ade2-101 rrp7A63::pCS51 his3A200 leu2Al Abbpl::HIS3MX4
POM152::kanMX6 this study
YCS112-2 MA7a ura3-52 lys2-801 ade2-101 trp l A63::pCS53 his3A200 leu2Al Abbpl::HIS3MX4
POM152::kanMX6 this study
YCS113 MATa ura3-52 lys2-801 ade2-101 trp l A63 his3A200 leu2Al spc29-2 POM152::kanMX6 this study
YPH499 MATa ura3-52 lys2-801 ade2-101 trp lA 63  his3A200 leu2Al Sikorski and Hieter
(1989)
YPH501 MATala ura3-52 lys2-801 ade2-101 tr p lA63 his3A200 leu2Al Sikorski and Hieter
(1989)
YPH500 MATa ura3-52 lys2-801 ade2-101 tr p lA63 his3A200 leu2Al Sikorski and Hieter
(1989)
31CG37 MATa lys2-801 ade2-101 trp l A63 his4 cdc37-l B. Wickner
2 .1 .10  Antibodies
Table IV: Antibodies
Antibody dilution source
goat anti-mouse CY2 1:200 Dianova, Hamburg, Germany
goat anti-mouse CY3 1:500 Dianova, Hamburg, Germany
goat anti-rabbit CY2 1:200 Dianova, Hamburg, Germany
goat anti-rabbit CY3 1:1000 Dianova, Hamburg, Germany
goat anti-mouse nanogold 1:100 Nanoprobe, New York, USA
goat anti-rabbit nanogold 1:100 Nanoprobe, New York, USA
goat anti-mouse peroxidase 1:4,000 Dianova, Hamburg, Germany
goat anti-rabbit 12 nm gold 1:40 Jackson Immuno Research, West Grove, USA
goat anti-rabbit peroxidase 1:5,000 Dianova, Hamburg, Germany
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Table IV  continued
Antibodv dilution source
mouse anti-HA (12CA5) 1:20 E. Schiebel
mouse anti-his 1:200 Dianova, Hamburg, Germany
mouse anti-Myc (9E10) 1:20 E. Schiebel
mouse anti-Myc 1:500 Roche, Lewes, UK
mouse anti-tubulin (WA3) 1:20 E. Schiebel
rabbit anti-Bbplp 1:200 this study
rabbit anti Cnm67p 1:800 E. Schiebel
rabbit anti-Karlp 1:100 E. Schiebel
rabbit anti-Mps2p 1:200 this study
rabbit anti-Spc24p 1:200 E. Schiebel
rabbit anti-Spc42p 1:1000 E. Schiebel
rabbit anti-Spc72p 1:200 E. Schiebel
rabbit anti-Spc97p 1:200 E. Schiebel
rabbit anti-Spc98p 1:500 E. Schiebel
rabbit anti-SpcllOp 1:500 E. Schiebel
rabbit anti-Tub4p 1:1000 E. Schiebel
2.1.11 Media
All media were autoclaved unless specified otherwise.
2.1.11.1 Media for yeast
YPD: 10 g yeast extract 
20 g bacto peptone 
20 g glucose
to final volume 11 of H2 O
YPAD: 11 YPD 
100 mg adenine
YPD-plates: 11 YPD 
20 g agar
G418-plates: 200 ml autoclaved YPD/agar-medium at less than 50 °C 
0.2 g G418 in 20 ml H2O, sterile filtered
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SC-medium:
SC-plates:
6.7 g bacto-yeast nitrogen base without amino acids 
20 g glucose 
2 g drop out mix 
to final volume 11 of H2O
drop out mix: 
ammino acid mix:
adenine 5 g
alanine 20 g
arginine 20 g
asparagine 20 g
aspartate 20 g
cysteine 20 g
glutamine 20 g
glutamate 20 g
glycine 20 g
inositol 20 g
isoleucine 20 g
lysine 20 g
methionine 20 g
para-aminobenzoic acid 2 g
phenylalanine 20 g
proline 20 g
serine 20 g
threonine 20 g
tyrosine 20 g
valine 20 g
36.7 g of the ammino acid mix were mixed with the following 
ammino acids/bases for the specific drop out mix:
histidine 2g
leucine 4 g
uracil 2 g
tryptophan 2 g
6.7 g bacto-yeast nitrogen base without amino acids 
20 g glucose
2 g drop out mix (see above) 
to final volume 0.5 1 of H2 O
20 g agar
to final volume 0.5 1 of H2 O
Both solutions were autoclaved separately and after cooling 
down to 50 °C, they were mixed slowly.
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SC-Raf-medium: 1.34 g bacto yeast nitrogen base without amino acids
0.4 g drop-out mix 
4 g raffinose
to final volume 0.21 of H2O 
sterile filtered
SC-Raf/Gal-medium: 1.34 g bacto yeast nitrogen base without amino acids
0.4 g drop-out mix 
4 g raffinose 
4 g galactose
to final volume 0.21 of H2O 
sterile filtered
SC-Raf/Gal-plates: 1.34 g bacto yeast nitrogen base without amino acids
0.4 g drop-out mix 
4 g raffinose 
4 g galactose
to final volume 0.11 of H2O 
sterile filtered
4 g bacto-agar in 100 ml H2O, autoclaved
Both solutions were mixed after they had cooled down to 50 °C
5-FOA-plates: 1.34 g bacto yeast nitrogen base without amino acids
0.4 g drop out mix SC-Ura 
4 g glucose 
10 mg uracil 
0.2 g 5-FOA
to final volume 0.11 of H2O 
sterile filtered
4 g bacto-agar in 100 ml H2O, autoclaved
Both solutions were mixed after they had cooled down to 50 °C.
Spo-plates: 2.5 g yeast extract
15 g KAc 
0.4 g glucose
20 mg: His, Leu, Lys, Trp, Met, Arg 
40 mg : Ade, Ura, Tyr 
100 mg Phe 
350 mg Thr
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20 g agar
to final volume 11 of H2O
2.1.11.2 Media for bacteria
SOC-medium: 20 g bacto tryptone
5 g yeast extract
20 g glucose
2.5 mM KC1
10 mM NaCl
10 mM MgCl2
10 mM MgS(>4
to final volume 11 of H20
TY-medium: 10 g bacto-tryptone 
5 g yeast extract 
5 g NaCl 
pH 7.5
to final volume 11 of H20
TY-plates: 11 TY-medium 
20 g bacto-agar
TY with ampicillin: Ampicillin (stock solution: 100 mg/ml in H20 )  diluted 
1:1000 in TY-medium
For plates: TY-plate solution was autoclaved and cooled 
down, then ampicillin was added.
TY with chloramphenicol: chloramphenicol (stock solution: 34 mg/ml in ethanol) 
diluted 1:1000 in TY-medium
For plates: TY-plate solution was autoclaved and cooled 
down, then chloramphenicol was added.
TY with kanamycin: kanamycin (stock solution: 30 mg/ml in H20 ) diluted 
1:1000 in TY-medium
For plates: TY-plate solution was autoclaved and cooled 
down, then kanamycin was added.
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2.1.12 Filters and membranes
Chromatography paper 3 mm
Mobicol filter columns (1 ml, 90 pm pore size)
Nalgene® bottle top filter (250 ml, 500 ml)
Protran® nitrocellulose transfer membrane
Supor® Acrodisc® 32 (0.45 pm)
2.1.13 Photographic material
Super RX Fuji medical X-ray film
2.1.14 Equipment
ABI Prism™ 377 DNA sequencer 
AC211S balance 
Axiophot microscope 
Beat beater
Capacitance Extender 
Centrifuge 4K15 
Centrifuge 5417C and 5417R 
Chilled CCD camera C5985 
Chilled CCD camera controller 
Clean bench Lamin Air® HB 2448
Delta 350, Mettler pH-electrode
Diamond knife
DU650 spectrophotometer
Whatman, Maidstone, UK 
Bioscience, Cramlington, UK 
Nalge Nunc International, 
Rochester, USA 
Schleicher & Schuell, Dassel, 
Germany
Pall Corporation, Ann Arbor, 
USA
Fuji Photo Film Co., LTD, Tokyo, 
Japan
Perkin Elmer (Wellesley, USA) 
Sartorius (Goettingen, Germany) 
Zeiss (Jena, Germany)
Biospec Products (Bartlesville, 
USA)
Biorad (Hemel Hempstead, UK) 
Sigma (Dorset, UK)
Eppendorf (Hamburg, Germany) 
Hamamatsu (Bridgewater, USA) 
Hamamatsu (Bridgewater, USA) 
Heraeus Instruments (Hanau, 
Germany)
Mettler (Giessen, Germany) 
TAAB (Aldermasten, UK) 
Beckman (Fullerton, USA)
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Electron microscope Zeiss 902 
FACScan
Gel blotter
Gel electrophoresis chamber 
Gene Pulser™
Genie 2 plus computer 
HT shaker
Incubators B12, BK600, B6420 and Cytoperm
Laseijet 2100 M 
Mettler isoCall balance 
Mettler PE360 balance 
Microferm® fermentor
Microfuge™ II and J-6B centrifuge 
Microwave
Milli Q® and Milli RO Watersystems
Mini-Protean II™ gel electrophoresis chamber
Mini-sub® cell GT gel electrophoresis chamber
Multi Drive XL
OCE 3107C printer
OCE 3165 printer
Omega™ autoclave
Orbital shaker 
Personal cycler 
Polytron PT 3100
Power Mac G4
Zeiss (Jena, Germany)
Becton & Dickinson (Franklin 
Lakes, USA)
Max Planck Institute technial 
support (Munich, Germany) 
Biometra (Goettingen, Germany) 
Biorad (Hemel Hempstead, UK) 
Viglen (Alperton, UK)
Infors AG (Bottingen, Switzer­
land)
Heraeus Instruments (Hanau, 
Germany)
Hewlett Packard (Boise, USA) 
Mettler (Giessen, Germany) 
Mettler (Giessen, Germany)
New Brunswick Scientific Co. Inc. 
(Edison, USA)
Beckman (Fullerton, USA) 
Panasonic (Tokyo, Japan) 
Millipore (Watford, UK)
BioRad (Hemel Hempstead, UK) 
BioRad (Hemel Hempstead, UK) 
Pharmacia (Uppsala, Sweden) 
OCE (Venlo, Netherlands)
OCE (Venlo, Netherlands) 
Prestige™ (Medical Blackburn, 
UK)
Forma Scientific (Marjetta, USA) 
Biometra (Goettingen, Germany) 
Kinematica (Lucerne, Switzer­
land)
Apple Macintosh (USA)
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Power Pack P25 
Power supply EPS 3500 
Power supply modell 200/2.0 
Pulse Controller 
RCT basic stirrer
Reichert Ultracut S 
Rollermixer SRT2 
Scanner Arcus II 
Sonopuls GM 200
Sorvall® RC5B centrifuge 
The imager™
Thermal printer 8670 PS 
Thermomixer 5436 
Tip sonicator UW 200
Ultra Cut S Microtone 
Ultrasound incubator Transsonic 420 
UV transiluminator UVI-tec 
Vacuum concentrator 
Varifuge 2.3RS
Vortexer VF2
Vortex-Genie 2™
Biometra (Goettingen, Germany) 
Pharmacia (Uppsala, Sweden) 
BioRad (Hemel Hempstead, UK) 
Biorad (Hemel Hempstead, UK) 
IKA Labortechnik (Staufen, 
Germany)
Leica (Wetzlar, Germany)
Stuart Scientific (Stone, UK)
Agfa (USA)
Bandelin electronics (Berlin, 
Germany)
Kendro (Bishop’s Stortford, UK) 
Appligene (Heidelberg, Germany) 
Kodak (USA)
Eppendorf (Hamburg, Germany) 
Bandelin electronics (Berlin, 
Germany)
Zeiss (Jena, Germany)
Elma® (Singen, Germany)
UVP Inc. (San Gabriel, USA) 
Bachhofer (Reutlingen, Germany) 
Heraeus Instruments (Hanau, 
Germany)
IKA-labortechnik (Staufen, 
Germany)
Scientific Laboratories (Bohemia, 
USA)
BioRad (Hemel Hempstead, UK) 
Kodak (USA)
Wide mini-sub® cell gel electrophoresis chamber 
X-omat 480 RA processor
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2.1.15 Software
Amplify 1.2 
CellQuest
DNA strider™ 1.2
Endnote 3.0
Fotolook 
Freehand 7.0
Nestcape Communicator 4.7
NIH Imagel.62
Photoshop 5.0 
Powerpoint® 97 SR-1
Word 97 SR-1
Bill Engels (Madison, USA) 
Becton & Dickinson (Franklin 
Lake, USA)
Christian Marck (Gif-Sur-Yvette 
Cedex, France)
Niles Software Inc. (Berkley, 
USA)
Agfa (USA)
Macromedia (USA)
Netscape Communicator 
Corporation (USA)
National Institutes of Health 
(USA)
Adobe (USA)
Microsoft® Corporation (Santa 
Rosa, USA)
Microsoft® Corporation (Santa 
Rosa, USA)
2.1.16 Internet services
The following internet services were used:
Entrez-PubMed: http://www.ncbi.nlm.nih.gov:80/entrez/querv.fcgi
ExPASy http://www.expasv.ch/
MIPS http://www.mips.biochem.mpg.de
SIT http://www.genome.ad.fp/SIT/SIT.html
SGD http://genome-www.stanford.edu/cgi-bin/SGD/
SOSUI http://sosui.proteome.bio.tuat.ac.ip/sosuiframeO.html
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2.2 Methods
2.2.1 Polymerase chain reaction (PCR)
DNA fragments were amplified by PCR. Plasmid and chromosomal DNA were used as 
template. The DNA polymerase activity was dependent on the MgCl2 concentration. 
The annealing temperature was adjusted for each primer pair ([n(A,T) x 2 °C + n(C,G) 
x 3 °C] -  4 °C). The elongation time was calculated as 1 min per 1 kb. Samples were 
usually cycled 25 times (n=25).
2.2.1.1 Amplification of genes
The following PCR conditions were used as standard for the amplification of genes. In 
general, three different MgCl2 concentrations were tested.
Table V: PCR pipette schemata for the amplification of
genes
in nl 1 2 3
Template (200 ng) 1 / / /
Primer 3’ (10 piM) 1 / / /
Primer 5’ (10 iliM) 1 / / /
10 x PCR buffer 10 / / /
dNTPs (2 uM) 10 / / /
MgCl2 (25 mM) variable 8 16 24
Vent polymerase 0.2 / / /
Taq DNA polymerase 0.3 / / /
h 2o ad 100 68.5 60.5 52.5
The thermocycler was programmed as ft
Denaturing 4 min 94
Cycle:
Denaturing 1 min 94
Annealing 1 min 50
Elongation 1 min/kb 72
n=25
Elongation (fill in) 5 min 72
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2.2.1.2 Colony PCR
Colony PCR is a method to amplify DNA fragments from yeast directly without 
isolation of DNA prior to the PCR reaction. This technique was mainly used to check 
the integration of genes into the yeast chromosome by amplification of the marker 
gene. Therefore, 1 ml yeast culture (OD60o=0.8) was incubated with 50 pi zymolyase 
(1 mg/ml H2O) at RT for 10 min. The spheroblasted cells were harvested by 
centrifugation (2,700 ref, 1 min, RT) and the supernatant was discarded. The pellet was 
incubated at 92 °C for 5 min before it was used as a template for the PCR reaction. The 
oligo-nucleuotides for the amplification of chromosomal markers were designed to 
prime in the marker gene and upstream and downstream of the marker gene in the 
original chromosomal regions. The following substances were added to each template:
Table VI: PCR pipette schemata 
for colony PCR
in pi
Primer 3 ’ (10 pM) 0.25
Primer 5 ’ (10 pM) 0.25
10 x PCR buffer 2.5
dNTPs (2 pM) 2.5
MgCl2 (25 mM) 1.25
Taq DNA polymerase 0.5
h 2o 17.75
Standard conditions for the thermo cycler:
Denaturing 2 min 94 °C
Cycle:
Denaturing
Annealing
Elongation
30 sec 94 °C
30 sec 50 °C
1 min 30 sec 72 °C
n=25
Elongation (fill in) 5 min 72 °C
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2.2.1.3 Mutagenic PCR
Mutagenic PCR, PCR under in-optimal conditions, was employed to produce faulty 
copies of wild type genes, which could be used to construct conditional lethal mutants 
in yeast. Firstly, the optimal conditions (MgCl2 concentration, annealing temperature, 
elongation time) for the amplification of the DNA fragment were established as in
2.2.1. For the mutagenic PCR, the concentration of dATP was varied and/or MnCl2  
was added to compete for Mg2+- binding of the DNA polymerase. These conditions 
lead to mistakes by the amplification of the DNA fragment causing mutations in the 
sequence. In addition, Goldstar (see 2.1.3), a DNA polymerase was used which is 
known to frequently make mistakes during the amplification. Several conditions were 
tested:
Table VII: PCR pipette schemata for mutagenic PCR
in pi + 1 2 3 4 5
Template (200 ng) 1 / / / / / /
Primer 3’ (10 pM) 1 / / / / / /
Primer 5’ (10 pM) 1 / / / / / /
10 x PCR buffer 10 / / / / / /
dCTPs (2 pM) 2 ✓ / / / / /
dGTPs (2 pM) 2 / / / / / /
dTTPs (2 pM) 2 / / / / / /
dATPs (2 pM) variable 2 0.4 2 2 0.8 0.8
MgCl2 (25 mM) optimal / / / / / /
MnCl2 (25 mM) variable - - 4 6 4 6
goldstar 0.5 / / / / / /
h 2o ad 100 68.5 60.5 52.5 52.5 52.5 52.5
The PCR mix was cycled under optimal conditions established before (see 2.2.1).
2.2.1.4 Amplification of cassettes
Conditions for the amplification of cassettes for epitope tagging and deletion of genes 
were established as described in 2.2.1. Templates were chosen according to the 
application (see 2.2.16 and 2.2.17). The different plasmids (pYMl, pYM4, pYM5, 
pYM6 , pYM8  and pYM12) are listed in Table II. Sl/S2-primer pairs (see 2.1.6) were
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used for the amplification of deletion cassettes and S2/S3-primer pairs (see 2.1.6) for 
epitope tagging. PCR reactions were cycled under the following standard conditions:
Denaturing 5 min 94 °C
Cycle:
Denaturing 1 sec 94 °C
Annealing 1 sec 54 °C
Elongation 2 min 30 sec 72 °C
n=25
Elongation (fill in) 5 min 72 °C
2.2.2 Precipitation of DNA
Plasmid DNA was precipitated with ethanol or isopropanol. For the ethanol 
precipitation, two volumes of ethanol (ice cold) and 1/10 volume of 3 M sodium 
acetate were added to one volume of DNA. The sample was incubated on ice for 
10 min, before centrifugation in an Eppendorf centrifuge at 4 °C for 20 min.
For the isopropanol precipitation, 2 volumes of isopropanol and 1/10 volume of 3 M 
sodium acetate were added to one volume of DNA. The DNA was precipitated by 
centrifugation in an Eppendorf centrifuge at RT for 20 min.
The precipitate was washed in 70 % (v/v) ethanol, dried in the vacuum concentrator for 
5 min and taken up in an appropriate volume of H2O.
2.2.3 Restriction digest
The conditions (buffer, temperature) for restriction digests were chosen according to 
the manufacturer. Restriction of DNA with two restriction endonucleases (double 
digest) was done simultaneously if both enzymes had sufficient activity (more than 
75 %) under the same conditions. Otherwise the digests were done in succession. After 
completion of the first digest the enzyme was inactivated (heat inactivation or phenol 
chloroform extraction) before the second enzyme was added. In addition, if the 
enzymes had different optimal buffers, the partially restricted DNA was precipitated
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(ethanol or isopropanol precipitation) and taken up in the optimal buffer for the second 
restriction enzyme.
2.2.4 Gel electrophoresis
2.2.4.1 Separation of DNA
Nucleic acids were separated via the standard method of agarose gel electorphoresis 
which employs the migration of the negatively charged DNA in the electric field 
(Sambrook et al., 1989). The concentration of the agarose gels and the time of the 
electrophoresis were adjusted according to the expected fragment size. TAE-buffer and 
a current of 90 V were used as standard conditions. The DNA probes were loaded onto 
the gels after addition of 1/6 volume of DNA loading buffer (see 2.1.2). The Gibco 
1 kb ladder was used as size marker (see 2.1.5.1).
2.2.4.2 Separation of proteins (SDS-PAGE)
Proteins were separated under denaturing conditions by SDS-PAGE (Laemmli, 1970). 
BioRad Miniprotean gel systems were used for small acrylamide gels with 
concentrations of 8 , 1 0 , 1 2  and 18 % according to the expected size of the proteins. 
The Biometra gel system was useful for the separation of proteins on gradient gels due 
to the larger gel size. 4 % stacking gels were used for both systems.
Table VIII: Acrylamide gels for SDS-PAGE
type of gel 8 % 10 % 12 % 18 % 4 % stacking gel
(for 2 Miniprotean 
gels)
acrylamide (30 %) in ml 2.1 3.35 4.0 6 . 0 0.65
1.5 M Tris-HCl (pH 8 .8 ) in ml 2.5 2.5 2.5 2.5 -
0.5 M Tris-HCl (pH 6 .8 ) in ml - - - - 1.25
H2 O in ml 4.7 4.0 3.4 1.35 3.1
10 % (w/v) SDS in pi 1 0 0 1 0 0 1 0 0 1 0 0 50
10 % (w/v) APS in pi 50 50 50 50 25
TEMED in pi 5 5 5 5 5
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For the gradient gels, 8  % and 18 % solutions were prepared, whereby for the 18 % 
mixture 1 ml of H2O was replaced with 1 ml 50 % (v/v) glycerol. Both solutions were 
mixed with help of a gradient mixer while the gel was poured.
Protein samples were taken up or mixed with HU-buffer and were incubated at 65 °C 
for 5 min. After 5 min centrifugation at 15,300 ref, up to 20 pi (Miniprotean) or 30 pi 
(gradient gel) were loaded onto the gel.
The gradient gels were run at 25 mA and 200 V per gel for up to 6  h. The conditions 
for the Miniprotean gels were 25 mA and 180 V per gel, with the running time 
dependent on the percentage of the gel. Laemmli running buffer (see 2.1.2) was used 
for both applications.
2.2.5 Staining techniques
2.2.5.1 Staining of DNA
Agarose gels containing DNA which had been separated by electrophoresis were 
stained for 20 min in an ethidium bromide solution (20 ng in 20 ml H2 O). Afterwards, 
the gels were washed in H2O for 20 min before the DNA was analysed with the UV 
transiluminator.
2.2.5.2 Staining of proteins
The choice of the staining method was dependent on the expected protein amount. 
Coomassie Blue staining was used as standard method. The more sensitive Fairbanks 
method (Fairbanks et al., 1971) was suitable to stain protein bands containing as less as 
100 ng of protein. If Fairbanks staining was unsuccessful, protein gels were destained 
and re-probed by silver staining.
2.2.5.2.1 Coomassie Blue staining
The acrylamide gel was incubated in staining solution consisting of 0.25 % (w/v) Serva 
blue G (Serva, Heidelberg, Germany), 7 % (v/v) acetic acid and 50 % (v/v) methanol 
for a minimum of 30 min. Afterwards, the gel was washed in destain solution
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(7 % (v/v) acetic acid, 50 % (v/v) methanol) until the background was again 
transparent. The gel was finally washed in H2O and was stored in H2O at 4 °C, or was 
dried in the gel dryer.
2.2.5.2.2 Fairbanks staining
The Fairbanks method was mainly used to stain gradient gels. Firstly, the gel was 
incubated in destain solution (7 % (v/v) acetic acid, 50 % (v/v) methanol) before it was 
transferred to the staining solution (25 % (v/v) isopropanol, 10 % (v/v) acetic acid, 
0.05 % (w/v) Serva blue G (Serva, Heidelberg, Germany)). After 45 min of staining the 
gel was slowly destained in 1 0  % (v/v) isopropanol, 1 0  % (v/v) acetic acid, 
0.005 % (w/v) Serva blue G for 30 min and then in 10 % (v/v) acetic acid, 
0.002 % (w/v) Serva blue G for 30 min. Finally, the gel was incubated in 10 % (v/v) 
acetic acid until the background was reduced completely. The gel was washed several 
times in H2O before it was dried in the gel dryer or it was stored in H2O at 4 °C.
2.2.5.2.3 Silver staining
This silver staining method was suggested by A. Shevchenko (EMBL, Heidelberg, 
Germany; personal communication) as suitable for staining of proteins which should 
be analysed by MALDI-MS (see 2.2.26). The chemicals used in this protocol do not 
covalently modify proteins and therefore, do not interfere with the identification of 
peptide weights by MALDI-MS.
The SDS-gel was rinsed two times for 2 min in H2 O. The gel was incubated for 1 h in 
H2O on a shaker. The longer the washing time the more of the yellowish background 
could be removed. The gel was incubated in 0.02 % (w/v) sodium thiosulfate for 
2 min. After two washes with H2O the gel was submerged in chilled 0.1 % (w/v) silver 
nitrate for 30 min on a shaker in the cold room. The silver nitrate solution was 
discarded and the gel was rinsed twice for 30 sec in H2O. The gel was developed in a 
solution consisting of 0.04 % (v/v) formaldehyde in 2 % (w/v) sodium carbonate. The 
developer solution was replaced if it turned yellow. The staining was stopped by 
discarding the developing solution and addition of 1 % (v/v) acetic acid. The gel was
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washed several times in 1 % (v/v) acetic acid. The gels were stored in 1 % (v/v) acetic 
acid at 4 °C.
2.2.6 Extraction of DNA from agarose gels
Nucleic acids were isolated from agrose gel slices using the Qiaex™ gel extraction kit 
(Qiagen).
2.2.7 Culture of strains
2.2.7.1 Culture of E. coli strains
Liquid cultures of E.coli were inoculated by transferring cells from freezer stocks, 
plates or pre-cultures with sterile glass pipettes into the appropriate growth medium. 
TY-medium (see 2.1.11.2), a non-selective growth medium was used for growing 
DH5a and Sure cells. TY-Ampicillin-medium (see 2.1.11.2) was used for the selection 
of plasmids carrying the bla gene for ampicillin resistance (pRS-vectors, pGEX-5X-l, 
pEG202, pACTII). TY-chlorampenicole-medium (see 2.1.11.2) selected for plasmids 
with the chloramphenicol marker (pLysS) and TY-kanamcyin for the pET28c plasmid 
harbouring the kan gene. The culture volume was dependent on the application. In 
general, cultures were incubated overnight at 37 °C. In special cases, cultures were 
incubated shorter and at lower temperatures, for example to avoid degradation of 
proteins expressed in the pGEX or the pET vector systems.
If E. coli cells were grown on plates, the medium was selected accordingly (see above) 
and plates were incubated overnight at 37 °C. Strains from liquid culture were plated 
out using a sterile spatula. Cells from freezer stocks or plates were transferred using 
sterile glass pipettes or sterile tooth picks.
2.2.7.2 Culture of yeast strains
In contrast to E. coli, yeast can not be grown successfully in liquid culture if inoculated 
directly from freezer stocks. Therefore, yeast cells from freezer stocks were firstly 
incubated on plates. Newly made yeast strains that are yeast strains which have been
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genetically manipulated were usually grown on plates first. For growth of yeast cells in 
liquid culture, a pre-culture was inoculated with cells from plates and incubated 
overnight. The main culture was inoculated with the pre-culture considering the growth 
rate of the strain and the culture volume. For example, a YPH499 culture which had 
been incubated at OD6oo=0.003 would have a OD6oo=0.8 after about 12 h. The 
optimum growth temperature of wild type strains is 30 °C. Temperature sensitive 
mutants were incubated at the permissive temperature before shift to the restrictive 
temperature. The growth medium was dependent on the application. Wild type strains 
were grown in YPD, YPAD or SC-complete medium (see 2.1.11.1). Plasmids were 
selected for by growth in SC-medium lacking the amino acid or base whose synthesis 
was encoded by the selective marker of the plasmid. If strains were manipulated by 
chromosomal integration of genes, the transformation was established by growth on 
selective medium before these strains were grown on non-selective medium.
If large culture volumes were needed, yeast strains were grown in fermenters. Up to 
36 1 of culture could be obtained.
2.2.8 Cloning
In this study, transgenic E. coli strains containing plasmid-DNA coding for yeast genes 
were produced. Yeast strains were altered to carry plasmids coding for additional 
copies of genes or mutated yeast genes. Chromosomal copies of yeast genes were 
manipulated by deletion, mutation and epitope tagging.
Genes were amplified by PCR and the primers were often designed to harbour 
restriction sites for endonucleases to simplify the cloning. Plasmids were first 
amplified in E. coli before transformation into yeast. The integration of DNA into the 
yeast chromosome is possible due to homologues recombination.
2.2.8.1 Preparation of vectors
Plasmid DNA was prepared by restriction digest. After the restriction digest, the 
enzymes were inactivated by heat (65 °C, 10 min) or phenol/chloroform extraction. 
The plasmid backbone was separated from the cut out fragment by agarose gel
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electrophoresis (see 2.2.4.1). The plasmid was subsequently extracted from the gel (see
2.2.6). If only one enzyme was used for the linearisation of the vector or if the enzyme 
was a blunt-end cutter, the DNA ends had to be dephosphorylated to avoid re-ligation. 
Therefore, 3 pg of cut plasmid were taken up in 89 pi H2O, 10 pi alkaline phophatase 
buffer and 1 pi alkaline phosphatase and incubated at 37 °C for 1 h. The alkaline 
phosphatase was inactivated by incubation at 65 °C for 1 h. The plasmid DNA was 
precipitated and taken up in 30 pi H20 .
2.2.8.2 Preparation of inserts
Genes were amplified by PCR (see 2.2.1). They were either ligated into vectors using 
restriction sites in the PCR primers or in the gene itself. After the restriction digest (see 
2.2.3), DNA fragments were separated by agarose gel electrophoresis (see 2.2.4.1) and 
the gene was isolated by gel extraction (see 2 .2 .6 ).
In addition, some fragment were ligated blunt end, if no suitable restricition sites were 
available. Therefore, sticky ends were filled in with Klenow polymerase. For this, the 
following reaction mix was prepared and the mixture was incubated for 3 h at 37 °C:
200 ng of DNA 
5 mM NTPs each
1 u Klenow enzyme
2 pi Klenow buffer 
made up to 20 pi H20
After the fill in reaction, the Klenow enzyme was heat inactivated (65 °C, 10 min) and 
the DNA was precipitated (see 2.2.2), washed and dried and then taken up in H20 . The 
fragments could then be ligated into plasmids (see 2.2.8.3).
MATERIALS AND METHODS 69
2.2.8.3 Ligation
For the ligation of DNA fragments into plasmids, 50 ng plasmid DNA, 1 pi ligation 
buffer 0.4 pi ATP (25 mM), 1 pi ligase and 200 ng fragment-DNA in an final volume 
of 10 pi were incubated overnight in the cryostate at 13 °C.
2.2.8.4 Competent cells
In this study, competent yeast and E. coli cells were used for transformation. E. coli 
cells were usually sensitised by the CaCl2 -method. For the transformation of E. coli (see 
2.2.8.5.1) with yeast-mini DNA which is low in DNA concentration, electro-competent 
cells were prepared. Lithium chloride competent yeast cells were used for the 
transformation with plasmids and PCR fragments.
2.2.8.4.1 Competent E.coli cells
2.2.8.4.1.1 CaCl2-competent cells
Firstly, a 10 ml TY pre-culture was inoculated with DH5a (see 2.2.7.1) cells. It was 
incubated overnight at 37 °C. Secondly, 0.5 ml of pre-culture were transferred into a 
flask with 100 ml TY- medium. This culture was incubated at 37 °C until OD6oo=0.3 to 
0.4 was reached (about 3 to 4 h). Afterwards the culture was incubated on ice for 
10 min. The cells were harvested by centrifugation at 4 °C at 2,700 ref for 5 min. The 
pellet was resuspended in 5 ml cold 50 mM CaCL and the cells were again harvested 
by centrifugation. After the CaCL washing step had been repeated once more, the cells 
were taken up in 0.5 ml CaCL. The cells were used immediately or glycerin was added 
to a final concentration of 2 0  % and the cells were frozen in liquid nitrogen and stored 
a t- 8 0  °C.
2.2.8.4.1.2 Electro-competent cells
An E.coli culture was prepared as described in 2.2.8.4.1.1 and the culture was chilled 
on ice for 30 min. The cells were harvested by centrifugation at 4 °C at 1,090 ref for 
10 min. The pellet was taken up in ice cold water and the cells were harvested again by 
centrifugation. This washing step was repeated twice more. The pellet was taken up in
MATERIALS AND METHODS 70
an equal volume of ice-cold 10 % (v/v) glycerol. Cells were used immediately for 
transformation (see 2.2.8.5.1) or were frozen in liquid nitrogen and stored at -  80 °C.
2.2.8.4.2 Competent yeast cells
Yeast medium (10 ml) was inoculated and this pre-culture was incubated overnight at 
the optimal temperature for the specific yeast strain. The following day, 200 ml of 
medium were inoculated with the pre-culture (OD6oo=0.003) and the culture was 
harvested by centrifugation (4 °C, 1,090 ref, 5 min) at OD6oo=0.6 to 0.8. The cells were 
resuspended in one culture volume of H20  and the cells were again harvested by 
centrifugation. The pellet was then taken up in V* culture volume of LiSorb and the 
cells were spun down by centrifugation. The supernatant was removed completely and 
the cells were resuspended in 300 pi LiSorb per 50 ml culture volume. Salmon sperm 
DNA that had been denatured at 95 °C for 5 min was cooled on ice and 5 pi DNA were 
added to 50 pi yeast cells. The cells were used immediately or were frozen for storage 
at -  80 °C.
LiSorb: 100 mM LiOAc
10 mM Tris-HCl (pH 8.0)
1 mM EDTA (pH 8.0)
1 M Sorbitol 
sterilfiltered
2.2.8.5 Transformation
Competent E. coli and yeast cells prepared as described in 2.2.8.4. were used for 
transformation.
2.2.8.5.1 Transformation of bacteria cells
2.2.8.5.1.1 Transformation of CaCI2-competent cells
50 pi of CaCl2 -competent E. coli cells were incubated with up to 5 pg of plasmid DNA 
on ice for up to 1.5 h. Cells were heat shocked at 42 °C for 60 sec, before they were 
taken up in 1 ml SOC-medium (see 2.1.11.2). They were incubated in a shaker at 37 °C
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for one hour. Cells were harvested in an Eppendorf centrifuge (4 °C, 2,700 ref, 5 min), 
taken up in 100 pi TY-medium (see 2.2.11.2) and plated out on selective plates.
2.2.8.5.1.2 Transformation of electro-competent cell
100 pi of electro-competent E. coli cells were incubated with up to 2 pg of plasmid 
DNA in a 100 pi electroporation cuvette on ice for up to 1 h. The cells were 
transformed using a BioRad electroporator at the following settings: 1.8 kV, 100 Ohms 
and 125 pED. The cells were taken up in 1 ml SOC medium and treated as described in
2.2.8.5.I.I.
2.2.8.5.2 Transformation of yeast cells
Lithium competent yeast cells (50 pi, see 2.2.8.4.2) were mixed with 0.5 to 5 pi 
plasmid DNA (up to 5 pg) and 300 pi LiPEG (see below) by vortexing. The mixture 
was incubated at RT for 20 min. DMSO (35 pi) was added to the cells under vortexing. 
The cells were incubated at 42 °C (wild type: 15 min; conditional lethal mutants: 
5 min) and afterwards were harvested by centrifugation (4 °C, 1,090 ref, 5 min). Cells 
were taken up in 200 pi PBS and were transferred onto selective plates. 
Transformations using the marker gene for kanamycin resistance were taken up in 3 ml 
YPD-medium and were incubated at 30 °C for 3 h before transfer on selective plates.
LiPEG: 100 mM LiOAc
10 mM Tris-HCl (pH 8.0)
1 mM EDTA (pH 8.0)
40 % (w/v) Polyethylene glycol 
sterilfiltered
2.2.9 Freezer stocks
2.2.9.1 Freezer stocks of E. coli strains
A liquid culture of E. coli cells (1 ml) was mixed with 0.5 ml 50 % (v/v) glycerol in a 
sterile cryo-tube by vortexing. The sample was stored immediately at -  80 °C.
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2.2.9.2 Freezer stocks of yeast strains
About 10 mm3 of fresh yeast cells from liquid cultures or plates were transferred into a 
sterile cryo-tube containing 1 ml 15 % (v/v) glycerol. The cells were dispersed by 
vortexing. To avoid the sedimentation of cells, the mixture was quickly frozen by 
placing the tubes on dry ice before storage in the -  80 °C freezer.
2.2.10 Isolation of DNA
2.2.10.1 Isolation of plasmid DNA from E. coli
Plasmid DNA was isolated from E. coli cells by alkaline lysis. For the isolation of 
Mini-DNA (up to 20 ng) cells of 1 ml culture were harvested by centrifugation (4 °C, 
2,700 ref, 5 min) in an Eppendorf centrifuge. The pellet was taken up in 300 pi Qiagen 
buffer 1 (see 2.1.2). After addition of 300 pi Qiagen buffer 2 (see 2.1.2), the solution 
was mixed gently and before Qiagen buffer 3 (see 2.1.2) was added and the solution 
was again mixed with care. The sample was spun in an Eppendorf centrifuge (4 °C,
20,800 ref, 20 min) and the supernatant was transferred into a new Eppendorf tube. 
The plasmid DNA was precipitated by addition of 0.5 ml isopropanol and 
centrifugation (RT, 20,800 ref, 20 min). After washing and drying, the DNA was taken 
up in 50 pi H2O.
Larger amounts of plasmid DNA (up to 200 pg) were isolated from a 50 ml E. coli 
culture using the Qiagen MIDI kit (see 2.1.4).
2.2.10.2 Isolation of plasmid DNA from yeast (plasmid rescue)
DNA containing plasmid DNA was isolated from yeast. Since the yield is usually very 
low, the plasmids were then transformed into E. coli cells for amplification.
Cells of 1 ml yeast overnight culture or about 2 mm of yeast cells from a fresh plate 
were washed in 1 ml of H2O. The cells were pelleted by centrifugation (4 °C, 1,090 ref, 
5 min), taken up in 0.5 ml of S-buffer (see below) and incubated for spheroblasting at 
37 °C for 30 min. After the cells were spheroblasted (cells were dark and round under
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the light microscope), they were lysed in 0 . 1  ml lysis solution (see below) by 
incubation at 65 °C for 30 min. 3 M potassium acetate (166 pi) was added and the cells 
were chilled on ice for 10 min. The sample was spun in an Eppendorf centrifuge (4 °C,
20,800 ref, 1 0  min) and the supernatant was transferred into a new tube before the 
DNA was precipitated by adding 0.8 ml of cold ethanol. After the pellet was washed 
with 70 % (v/v) ethanol, the DNA was dried and taken up in 40 pi of H2O. About 2 pi 
of DNA were used for the transformation of 100 pi of E. coli cells (see 2.2.8.5.1.2).
S-buffer: 10 mM K2HP0 4 pH 7.2
10 mM EDTA
50 mM p-mercaptoethanol
50 pg/ml zymolyase (25 T)
Lysis solution: 25 mM Tris-HCl pH 7.5
25 mM EDTA 
2.5 % (v/v) SDS
2.2.10.3 Isolation of chromosomal DNA from yeast
Chromosomal DNA was isolated from yeast as template for the amplification of wild
type genes. Furthermore, for the testing of chromosomal integration of epitope tags or
deletion of genes by amplification of marker genes by PCR.
Cells of a 1.5 ml yeast culture (OD60o=1.0) were harvested by centrifugation (4 °C, 
1,090 ref, 5 min) and the cells were washed with 1 ml of H20 . The cells were taken up 
in 200 pi Qiagen buffer 1 (see 2.1.2) containing 2 ml p-mercaptoethanol and 0.04 mg 
zymolyase (20,000 U/mg). The mixture was incubated at 37 °C for 1 to 2 h. The tubes 
were occasionally inverted to stop the sedimentation of cells. After this spheroblasting 
step, 200 pi Qiagen buffer 2 (see 2.1.2) were added and the solutions were mixed 
carefully. The cells were incubated at 65 °C for 20 min to complete the formation of 
spheroblasts. Qiagen buffer 3 (200 pi, see 2.1.2) was added and the cells were set on 
ice for 15 min to precipitate proteins. The solution was centrifuged (RT, 15,300 ref, 
3 min) and the supernatant was transferred into a new tube. The chromosomal DNA 
was precipitated by addition of 600 pi isopropanol and incubation at RT for 5 min. The 
sample was centrifuged at RT and 15,300 ref for 30 sec and the supernatant was
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removed. The DNA pellet was incubated in 1 ml of 70 % (v/v) ethanol for at least 
10 min to allow the diffusion of salt ions into the washing solution. After 
centrifugation (RT, 15,300 ref, 30 sec) the pellet was dried very shortly, the DNA was 
taken up in 35 pi of H2 O and was incubated at RT on a shaker for at least 15 min. The 
chromosomal DNA was stored at -  20 °C.
2.2.11 Measurement of DNA concentration
The concentration of plasmids and oligonucleotides was measured according to 
Sambrook (1989). The DNA was diluted 1:1000 with H2O and the absorption was 
measured at 260 nm (A26 0) using a Beckman spectrometer. The concentration of the 
DNA was calculated with the following formulas whereby S represents the size of the 
DNA in kilobases:
Single stranded DNA: C (pmol/pl) = A26o'(10 x S)
Double stranded DNA: C (pmol/pl) = A26o'(13.2 x S)
2.2.12 Measurement of protein concentrations
The concentration of proteins was measured by the TCA-method (Trichloroacetic 
acid). For example, protein concentrations were measured to load equal amounts of 
proteins on SDS-PAGE gels and to ensure that samples contained similar amounts of 
total yeast extract for immunoprecipitations. Proteins were concentrated in solution by 
the following protocol. 300 pi of protein solution were mixed with 300 pi 30 % (w/v) 
TCA. The suspension was measured in the photometer at 340 nm (A340). If necessary 
the measurement was calibrated using BSA solutions of known concentrations.
2.2.13 Western blotting
Proteins that had been separated by SDS-PAGE (see 2.2.4.2) were transferred onto 
nitrocellulose membranes (see 2.1.12) by electro blotting. Therefore, the acrylamide 
gel was soaked in blotting buffer (see 2.1.2) for at least 5 min. One sheet of 
nitrocellulose, slightly larger in size than the protein gel and 6 sheets of 3 mm
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Whatman paper (see 2.1.12) which were larger than the nitrocellulose sheet were 
soaked in blotting buffer for 3 min. A sandwich consisting of 3 Whatman sheets, one 
nitrocellulose sheet, the protein gel topped with 3 Whatman papers was formed in a 
blotting apparatus. The standard blotting conditions were a maximum of 0.2 mA per 
gel for 1.5 h. Proteins on nitrocellulose sheets were stained with Ponceou S solution 
(1 % (v/v) acetic acid, 0.5 % (w/v) Ponceau S) for 2 min before the background was 
reduced by washing with H2O.
In general, blots were blocked in TBS (see 2.1.2) containing 1 % (w/v) milk powder 
(Premier Brand, Moreton, UK) overnight at 4 °C. The blots were washed twice with 
TBS before they were incubated at RT for up to 1.5 h with the primary antibody (see 
2.1.10) in TBS or TBS containing 0.1 % (w/v) milk. The antibody solution was 
discarded and the blots were washed up to 5 times with TBS or TBS containing 0.1 % 
(v/v) Tween 20. After incubation at RT with the secondary antibody (see 2.1.10) 
coupled to horse radish peroxidase (HRP) for up to 1 h in TBS or TBS containing 
0.1 % (w/v) milk, the blots were washed 3 times with TBS containing 0.1 % (v/v) 
Tween 20 and twice with TBS or 5 times with TBS. The blots were probed with the 
ECL kit (see 2.1.4) and fluorescence emission was recorded on X-ray films (see
2.1.13).
2.2.14 Automated sequencing
Plasmid DNA was sequenced by automated cycle sequencing using an ABI sequencer. 
This method is based on the principle method developed by Sanger et al. (1977). For 
this study, fluorescent labelled bases were used (Big dye labelling mix, ABI) to 
terminate the elongation reaction. The primer was chosen according to the application. 
Double strand DNA (200 to 500 ng) and about 25 ng of primer DNA were mixed with 
6 p,l ABI Big-dye and the reaction mix was cycled in a thermal cycler with the 
following programme:
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Denaturing 5 min 0 n
Cvcle:
Denaturing 30 sec 95 °C
Annealing 10 sec 55 °C
Elongation 4 min 60 °C
n=25
The DNA was then precipitated by ethanol precipitation (see 2.2.2), washed and dried. 
Preparation of sequencing gels, loading of gels and the analysis of the data were 
provided by the in-house sequencing service.
2.2.15 FACS analysis
The flow analysis cytometry system (or originally called the method of ‘Fluorescence 
Activated Cell Sorting’, FACS (Bonner et al., 1972)) was used to measure the DNA 
content of yeast cells. The DNA content is a good indicator for the cell cycle stage of 
yeast cells.
Cells of a 5 ml yeast culture (OD6oo=0.4 to 1.0) were sonicated for 1 min in the ultra 
sound bath before they were harvested by centrifugation (4 °C, 510 ref, 10 min) in an 
Eppendorf centrifuge. The pellet was resuspended in 2 ml 70 % (v/v) ethanol and the 
cells were incubated for at least 2 h on a roller. The cells were again spun, the 
supernatant was discarded and the cells were taken up in 0.5 ml 50 mM Tris-HCl 
(pH 7.8). The cells were pelleted by centrifugation and were resuspended in 0.5 ml 
50 mM Tris-HCl (pH 7.8). This washing step was repeated once more and the pellet 
was taken up in 0.8 ml 50 mM Tris-HCl (pH 7.8). 200 pi of RNAse A (5 mg/ml 
50 mM Tris-HCl (pH 7.8)) were added and the cells were incubated on a roller at RT 
overnight. The next day 100 pi RNAse A (5 mg/ml 50 mM Tris-HCl (pH 7.8)) were 
added and the cells were incubated at 37 °C for 1 h. The cells were spun, taken up in
0.5 ml of pepsin (5 mg/ml 55 mM HC1) and were incubated at 37 °C for 30 min. After 
centrifugation, the cells were washed with 1 ml buffer w (200 mM Tris-HCl (pH 7.5) 
containing 211 mM NaCl and 78 mM MgCk) and were pelleted again. The cells were
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then resuspended in 0.5 ml of buffer w and 55 pi of 500 pg/ml propidium iodide in 
water were added. The cells were incubated for at least 15 min. Afterwards 50 pi cell 
suspension were transferred into a FACS tube (Falcon 2052) containing 2 ml 50 mM 
Tris-HCl (pH 7.8). The cells were again sonicated in the ultra sound bath for 2 min 
before reading on the FACS. A minimum of 50,000 events was measured at ‘Low 
Flow’ rate. Forward and side scatters were analysed with the CellQuest software (see 
2.1.16).
2.2.16 Epitope tagging of yeast strains
Epitope tagging of yeast genes was done using PCR based techniques (Knop et al., 
1999; Longtine et al., 1998; Schneider et al., 1995; Wach et al., 1997) and homologues 
recombination in yeast. Modules, containing the genes coding for epitope tags and 
selection markers were used as PCR templates. In this study, cassettes for 3’-tagging 
with GFP-, Myc-, HA- and Protein A were used (Knop et al., 1999) (see 2.1.7). 
Selection markers were KanMX6, His3MX6 (Wach et al., 1994, 1997) and the TRP1 
gene from Kluyveromyces lactis (klTRPl). The primers (S2 and S3 primers, see 2.1.6) 
were designed to amplify cassettes and to contain homologues regions for the 
integration into the chromosome. Amplification of cassettes by PCR was done as 
described in 2.2.1.4. PCR products were precipitated by ethanol precipitation (see
2.2.2), were washed and taken up in water. Haploid wild type strains like YPH499 and 
ESM357 (see 2.1.9) were transformed (see 2.2.8.5.2) with the PCR product and the 
integration of cassettes into the chromosome was controlled on selection plates. 
Integration was additionally tested by colony-PCR (see 2.2.1.2) and Western blotting 
with antibodies directed against the tags (see 2.2.13).
2.2.17 Construction of yeast deletion strains and shuffle strains by 
microscopic dissection (spore analysis)
One copy of a specific gene was deleted in the diploid YPH501 strain by replacing the 
ORF with a marker gene. The primers (SI and S2 primer, see 2.1.6) were designed to 
amplify the marker gene. In addition, they contained flanking regions homologous to 
sequences upstream and downstream of the coding region. The markers were amplified
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by PCR (see 2.2.1.4) using the pFA6-kanMX4 or pFA6-HIS3MX6 modules (Wach et 
al., 1994) (see 2.1.7). The PCR products were precipitated by ethanol precipitation (see
2.2.2), were washed and taken up in water. They were transformed (see 2.2.8.5.2) into 
diploid YPH501 (see 2.1.9) cells and the integration of cassettes into the chromosome 
was controlled on selective plates (SC-His or kanamycin plates). Integration was 
additionally tested by colony-PCR (see 2.2.1.2).
The constructed strain was then further investigated by spore analysis. Firstly, the 
strain was forced to sporulate due to sub-optimal growth conditions. Therefore, cells 
were plated out on SPO-plates (see 2.1.11.1) which only provided Va of the optimal 
amino acid content required for normal growth. Cells were incubated for up to 4 d at 
23 °C. Formation of tetrads containing four spores was controlled under the phase 
contrast microscope. Tetrads (2 mm ) were scraped of the SPO-plate and were taken 
up in 200 pi of H2O. 3 pi of zymolyase 20T (stock solution: 27 mg/ml H2O) were 
added and the cells were incubated at RT for up to 10 min. The terades were separated 
into 4 single spores with the dissecting microscope. Firstly, the spores were incubated 
on YPD-plates. If all four spores were able to grow and two out of four spores were 
able to grow after replica plating (see 2.2.19) on selective plates, the deleted gene was 
non-essential. If only two out of four spores grew on non-selective plates and these two 
spores did not grow on selective plates, the deleted gene was essential for growth.
Shuffle strains are strains which lack the chromosomal copy of a gene, but carry a wild 
type copy of this gene on a CEN-based t/RA3-plasmid. These strains were constructed 
as follows. A diploid strain with one copy of a specific gene replaced with a marker 
(HIS3, KAN) was transformed (see 2.2.8.5.2) with a pRS316 plasmid carrying a wild 
type copy of the specific gene with its own promoter. The strain then underwent spore 
analysis. Colonies which evolved from a single spore and carried the deletion marker 
(HIS3 or KAN) as well as the URA3 marker were selected.
2.2.18 Construction of conditional lethal yeast strains
Conditional lethal mutants are yeast strains which carry mutations in a specific gene or 
a specific region of a gene. The strains were selected that the mutation only leads to a
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growth defect if the strain is incubated above the permissive temperature. In this study, 
temperature sensitive mutants in BBP1 and MPS2 were constructed using PCR 
techniques and homologous recombination. Defects leading to the growth inhibition 
were analysed and potential functions of the gene product were proposed.
For the construction of a conditional lethal yeast strain, the selected gene was 
mutagenised by PCR (see 2.2.1.3). A CEN plasmid containing the wild type copy of 
the gene was constructed (see 2.2.8) and two restriction sites were selected to cut out a 
region of the gene which should be mutated. The mixture of mutated PCR fragments 
obtained in the different mutagenic PCR reactions and the plasmid containing flanking 
regions of the wild type gene were transformed (see 2.2.8.5.2) into the shuffle strain 
(see 2.2.17). If homologues recombination took place, the PCR fragment had been 
ligated into the cut vector and the yeast strain obtained the ability to grow on plates 
selective for the plasmid marker gene. Transformants were incubated at 23 °C 
(permissive temperature) on plates selective for the markers of the shuffle strain and 
the multi-copy plasmid. At least 50,000 colonies were investigated. The cells were 
replica plated (see 2.2.19) on 5-FOA plates to select against the C//?A3-plasmid of the 
shuffle strain carrying the wild type gene (see 2.2.20). The remaining colonies were 
replica plated on plates selecting for the marker gene of the multi-copy plasmid and 
were tested for growth at 30 °C, 33 °C, 35 °C and 37 °C. Colonies which were unable 
to grow at these temperatures were selected and the plasmids were isolated by yeast 
DNA isolation (see 2.2.10.2). The plasmids were then transformed into E. coli cells 
(see 2.2.8.5.1.2), were amplified and then isolated using the Qiagen Midi kit (see
2.2.6). The plasmids were re-transformed into the yeast shuffle strain. Transformants 
were replica plated on 5-FOA-plates and were tested for growth above 23 °C. Inserts of 
plasmids which were still able to cause a synthetic lethal phenotype were cloned into 
yeast integration vectors and the genes were integrated into the chromosome. 
Conditional lethal mutants were analysed throughout the cell cycle using FACS 
analysis (see 2.2.15), immunofluorescence (see 2.2.33.2) and morphological electron 
microscopy (see 2.2.34.1).
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2.2.19 Replica plating
Replica plating is a technique to transfer yeast colonies from one plate to another 
thereby the original pattern of colonies is maintained. Yeast cells were grown on plates 
and the yeast colonies were transferred onto a sterile velvet cloth, which was held in 
place on a solid plastic cylinder. The pattern was then transferred onto other plates by 
carefully pressing the new plate onto the velvet. The plates were incubated for 1 day at 
the appropriate temperature.
2.2.20 5-FOA selection
Plasmids containing the URA3 marker gene could be counter selected for by incubation 
of strains on 5-FOA (5-fluoro-orotic acid) plates. Strains which contain a URA3 gene 
can convert 5-FOA to 5-fluoro-uridine monophosphate (5-FUMP) which will be 
converted into fluorodeoxyuridine which is a potent inhibitor of thymidylate synthetase 
and therefore toxic to cells. Taken together, cells which keep the URA3 plasmid, die 
due to accumulation of the toxic metabolite and cells which loose the URA3 plasmid 
are able to grow unaffectedly on 5-FOA plates (see 2.1.11.1). Cells were incubated on 
5-FOA plates for up to 3 d. Cells which grew on 5-FOA-plates but not on plates 
lacking uracil were selected.
2.2.21 a-factor arrest
Yeast cells can be arrested in the cell cycle with the help of the mating pheromone a- 
factor. a-factor is produced by haploid a-type cells to signal haploid a-type cells their 
wish to mate. Once in contact with a-factor, haploid a-type cells will form a mating 
projectile (shmoo) and arrest in Gi.
Yeast strains (mat a) were grown in liquid culture until OD6oo=0.3 to 0.4. a-factor 
(stock solution: 1 mg a-factor/ml DMSO) was added in a dilution of 1:100 (wild type
cells) or 1:1000 (bar -  yeast strains) and the cultures were incubated for up to 2.5 h in a
shaker (wild type: 37 °C, conditional lethal strains: 23 °C). A culture was regarded as 
arrested in Gi if more than 90 % of cells had developed a shmoo. The shmoo was
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visible under the light microscope. Cells were released from a-factor by washing the 
cells three times with YPD-medium.
2.2.22 Preparation of total cell extract
2.2.22.1 Lysis of E. coli cells by sonication
E. coli cells were lysed by sonication. For example, cells from a 400 ml culture 
(O D 6 o o = 0 .4 )  were harvested by centrifugation (4 °C, 2,700 ref, 5 min) and the pellet 
was taken up in 20 ml PBS and transferred into a 50 ml Falcon tube. 5 mM 
benzamidin, 1 mM EDTA and 1 mM PMSF were added and the Falcon tube was 
placed on ice for sonication. The cells were lysed up to 8 times for 2 min with an 
output of the tip sonicator of 40 %. When over 90 % of cells appeared dark and broken 
under the light microscope, 1 % (v/v) Triton-X-100 was added and the cells were 
incubated on ice for 30 min to complete the lysis. The lysed cells were centrifuged 
(4 °C, 10,600 ref, 5 min) and the supernatant contained the soluble fraction of proteins 
while proteins insoluble under these conditions, remained in the pellet. The supernatant 
obtained with this method was for example used for the purification of GST-fusion 
proteins from E. coli (see 2.2.25.1).
2.2.22.2 Lysis of yeast cells using TCA
This rather quick way of producing total cell extract from yeast was mainly used to 
check the expression of yeast gene fusions (see 2.2.16) by Western analysis (see
2.2.13).
A yeast culture of 1.5 ml (OD60o=0.8) was harvested by centrifugation (4 °C, 1,090 ref, 
5 min) in an Eppendorf centrifuge. The pellet was taken up in 1 ml of H2O. The cells 
were again centrifuged and taken up in 1 ml of H2O containing 150 pi 1.85 M NaOH 
and 7.5 % (v/v) of |3-mercaptoethanol. The solution was mixed by vortexing and 
150 pi of 55 % (w/v) TCA were added and the cells were incubated on ice for 10 min. 
The lysed cells were centrifuged (4 °C, 20,800 ref, 10 min) and the supernatant was 
removed. The precipitated proteins were taken up in HU-buffer and the sample was 
incubated at 65 °C for 15 min to dissolve the denatured proteins. The sample was
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centrifuged (RT, 20,800 ref, 5 min) to pellet insoluble fragments. It was loaded on an 
acrylamide gel and proteins were separated by SDS-PAGE (see 2.2.4.2).
2.2.22.3 Lysis of yeast cells with glass beads
Lysis of yeast cells using glass beads was used for producing cell extract suitable for 
affinity purification of protein complexes (see 2.2.25). Firstly, the extraction conditions 
had to be established for each protein:
A yeast culture (200 ml) was grown to OD6oo=0.8 and the cells were harvested by 
centrifugation (4 °C, 1,090 ref, 5 min). The pellet about 1 g of cells was taken up in 
3 ml of basis-buffer (50 mM Tris-HCl pH 7.5, 10 mM EDTA, 1 mM EGTA, 5 % (v/v) 
glycerol) containing 100 mM NaCl and proteinase inhibitors (complete MINI, Roche, 
Lewes, UK). Ice cold acid washed glass beads (0  425-600 pm, Sigma, Dorset, UK) 
were added up to 3 mm below the surface of the solution. The cells were lysed by 
vortexing up to 24 times for 30 sec. The samples were cooled on ice in between 
vortexing. The supernatant was taken of with a pipette and was divided into six 
Eppendorf tubes and the samples were centrifuged (4 °C, 20,000 g, 10 min). A sample 
of the supernatant was kept at -  20 °C and the rest was discarded. One pellet each was 
resuspended in the following buffers:
1. basis-buffer (see text above), 100 mM NaCl
2. basis-buffer (see text above), 100 mM NaCl, 1 % (v/v) Triton-X-100
3. basis-buffer (see text above), 1 M NaCl, 1 % (v/v) Triton-X-100
4. basis-buffer (see text above), 1 M NaCl, 1 % (w/v) SDS
5. RIPA (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 % (v/v) Triton-X-100,
0,5 % (w/v) desoxycholate, 1 % (w/v) SDS)
6 . RIPA (see above), 1 M NaCl
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A small stirring bar was added and the samples were stirred on ice for 30 min. The 
samples were centrifuged (4 °C, 20,000 g, 10 min) and each supernatant was mixed 
with an equal volume of HU-buffer (see 2.1.2). Each pellet was resuspended in 400 pi 
HU-buffer and all samples were incubated at 65 °C for 10 min. The samples were 
centrifuged (4 °C, 20,000 g, 10 min) and analysed by SDS-PAGE (see 2.2.4.2) and 
Western blotting (see 2.2.13). The best extraction conditions for Bbplp and Mps2p 
were established as basis-buffer, 100 mM NaCl, 1 % (v/v) Triton-X-100. The total 
yeast extract was then prepared as follows:
Yeast cultures with a volume of 200 ml to 121 were grown to OD6oo=0.6 to 1.2 and 
were harvested by centrifugation (4 °C, 1,090 ref, 10 min). The pellet was resuspended 
in the optimal extraction buffer (2 ml buffer/g cells; see above) excluding the detergent 
and proteinase inhibitors (complete MINI, Roche, Lewes, UK). The cells were lysed by 
vortexing with glass beads as described above. Pellets up to 4 g were lysed in Falcon 
tubes while larger amounts were lysed in the bead beater (see 2.1.14). The detergent 
was added to the cell/buffer/glass bead solution and the sample was stirred on ice for 
up to 40 min. The liquid was transferred into a new centrifuge tube and the samples 
was centrifuged (4 °C, 20,000 g, 10 min). The supernatant was used for the affinity 
purification of proteins (see 2.2.25).
2.2.23 Preparation of polyclonal antibodies
In this study, antibodies against Bbplp and Mps2p were raised in rabbits. In both cases 
GST-fusion proteins were expressed in E. coli and the proteins were purified using 
glutathion sepharose (see 2.2.25.1) before they were used for the immunisation. 
Antibodies were raised against the N-terminus of the proteins only.
2 .2 .2 3 .11mmunisation
Before the first immunisation 2 ml of blood were taken as pre-immunserum sample. 
The blood was incubated at 37 °C for 1 h and was then kept over night at 4 °C. The 
blood sample was centrifuged at RT and 2,000 ref in a 15 ml Falcon tube in a Beckman 
centrifuge. The supernatant was kept at -  20 °C.
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For the first injection, 500 \x\ of purified protein (1 mg protein/ml, see 2.2.25.1) were 
mixed with 1 ml complete Freund’s Adjuvant (Sigma, Dorset, UK) with the 
ultrasonicator. The second immunisation was timed about 4 weeks after the first 
injection. For this injection and the two following injections, always four weeks apart, 
500 pi of purified protein were mixed with 1 ml incomplete Freund’s Adjuvant 
(Sigma, Dorset, UK) with the ultrasound mixer shortly before the application.
2.2.23.2 Test bleed
After the second immunisation, 2 ml of blood sample were taken. The blood was 
incubated at 37 °C for 1 h and was then kept over night at 4 °C. The sample was 
centrifuged at RT and 2,000 ref in a 15 ml Falcon tube in a Beckman centrifuge. The 
supernatant contained the antibodies and the pellet was discarded. A protein blot was 
prepared, which contained six lanes with the epitope tagged version of the protein and 
six lanes loaded with cell extract from yeast cells over-expressing the specific protein. 
The blot was arranged in a special apparatus (Max Planck Institute technical support, 
Munich, Germany), in which the serum could be applied in narrow chambers in 
different dilutions. The blots were treated as for normal Western blotting (see 2.2.13). 
The serum was applied in 5 different dilutions (1:10, 1:50, 1:100, 1:500, 1:1000). Two 
lanes were tested with pre-immunserum which served as negative control. According 
to the quality of the signal, the number of further immunisations was decided.
2.2.23.3 Affinity purification of antibodies
Firstly, one pre-column containing CNBr-sepharose (Pharmacia, Uppsala, Sweden) 
coupled to GST and a main column containing CNBr-sepharose coupled to the antigen 
(GST-Bbplp, GST-Mps2p) were prepared. Therefore, the antigen-GST fusion proteins 
were purified as described under 2.2.25. The purified proteins were filled into a dialyse 
tube. For the pre-column, BL21 pLysS cells containing pGEX-5X were induced with 
IPTG (compare 2.2.25) and the cells were harvested by centrifugation. The pellet was 
resuspended in 10 to 20 ml CB-buffer (100 mM NaHC0 3 , 0.5 M NaCl, pH 8.3) and 
were lysed with the tip sonicator as described in 2.2.22.1. The lysed cells were 
centrifuged (4 °C, 20,000 g, 10 min) and the supernatant was filled in a dialyse tube.
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The two protein solutions were dialysed against CB-buffer (see above) at 4 °C 
overnight. Meanwhile, the CNBr-resin was prepared. CNBr-spharose (2 g) was swelled 
in 400 ml 1 mM HC1 for 15 min. The resin was washed on a glass filter with 400 ml 
of 1 mM HC1 with a spatula. The resin was transferred into a Falcon tube and the HC1 
was aspirated off. The sepharose was washed in 10 volumes CB-buffer (4 °C, 510 ref, 
2 min). The dialysed protein samples were mixed with two volumes of CNBr- 
sepharose each. They were incubated at RT for 2 h to allow the binding of the proteins 
to the sepharose. The matrix was pelleted by centrifugation (4 °C, 510 ref, 2 min) and 
the supernatant was removed. The beads were either resuspended in 0.2 M glycine 
pH 8.0 or in 1.0 M ethanolamine pH 9.0 followed by an incubation at RT for 2 h. The 
beads were washed once in 100 mM NaOAc pH 4.0, 0.5 M NaCl (4 °C, 510 ref, 2 min) 
before they were packed into disposable polystyrene columns (Pierce, Rockford, USA). 
Each column was washed three more times with 100 mM NaOAc pH 4.0, 0.5 M NaCl, 
subsequently with 2 volumes PBS. PBS 1 % (w/v) SDS was added to the columns and 
when the buffer had penetrated the matrix, the columns were sealed and incubated at 
65 °C for 40 min. The columns were again washed with 2 volumes PBS 1 % (w/v) 
SDS at RT. Afterwards, the columns were washed with 4 volumes of PBS 1 % (v/v) 
Triton-X-100. The pre-column was placed above the main column and the serum was 
applied (flow rate: 5 ml/1 h). When all the serum had penetrated, 2 volumes PBS were 
added to the pre-column. The pre-column was removed and the main column was 
washed with 3 volumes PBS 1 % (v/v) Triton-X-100 and 4 volumes PBS. Before the 
elution of the antibody, the main column was cooled down to 4 °C. For the elution, 
1 ml cold glycine-buffer (0.2 M glycine, 1 mM EGTA, pH 2.5) was added to the 
column. The flow through was collected in an Eppendorf tube containing 300 \i\ 1 M 
Tris-HCl pH 8.0 which neutralised the solution. The eluate and the Tris-buffer were 
mixed immediately and the mixture was kept on ice. The elution was repeated seven 
times. Then, 1 ml 4 M guanidium-HCl pH 7.0 was added to the main column and the 
flow through was collected. This step was repeated four times. All fractions were 
tested for protein with Bradford reagent (Sigma, Dorset, UK). The glycine solutions 
which contained protein were pooled and so were the guanidium solutions and 
0.2 % (w/v) BSA was added. Both solutions were dialysed against PBS at 4 °C
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overnight. The dialysed antibody solutions were aliquoted and stored at -  80 °C. 
Affinity purified antibodies were tested by Western blotting (see 2.2.13).
2.2.24 Coupling of antibodies to beads
Antibodies were immobilised to sepharose beads (protein A sepharose 4 Fast Flow, 
Amersham Pharmacia, Uppsala, Sweden; protein G sepharose 4B Fast Flow, Sigma, 
Dorset, UK) for the immunoprecipitation of proteins from yeast (see 2.2.25.3).
Sepharose beads (1 ml) were washed (4 °C, 200 ref, 5 min) twice in 5 ml PBS to 
remove the storage buffer. The binding capacity of spharose beads is about 25 mg to 
35 mg of IgG per 1 ml drained beads depending on the product. Sepharose beads 
(1 ml) were incubated overnight at 4 °C with 1 to 5 ml of antibody solution in PBS to 
allow the binding of the antibody to protein A/G. Polyclonal antibodies directed 
against a specific protein or mouse monoclonal anti-HA (12CA5) or anti-Myc (9E10) 
(see 2.1.10) antibodies were used. The beads were sedimented by centrifugation (4 °C, 
200 ref, 5 min), the supernatant was removed and the beads were washed twice with 
10 ml of 0.2 M sodium-borate buffer (pH 9.0). The beads were resuspended in 10 ml of 
0.2 M sodium-borate buffer (pH 9.0). Dimethylpimelimidate (50 mg) was added to a 
final concentration of 20 mM. The beads were incubated with the cross linking agent 
for 1 h at RT. The beads were spun down by centrifugation (4 °C, 200 ref, 5 min) and 
they were washed once with 10 ml 0.2 M ethanoldiamine (pH 8.0). They were 
incubated in 10 ml of 0.2 M ethanoldiamine (pH 8.0) at RT for 2 h to quench any 
remaining cross linker activity. The beads were pelleted (4 °C, 200 ref, 5 min), the 
supernatant was discarded and the beads were washed in 10 ml PBS. The beads were 
stored in 5 ml PBS containing 0.1 % (w/v) sodium azide at 4 °C. To check the 
coupling efficiency, an equal volume of beads was sampled before and after the cross 
linking reaction. The beads were taken up in HU-buffer (see 2.1.2) and they were 
incubated at 65 °C for 10 min. The two samples were analysed by SDS-PAGE (see
2.2.4.2). The crosslinked antibodies were not eluted from the matrix. In contrast, the 
uncoupled IgGs were released and were detectable in the Coomassie Blue stained gel 
(see 2.2.5.2.1).
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2.2.25 Affinity chromatography
Proteins were enriched from bacteria and yeast cell extract by affinity chromatography.
2.2.25.1 Purification of GST-protein-fusions from E.coli
The pGEX-5X vector system was used for the expression of yeast genes in E. coli. 
Yeast genes were ligated into the pGEX-5X-l vector (see 2.1.7) and were cloned into 
the BL21 pLysS strain (see 2.2.8). The pLysS vector encodes lysosyme which is 
expressed continuously and simplifies cells lysis. The gene is under control of the tac 
promotor which is activated by the inactivation of the lac Iq suppresser by addition of 
IPTG. The vector was constructed that the expressed protein will contain a GST-tag. 
This GST-tag will allow the purification of the protein via binding to glutathione 
sepharose. Strains were selected for chloramphenicol (pLysS) and ampicillin (pGEX- 
5X-1) resistance.
Firstly, the optimal induction conditions were established. 1.5 ml of TY-Amp- 
chloramphenicol-medium were inoculated with the specific B121 strain and cells were 
incubated at 37 °C overnight. The next day, 10 ml of selective medium were inoculated 
with 200 pi overnight culture and were incubated at 30 °C for 2 h. IPTG was added to 
a final concentration of 0.2 mM and the culture was incubated on a shaker at 30 °C for 
another 3 to 4 h. The cells were harvested by centrifugation (4 °C, 2,700 ref, 5 min). 
The pellet was taken up in 50 pi of HU-buffer (see 2.1.2) and the sample was 
incubated at 65 °C for 10 min. The samples were analysed by SDS-PAGE (see 2.2.4.2) 
and Coomassie Blue staining (see 2.2.5.2.1). If the protein was degraded, different 
concentrations of IPTG and varied incubation times were tested. The optimal 
conditions for the isolation of Bbplp and Mps2p were 0.5 mM IPTG for 2 h at 30 °C.
For the purification, the volume of the culture was scaled up to 400 ml and the 
induction was done under the established conditions. The cells were lysed as described 
in 2.2.22.1. Glutathione sepharose 4 B (1 ml; Amarsham Pharmacia, Uppsala, Sweden) 
was washed twice with PBS (4 °C, 200 ref, 5 min) before it was added to the cell 
lysate. To allow the binding of GST to the beads, the solution was incubated on an
MATERIALS AND METHODS 88
overhead mixer at 4 °C for 2 h. The beads were washed once in PBS containing 
0.1 % (v/v) Triton-X-100 and twice in PBS (4 °C, 200 ref, 5 min). The beads were 
finally taken up in 10 ml PBS and were loaded on disposable polystyrene columns 
(Pierce, Rockford, USA). The beads were washed with PBS until the flow through was 
free of proteins. The protein content of the flow through was checked with Bradford 
reagent (Sigma, Dorset, UK). For the elution of the protein 1 ml 10 mM glutathion in 
50 mM Tris-HCl pH 8.0 was added to the sealed column. After 10 min, the flow 
through was collected. This procedure was repeated twice more. Of each flow through 
10 pi were mixed with 10 pi HU-buffer (see 2.1.1). The samples were analysed by 
SDS-PAGE (see 2.2.4.2) and Coomassie Blue staining (see 2.2.5.2.1).
2.2.25.2 Enrichment of ProA-fusion proteins from yeast extract
Protein A (ProA) binds IgGs with high affinity and therefore it is possible, to enrich 
ProA tagged proteins using IgG sepharose beads (Amarsham Pharmacia, Upsala, 
Sweden). The following protocol was used to isolate Bbplp-ProA fusion proteins and 
the interacting protein Mps2p. Yeast cells (15 g), either of cells expressing Bbplp- 
ProA or of YPH499 cells (wild type control) were lysed in the beat beater under 
optimal extraction conditions for Bbplp-ProA (see 2.2.22.3; basis-buffer: 50 mM Tris- 
HCl pH 7.5, 10 mM EDTA, 1 mM EGTA, 5 % (v/v) glycerol containing 100 mM 
NaCl and 1 % (v/v) Triton-X-100). A sample of total yeast extract was mixed with an 
equal volume of HU-buffer (see 2.1.2) and was kept at -  20 °C. This sample was used 
as control for the total concentration of the target protein.
IgG sepharose beads (4 ml bed volume) were washed in 10 ml 0.5 M acetic acid 
pH 3.4. The beads were sedimented by centrifugation (4 °C, 200 ref, 5 min). The 
supernatant was discarded and the beads were washed with TST (50 mM Tris-HCl 
pH 7.6, 150 mM NaCl, 0.05 % (v/v) Tween 20) until the pH was neutral. This 
procedure was repeated once more. The beads were packed into two disposable 2 ml 
polystyrene columns (Pierce, Rockford, USA). The columns were cooled to 4 °C and 
one was loaded with wild type yeast extracts and the other with the Bbpl-ProA yeast 
extract. The columns were washed with following buffers at a flow rate of 0.3 ml/min:
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20 ml basis buffer (see text above), 0,35 M NaCl, 1 % (v/v) Triton-X-100 
5 ml basis buffer (see text above), 0,5 M KC1,1 % (v/v) Triton-X-100 
10 ml basis buffer (see text above), 0,5 M NaCl, 1 % (v/v) Triton-X-100 
20 ml TST (see text above)
5 ml 5 mM ammonium acetate (NH4OAC) pH 6.5 
5 ml 5 mM NH4OAc pH 5.5 
5 ml 5 mM NH4OAc pH 5.0
The proteins were eluted by addition of 4.5 ml 0.5 M NH4OAc pH 3.5. The eluate was 
collected and divided into 0 . 8  ml portions which were dried in the vacuum 
concentrator over night. The dried pellet was taken up in H2O and was dried again in 
the speed vac. This step was repeated until all salt was removed. Each pellet was taken
up in 30 pi of HU-buffer (see 2.1.2) and was incubated at 65 °C for 10 min.
The sepharose beads were taken up in HU-buffer and were incubated at 65 °C for 
10 min. The samples were centrifuged (RT, 15,300 ref, 5 min) and the supernatant was 
stored at -20 °C. This sample was used as a control for the elution efficiency.
All samples were analysed by SDS-PAGE (see 2.2.4.2) and Fairbanks staining (see
2.2.5.2.2). Unique protein bands were analysed by MALDI-MS (see 2.2.26).
2.2.25.3 Immunoprecipitation of yeast proteins
Proteins and their interacting protein partners were enriched by immunoprecipitation. 
Therefore, HA- and Myc-fusion proteins or wild type proteins were precipitated using 
antibodies against the HA- and Myc-epitopes or against proteins directly. The optimal 
extraction conditions for each protein were established as described in 2.2.22.3 and cell 
extracts were prepared accordingly. In this study, the optimal extraction buffer for 
proteins was established as basis-buffer (50 mM Tris-HCl pH 7.5, 10 mM EDTA, 
1 mM EGTA, 5 % (v/v) glycerol) containing 100 mM NaCl and 0.5 % (v/v) Triton-X- 
100. A sample of the total yeast extract was mixed with an equal volume of HU-buffer 
(see 2.1.2) and was kept at -20 °C. This sample was used as control for the total 
concentration of the target protein. Sepharose beads which had been coupled to
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antibodies were prepared as in 2.2.24. The sepharose beads were washed twice in 
basis-buffer (4 °C, 200 ref, 5 min). About 50 pi of drained beads were added to the 
yeast extract of 0.5 g yeast pellet. Proteinase inhibitors were added (complete MINI, 
Roche, Lewes, UK) and the yeast lysate sepharose mixture was incubated in a roller 
mixer at 4 °C for 4 h. The beads were harvested by centrifugation (4 °C, 200 ref, 
5 min) and the supernatant was taken off. A sample of the supernatant was mixed with 
an equal volume of HU-buffer (see 2.1.2) and was kept at -20 °C. This sample was 
used, in combination with the sample of total yeast extract (see above) as control for 
the binding efficiency of the antibody beads. The beads were washed once in 1.5 ml 
extraction buffer (see above), before they were transferred into spin columns (Mobicol, 
MoBiTec, Bioscience, Cramlington, UK). The beads were washed in the spin columns 
twice with extraction buffer and 3 times with basis-buffer (see above; 4 °C, 200 ref, 
5 min). The bottom of the columns was sealed and an equal volume of HU-buffer was 
added to the sepharose beads. After the top had been sealed, the columns were 
incubated at 65 °C for 20 min to brake the protein-antibody binding. The columns were 
placed in an Eppendorf tube and the HU-buffer containing the dissolved proteins was 
harvested as flow through by centrifugation (4 °C, 15,300 ref, 5 min). The proteins 
were analysed by SDS-PAGE and/or Western blotting. In some cases, protein bands 
were identified by MALDI-MS (see 2.2.26).
The following control experiments were undertaken to test the specificity of the 
precipitation. As control for the immunoprecipitation of fusion-proteins, a wild type 
strain was treated identically to the strain with the tagged gene. To detect non-specific 
binding in a precipitation using antibodies recognising the yeast protein directly, two 
controls were done. Firstly, sepharose A/G beads which had been treated with the same 
coupling reagent were used for a mock precipitation. This control would have shown 
unspecific binding of yeast proteins to beads. Secondly, beads coupled to an unrelated 
polyclonal antibody or to pre-immunserum were used for the precipitation. Here, non­
specific binding of antibodies to yeast proteins would have been detected.
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2.2.26 MALDI-MS
Analysis of proteins by MALDI-MS (Karas and Hillenkamp, 1988) was performed in 
collaboration with Anna and Andrej Shevchenko (EMBL, Heidelberg, Germany). The 
samples were digested with trypsin and the mass of the resulting peptides was 
determined after ionisation by time of flight. The mass of the trypsin peptides is 
characteristic for each protein. Since the whole yeast genome is sequenced, all ORFs 
and hypothetical ORFs are known and the proteins can be identified according to the 
peptide masses.
2.2.27 In vitro binding assay
In this study, the binding of 6His-N-Mps2p to GST-Bbplp, GST-N-Bbplp and GST- 
C-Bbplp was investigated by in vitro binding. Therefore, 6His-N-Mps2p, GST-Bbplp, 
GST-N-Bbplp, GST-C-Bbplp and GST were expressed in E.coli as described in 
2.2.25.1. Cells were lysed according to 2.2.22.1. Triton-X-100 was added to final 
content of 0.1 % (v/v) to the lysate of cells expressing 6His-N-Mps2p. The lysate was 
incubated for up to 1 h on ice. Meanwhile, GST-Bbplp, GST-N-Bbplp, GST-C-Bbplp 
and GST were bound to glutathion sepharose as described in see 2.2.25.1 Methods for 
the purification of proteins from E. coli. After the binding the sepharose resins were 
washed once in PBS containing 0.1 % (v/v) Triton-X-100 and twice in PBS (4 °C, 
510 ref, 2 min). Of each resin 50 pi were taken off and were kept at 4 °C (control 
sample for binding to resin). The 6His-N-Mps2p lysate was centrifuged (4 °C, 
20,800 ref, 10 min). A 50 pi sample of the 6His-N-Mps2p supernatant was frozen 
(control samples for expression of 6His-N-MRS2. The rest of the supernatant was 
divided in four equal portions which were incubated with the four different resins at 
4 °C for 1 h. After the incubation, the resins were washed once in PBS, 0.1 % (v/v) 
Triton-X-100 and twice in PBS (4 °C, 510 ref, 2 min) before they were transferred into 
a spin column (Mobicols). The resins were washed three times more with PBS. Finally, 
the resins and all other control samples were resuspended in HU-buffer and the 
mixtures were incubated at 65 °C for 10 min. Glutathion sepharose beads and larger 
particles were sedimented by centrifugation (RT, 20,800 ref, 5 min) and the samples 
were analysed by SDS-PAGE (see 2.2.4.2) and Western blotting (2.2.13).
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2.2.28 Yeast two-hybrid analysis
In this study, the yeast two-hybrid system (Fields and Song, 1989) was used to study 
the interaction of SPB components. The transcriptional activator Gal4p is composed of 
a DNA binding domain (Gal4pDNA) and an acidic transactivation domain (Gal4pTA). 
These two distinct regions can be fused to other proteins. Re-union of the two domains 
via interaction of the fusion-proteins lead to restoration of the transcriptional activity. 
As consequence, the functional transcripition of the LacZ reporter, coding for p- 
galactosidase is initiated, |3-galactosidase metabolises X-Gal, whereby a blue indigo 
dye accumulates after oxidation. Here, the bacterial DNA-binding protein LexA was 
use instead of the Gal4pDNA domain.
Genes were amplified by PCR (see 2.2.1.1) and were cloned (see 2.2.8) in frame into 
the two-hybrid vectors. Different combinations of two-hybrid vectors containing the 
LexADNA (pEG202, pMM5) or the Gal4pTA (pACTII, pMM6 ) domains were used. 
Plasmids were transformed into Mata and Mata yeast strains and transformants were 
selected on SC-Leu (pACTII, pMM6 ) or SC-His (pEG202, pMM5) plates. Strains were 
combined by replica plating (see 2.2.19) and mating on YPD-plates. Diploids were 
selected on double selective plates (SC-His-Leu). Diploid cells were overlaid with top 
agar containing the X-Gal substrate. The top agar was prepared as follows: 0.5 M 
sodium phosphate (pH 7.0), 1 % (w/v) SDS, 20 mM KC1, 2 mM MgCl2 solution was 
prepared and heated to 40 °C. Low melting agarose (400 mg) was dissolved in 30 ml 
H2O and cooled to 50 °C. The two solutions were mixed slowly and 1 ml of X-Gal 
(stock solution: 40 mg/ml dimethyl formamide) was added. The plates were overlaid 
and cells with very strong two-hybrid interactors already turned blue after 5 min.
In this study, the GAL1 promotor of the pMM5 and pMM6  plasmids (see 2.1.7) was 
expressed sufficiently without galactose induction.
2.2.29 Suppression analysis
The principle of suppression analysis is that slight overexpression of one or more genes 
might be able to complement for the function of a defective gene. Conditional lethal
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mutants which show a growth defect due to mutations in a single gene, can therefore be 
investigated for rescue of growth by overexpression of other yeast genes. The protein 
encoded by the overexpressed gene might take over or help with the functions of the 
protein encoded by the defective gene or work downstream of the non-functional gene. 
In some cases, negative suppression occurs. Thereby, overexpression of a gene leads to 
an increase in the growth defect of the mutant by possibly, further inhibiting the 
defective protein encoded by the mutated gene directly or indirectly. Taken together, 
suppression events are a good indication for the possible interaction of proteins or for 
the similarity in the cellular function of genes.
Conditional lethal mutants were transformed (see 2.2.8.5.2) with mulit-copy or single 
copy plasmids containing ORFs of yeast genes expressed from their own promoter. 
The strains were selected for the marker gene of the plasmid and cells were tested for 
growth at the restrictive temperature (positive suppression) or for growth inhibition at 
the permissive temperature (negative suppression).
In case of the Amps2 suppression screen, a library (YEpl3) was transformed (see
2.2.8.5.2) into the MPS2 shuffle (see 2.2.17) strain. The transformants were selected 
for the wild type plasmid (shuffle strain with pRS316-MPS2) and for the library 
plasmid {LEU-based plasmid pFL44), as well as for the deletion of MPS2 (HIS3 
marker gene). After counter-selection for the wild type plasmid on 5-FOA-plates (see 
2.2.20), the transformants were tested for growth at the restrictive temperature. The 
inserts of the YEpl3-library coded for 5 kb to 10 kb of yeast chromosomal DNA. In 
order to ensure the entire yeast genome was covered 50,000 transformants were 
screened for suppression. The plasmids leading to suppression were isolated by 
plasmid rescue (see 2.2.10.1). The plasmids were again transformed into the MPS2 
shuffle strain and were tested for suppression as described above. Plasmids, which still 
mediated suppression, were sequenced (see 2.2.14) and identified genes were 
subcloned and again tested for suppression as described above.
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2.2.30 Geldanamycin a ssay
Geldanamycin is a benzoquinoid ansamycin and was initially thought to inhibit protein 
tyrosine kinases (DeBoer et al., 1970). It is now known that geldanamycin blocks the 
interaction of substrates with Hsp90 (Whitesell et al., 1992).
For the geldanamycin assay (Morano et al., 1999), overnight cultures of yeast strains 
were grown until OD6oo=0 . 6  and about 2  x 1 0 6 cells were harvested by centrifugation 
(4 °C, 1,090 ref, 5 min). The cells were taken up in 200 pi of YPAD-medium and were 
mixed with 3 ml of autoclaved and cooled (to 50 °C) YPAD-medium containing 
0.8 % (w/v) agar. The agar/cell solution was evenly spread over a YPD-plate and the 
top agar was left to solidify. Aliquots of 2 mM geldanamycin in DMSO and of DMSO 
alone (10 pi) were spotted onto the top agar. The plates were dried before incubation at 
23 °C for 3 d.
2.2.31 Isolation of nuclei
A yeast culture (12 1) was grown in a fermenter until OD6oo=0.8. The cells were 
harvested by centrifugation in a Sorvall centrifuge (4 °C, 2,000 ref, 15 min). The 
pellets were taken up in water and they were pooled together. Cells (10 pi) were 
counted under the microscope and the whole cell content was calculated. The cells 
were harvested by centrifugation (4 °C, 2,000 ref, 15 min). The cells were resuspended 
in cold spheroblasting buffer (1.2 M sorbitol, 25 mM KPi-buffer pH 6.5, 10 mM (3- 
mercaptoehtanol) so that the cell concentration was about 1.5 x 109 cells/ml 
spheroblasting buffer. Per 1 ml spheroblasting buffer, 75 pi glusulase, 20 pi zymolyase 
(stock solution: 1 0  mg/ml spheroblasting buffer) and 1 0  pi mutanase (stock solution: 
1 mg/ml spheroblasting buffer) were added. The cells were incubated at 30 °C on a 
shaker until the cells were spheroblasted (about 3 to 4 h). Digestion of the cell wall 
which is indicated by cells becoming dark and rounded was monitored under the phase 
contrast microscope. Meanwhile, Ficoll-400 was dissolved in 1.2 M sorbitol to produce 
a solution of 7.5 % (w/v) Ficoll. An equal volume of 1.2 M sorbitol was added to the 
spheroblasted cells and the spheroblasts were pelleted by centrifugation in the Sorvall 
GS3 rotor (4 °C, 2200 rpm, 15 min). The supernatant was taken off carefully and the
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pellet was taken up in 45 ml of 1.1 M sorbitol. The Ficoll solution (30 ml per tube) was 
transferred into 50 ml Falcon tubes and 15 ml of spheroblast solution was added on top 
of each Ficoll cushion. The spheroblasts were filtered through the Ficoll cushion by 
centrifugation (4 °C, 2100 ref, 30 min) in a Beckmann centrifuge. The spheroblasts 
were taken up with the help of a glass pipette in the following solution per 1 0 10 cells: 
10 ml PVP-solution ( 8  % (w/v) PVP40, 1.57 g KH2P 0 4, 1.46 g K2HP04, 152 mg 
MgCl2 per 11 H20 , pH 6.5), 60 pi solution P (2 mg pepstatin A and 90 mg PMSF in 
5 ml ethanol), 24 pi Triton-X-100 ultra pure. The spheroblasts were placed on ice and 
they were lysed for at least three times with the polytron (see 2.1.14) at 12,000 rpm for 
3 min. Lysis was checked by removing a small aliquot, staining the DNA with DAPI 
(1 pg/ml) and analysing the sample under the fluorescent microscope. If the small 
DAPI dots, which resembled the nuclei, could be seen free from cell material, the lysis 
was completed. An equal volume of 0.6 M sucrose-PVP was added to the lysed 
spheroplasts and the solution was mixed before centrifugation in the GSA-rotor (4 °C,
12.000 rpm, 10 min). The pellet was taken up in 180 ml of 1.7 M sucrose-PVP. The 
solution was mixed with the polytron for 2 min at 2,000 rpm. Up to 12 sucrose 
gradients were prepared as follows: 8 ml of 2.3 M sucrose (nD= 1.4540) formed the 
bottom layer, 8 ml of 2.1 M sucrose (no=1.4420) the middle layer and 8 ml of 2.01 M 
sucrose (nD=1.4370) the top layer. The concentration of the sucrose solutions had been 
adjusted exactly with help of a refractometer (see 2.1.14). Each gradient was overlaid 
with 15 ml of lysed spheroblasts in 1.7 M sucrose-PVP. The tubes were balanced using
1.0 M sucrose-PVP. The gradients were centrifuged in the SW28-rotor in a vacuum 
centrifuge (4 °C, 14,000 rpm, 16 h). The gradient was sampled in 1 ml fractions. The 
fractions were analysed after addition of DAPI (1 [ig/ml) under the fluorescence 
microscope. The nuclei were at the interface of gradient 2.1 M and 2.3 M sucrose. The 
refraction index of the fractions containing nuclei was adjusted to nD=1.434 with 0.9 M 
sucrose-PVP if necessary. The yield of nuclei was determined by DNA measurement at 
260 nm in the spectrometer. Therefore, 10 pil of nuclei containing gradient fraction 
were added to 1 ml of 1 % (w/v) SDS and were measured. As blank 1 ml of 1 % (w/v) 
SDS was measured (OD260=140 equivals 1010 nuclei). The nuclei were spun in the 
50.2 TI rotor (4 °C, 36,000 rpm, 1 h) and were stored at -80 °C.
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2.2.32 Isolation of SPBs
SPBs were obtained by lysis of isolated nuclei (see 2.2.31). Therefore, 1010 nuclei were 
resuspended by vortexing in 1.0 ml lysis solution (1.5 % (v/v) Triton X-100,
2.0 % (w/v) digitonin, 20 % (v/v) DMSO, 0.1 mM MgCU), 10 pi solution P (2 mg 
pepstatin A and 90 mg PMSF in 5 ml ethanol) and 2 pi 2 % (w/v) DNAse I-solution 
(2 % (w/v) DNAse I in 0.25 M sucrose, 0.05 M tri-ethanolamine pH 7.4, 0.25 M KC1, 
5 mM MgCU). The nuclei were incubated at RT for 10 min. Beforehand, several 
sucrose solutions were prepared in bt-buffer (0.01 M bisTris pH 6.5, 0.1 mM MgCh) 
for the gradient centrifugation. The sucrose concentrations were adjusted exactly 
(2.5 M: nD= 1.4533; 2.25 M: nD=1.4414; 2.0 M: nD=1.4295; 1.75 M: nD=1.4174) with 
the refractometer. An equal volume of 2.5 M sucrose-bt-buffer was added to the lysed 
nuclei and they were centrifuged in a 50.2 TI rotor (4 °C, 5,500 rpm, 6  min). The 
supernatant was loaded onto a sucrose gradient prepared in a Beckman SW41 
polycarbonate tube (Beckman, Fullerton, USA). The gradient consisted of a bottom 
layer of 0.75 ml 2.5 M sucrose-bt, the second layer of 2 ml of 2.25 M sucrose-bt, the 
third layer of 2 ml of 2.0 M sucrose-bt and the top layer of 2 ml 1.75 M sucrose-bt. If 
more than one gradient was loaded, the tubes were balanced with 1.0 M sucrose-bt- 
buffer. The tubes were spun at (4 °C, 29,000 rpm, 6  h) in a SW41 rotor in a vacuum 
ultra-centrifuge. The gradients were unloaded from the top in 1 ml fractions. The SPBs 
were usually at the interface of the 2.0 M and 2.25 M sucrose layers. A 10 pi sample of 
each fraction was taken up in 10 pi HU-buffer (see 2.1.2) and the samples were 
analysed by Western blotting (see 2.2.13) using antibodies against known spindle pole 
body components. The fractions with good signals in the Western blot were used for 
electron microscopy (see 2.2.34).
2.2.33 Fluorescence microscopy techniques
The localisation of proteins in the cell was determined by fluorescence microscopy. 
Either proteins were localised by fluorescence microscopy using GFP labelled proteins, 
or by indirect immunofluorescence microscopy with antibodies against proteins or 
epitope tags of proteins. A Chroma (Zeiss, Jena, Germany) filterset was used with the
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following parameters: DAPI: G365, FT395, LP420; GFP/CY2: 450-490, FT510, LP 
520; CY3: BP546, FT580, LP590.
2.2.33.1 Direct fluorescence microscopy using GFP
Strains, expressing proteins fused to GFP were constructed as described in 2.2.16. 
Cells were grown until OD6oo=0.4 and 1 ml culture was harvested by centrifugation 
(4 °C, 1,090 ref, 5 min). The pellet was taken up in 1 ml H2O. The cells were spun 
down by centrifugation and were taken up in 200 pi H20  containing 0.2 pg DAPI. 
Cells (5 pi) were immobilised on microscope slides which had been covered with a 
0.4 % (w/v) low melting agarose coat beforehand. Fluorescent light emission from the 
GFP-tag and the DAPI stained DNA was detected with a Zeis Axiopot fluorescent 
microscope (see 2.1.14). Proteins could be localised in relation to the DAPI staining 
region (nucleus) and/or due to the pattern of GFP staining.
2.2.33.2 Indirect immunofluorescence
For the localisation of proteins which might be partially present in the cytoplasm, cells 
were prepared for immunofluorescence by formaldehyde fixation (Pringle et al., 1989) 
followed by a second fixation with methanol/acetone. For SPB components 
methanol/acetone was used as sole fixative (J. Kilmartin, Cambridge, UK). With the 
second method, cytoplasmic localisation of proteins is missed, since the cytoplasm is 
mostly extracted.
Antibodies against SPB components (anti-Spc72p antibody) were used to label the 
SPB. Novel proteins like Bbplp, Mps2p, Bfrlp and Poml52p were localised with 
antibodies against the epitope (HA, Myc) fused to the specific gene. Microtubules were 
stained with an anti-tubulin antibody. The DNA was visualised by DAPI staining.
2.2.33.2.1 Fixation and preparation of spheroblasts with the formaldehyde 
method
A yeast culture (10 ml) was grown to OD6oo=0.8, 1 ml 1 M KPO4 (pH 6.5). 
Formaldehyde (1.2 ml) was added and the cells were incubated at RT for up to 1 h. The
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fixation time is crucial, since the length of the incubation with formaldehyde can affect 
the epitope and therefore, the recognition of the epitope by the antibody. The optimal 
fixation time for each protein was determined empirically and fixation times of 15 min, 
30 min and 45 min were usually tested. The cells were harvested by centrifugation 
(4 °C, 510 ref, 5 min), taken up in 1 ml SP-buffer (0.1 M KPO4 , 1.2 M sorbitol). This 
step was repeated twice more. After the third washing step, the cells were resupended 
in 0.9 ml SP-buffer containing 20 mM p-mercaptoethanol and 0.1 ml zymolyase (stock 
solution: 2.5 mg zymolyase 20T in 1 ml SP-buffer containing 20 mM |3- 
mercaptoethanol). The cells were incubated at 30 °C for 15 to 45 min until cells were 
spheroblasted (about 90 % of cells appeared dark and round under the phase contrast 
microscope). The spheroblasts were put on ice for 5 min before sedimentation in an 
Eppendorf centrifuge (4 °C, 510 ref, 2 min). The spheroblasts were washed 3 times 
with 1 ml of cold SP buffer (4 °C, 510 ref, 2 min). Spheroblasts were used immediately 
or were kept at 4 °C for up to 24 h.
The cells were transferred onto microscopy well slides as follows. Firstly, 20 pi poly­
lysine were added to each well. After 2 min the poly-lysine was removed and each well 
was washed 5 times with H2O. The microscopy slide was dried and 20 pi spheroblasts 
were added to each well. After 10 min, the solution was removed carefully and the 
slide was transferred into cold methanol for 5 min. After the slide was bathed in cold 
acetone for 30 sec, the slide was air dried for about 10 min. The application of 
antibodies is described in 2.2.33.2.3.
2.2.33.2.2 Fixation and preparation of spheroblasts for the methanol/acetone 
method
About 6  ml of yeast culture of a O D 6oo=0.8 were harvested by centrifugation (4 °C,
1,090 ref, 5 min). The pellet was taken up in 1 ml 1.1 M sorbitol and 5 pi P- 
mercaptoethanol, 80 pi glusulase and 22 pi zymolyase 20T (stock solution: 27 mg/ml 
H2O) were added. The cells were then incubated at RT for 30 to 60 min. The formation 
of spheroblasts was followed by light microscopy and when 90 % of the cells were 
dark and round, the cells were harvested by centrifugation (4 °C, 510 ref, 2 min). The
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spheroblasted cells were washed once in 1.1 M sorbitol (4 °C, 510 ref, 2 min). The 
cells were then resuspended in 1 ml Wickerman solution (YPAD-medium containing
1.1 M sorbitol) and incubated at RT for 1 h. The cells were pelleted and washed for up 
to 3 times with 1.1 M sorbitol. After the final wash, the cells were taken up in 500 pi
1.1 M sorbitol. The cells were fixed on the microscope slide by bathing in methanol 
and acetone as described above.
2.2.33.2.3 Fluorescence labelling of proteins for light microscopy
The incubation of cells with antibodies was the same for both methods (described in
2.2.33.2.1 and 2.2.33.2.2). The cells on microscopy slides were blocked by addition of 
20 p i PBS-1 % (w/v) BSA (PBS-B) to each well. After 20 to 60 min each well was 
washed twice with 20 p i PBS-B. The primary antibody in PBS-B (20 p i) was added to 
the cells and the incubation time was up to 1.5 h. The cells were washed five times 
with 20 p i PBS-B, before 20 p i of secondary antibody in PBS-B were applied. After 
1 h the wells were washed up to six times with PBS. The slide was air dried before 4 p i 
DAPI/citiflour were added and the slide was sealed with a cover slip and nail varnish. 
The slide could be stored at -  20 °C for several months.
The following controls were done to distinguish between specific and non-specific 
binding of antibodies. If proteins were localised with antibodies against the epitope tag 
of the protein, a wild type strain was treated exactly the same as the strain expressing 
the protein fusion. If proteins were localised with antibodies specific for the protein 
itself, control cells were incubated only with the secondary antibody to test its 
specificity.
2.2.34 Electron microscopy techniques
In this study, the morphology of conditional lethal mutants in BBP1 was analysed in 
the cell cycle. Therefore, samples to study the cell morphology were prepared for cells 
harvested at 45 min, 1 h, 1 h 15 min and 1 h 30 min after release from a-factor arrest 
(see 2.2.21) and were analysed by electron microscopy (EM).
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Furthermore, proteins were localised by pre-embedding immunolabelling followed by 
electron microscopy. Bbplp was localised using whole cells, isolated nuclei and 
isolated SPBs and Mps2p was localised using isolated SPBs only.
Samples for morphological and immunolabelling EM, were stained by pre-embedding 
staining with osmium and uranyl acetate. After embedding in Spurr-resin (see below) 
ultra thin samples were prepared with a microtone (see 2.2.34.3). For all samples serial 
sections were prepared apart from samples containing immunolabelled SPBs for whom 
preparation of serial sections was not possible (see 2.2.34.2.3). For post-embedding 
staining, the samples were contrasted with uranyl acetate in methanol (Stempak and 
Ward, 1964) before staining with lead citrate (Reynolds, 1963). All solutions used in 
these protocols were sterile filtered to avoid contamination of samples with particles.
2.2.34.1 Electron microscopy to study morphology
A culture of yeast (15 ml, OD6oo=0.6 to 0.8) was harvested by centrifugation (4 °C,
1.090 ref, 5 min). The pellet was washed in 5 ml phosphate-Mg-buffer (40 mM 
K2HPO4-KH2PO4 pH 6.5, 0.5 mM MgCb) and the cells were spun once more (4 °C,
1.090 ref, 5 min). The pellet was taken up in 1 ml phosphate-Mg-buffer containing 
2 % (v/v) glutaraldehyde and the cells were fixed at RT for 30 min under constant 
motion. The fixed cells were washed once in phosphate-Mg-buffer (4 °C, 1,090 ref, 
5 min) and were then resupended in 1 ml of pre-treatment solution (0.2 M Tris-HCl 
pH 9.0, 20 mM EDTA, 0.1 M P-mercaptoethanol). The cells were incubated at RT for 
5 min before they were washed (4 °C, 510 ref, 5 min) twice in phosphate citrate-buffer 
(0.17 M KH2PO4, 30 mM sodium citrate, pH 5.8). The cells were taken up in 0.9 ml 
phosphate citrate-buffer and after addition of 0 . 1  ml glusulase, the cells were 
spheroblasted at RT overnight. After centrifugation (4 °C, 510 ref, 2 min), the 
supernatant was discarded and the cells were washed twice in 0.1 M sodium acetate 
pH 6.1. The pellet was taken up in 250 pi 2 % (v/v) osmium tetroxide in H2O and the 
cells were contrasted at RT for 15 min in the dark. The cells were washed twice with 
H2O before the cells were stained in 1 % (w/v) uranyl acetate in H2O at RT for 1 h in 
the dark. After two more washing steps (with H2O), the cells were dehydrated. Firstly, 
by incubation in 70 % (v/v) ethanol for 30 min. Secondly, in 95 % (v/v) ethanol for
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30 min and subsequently, twice in ethanol which was free of H2O. The cells were taken 
up in 0.5 ml Spurr resin (Agar Scientific, Stansted, UK) and were incubated for 1 h at 
RT. The cells were spun down by centrifugation (RT, 1,090 ref, 5 min), the Spurr-resin 
was removed and cells were taken up in new 200 pi Spurr-resin and were transferred 
into an EM tube (Polysciences, Warrington, USA). The cells were pelleted by 
centrifugation (RT, 15,300 ref, 15 min) in a horizontal Eppendorf centrifuge. The tubes 
were filled up to the top with Spurr-resin and the resin was polymerised at 65 °C for 
8  h.
2.2.34.2 Immunolabelling electron microscopy
2.2.34.2.1 Immunolabelling electron microscopy using yeast cells
Yeast cells of a 10 ml culture (OD6oo=0.8) of the strain YCS5-2 (BBP1-3Myc) were 
fixed for 45 min after addition of 1.2 ml formaldehyde (37 %) and 1 ml 1 M KPi- 
buffer (500 mM K2HPO4 , 500 mM KH2PO4 , pH 6.5). The cells were harvested by 
centrifugation (4 °C, 510 ref, 5 min). The cells were washed three times with S-buffer 
(40 mM KPi, pH 6.5, 0.5 mM MgCL, 1.2 M sorbitol) before they were resuspended in 
0.9 ml S-buffer containing (3-mercaptoethanol and 0.1 ml zymolyase 20T (stock 
solution: 2 mg/ml S-buffer containing p-mercaptoethanol). The cells were
spheroblasted at 30 °C for about 45 min until 90 % of cells appeared dark and rounded 
by phase contrast. The cells were chilled on ice for 5 min before they were washed 
three times in cold S-buffer (4 °C, 510 ref, 5 min). The cells were finally washed once 
in blocking buffer (PBS, 1 % (w/v) BSA, 100 mM lysine, 0.1 % (v/v) Triton-X-100) 
containing proteinase inhibitors (Mini complete, Roche, Lewes, UK). The pellet was 
taken up in 0.5 ml blocking buffer containing the primary antibody (anti-Myc; Roche, 
Lewes, UK; dilution 1:500). The cells were incubated at RT for 1 h. The excess of 
primary antibody was washed off with blocking buffer (3 times), before the secondary 
antibody (goat anti-mouse nanogold, dilution 1 :1 0 0 , pre-absorbed, see below) in 
blocking buffer was applied. After 1 h incubation time the cells were washed three 
times in PBS. The antibodies were crosslinked in PBS containing 1 % (v/v) 
glutaraldehyde at RT for 15 min. After two washing steps with PBS the cells were 
washed twice more with H2O.
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The secondary antibody was coupled to ultra-small gold particles which had to be 
silver enhanced. The silver enhancement method by Danscher was optimised for the 
application (Danscher et al., 1987).
Solution A: 100 g of gum arabic dissolved in H2O ad final volume of 200 ml
Solution B: 200 mM Hepes-buffer pH 5.8
Solution C: 0.285 g hydrochinone in 5 ml H2O (use immediately)
Solution D: 0.036 g silver lactate in 5 ml H2O (use immediately, keep in the dark)
The Danscher solution was prepared with 5 ml solution A, 1 ml solution B, 1.5 ml 
solution C, 1 ml H2O and 1.5 ml solution D. The cells were resuspended in 3 ml 
Danscher solution. Cells (1 ml) were transferred into 5 ml PBS to stop the silver 
enhancement reaction after 1 min, 5 min and 10 min. The cells were harvested by 
centrifugation and were washed twice in H2O (4 °C, 510 ref, 5 min). Pre-embedding 
staining with osmium tetroxide and uranyl acetate, dehydration of samples and 
polymerisation of the Spurr-resin was done as described in 2.2.34.1. Samples were 
serial sectioned (see 2.2.34.3) and stained (see 2.2.34.4).
The secondary antibody showed strong background staining during the optimisation of 
the protocol. Therefore, a batch of secondary antibody was incubated with fixed and 
spheroblasted cells for lh, just like the incubation of cells with the primary antibody 
(see above). The cells were spun down by (4 °C, 20,800 ref, 5 min), the supernatant 
containing the pre-absorbed antibody was kept at 4 °C and the dilution of the antibody 
was adjusted accordingly.
As control, wild type cells were treated exactly the same as the YCS5-2 cells.
2.2.34.2.2 Immunolabelling EM using isolated nuclei
The isolated nuclei (1010, see 2.2.31) were taken up in 1 ml S-buffer (40 mM KPi, 
pH 6.5, 0.5 mM MgCl2 , 1.2 M sorbitol) containing 1/10 volume of fromaldehyde 
(37 %). The nuclei were fixed for 30 to 40 min and were washed twice in PBS (4 °C, 
2,700 ref, 5 min) before they were taken up in 0.5 ml blocking buffer (PBS, 1 % (w/v) 
BSA, 100 mM lysine, 0.1 % (v/v) Triton-X-100 and proteinase inhibitors (Mini
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complete, Roche, Lewes, UK)). After incubation at RT for 30 min, the nuclei were 
washed three times in blocking buffer. The nuclei were taken up in blocking buffer 
containing the primary antibody (anti-Bbplp antibody, dilution: 1:5) and were 
incubated at RT for 1 h. This step was followed by 5 washing steps with blocking 
buffer. The nuclei were then incubated with the secondary antibody (goat anti-rabbit 
nanogold) in blocking buffer. The secondary antibody had been pre-absorbed with 
nuclei. Therefore, the antibody was incubated with fixed and blocked nuclei in the 
same way as described for the primary antibody (see before). The nuclei were spun 
down by centrifugation (4 °C, 20,800 ref, 5 min) and the supernatant containing the 
pre-absorbed antibody was used for the incubation. The dilution of the antibody was 
adjusted accordingly. After the incubation with the pre-absorbed secondary antibody, 
the nuclei were washed twice in PBS 0.1 % (v/v) Triton-X-100 and twice in PBS.
The cross-linking of antibodies, the silver enhancement, de-hydration, embedding in 
Spurr-resin and the polymerisation were done as described for whole cells. Samples 
were serial sectioned (see 2.2.34.3) and were stained (see 2.2.34.4).
As a control for the specificity of the secondary antibody, nuclei were prepared as 
described above but the incubation step with the primary antibody was omitted.
2.2.34.2.3 Immunolabelling EM using isolated SPBs
One batch of SPBs (about 105) obtained as described in 2.2.32, was taken up in 0.5 ml 
Bt-Mg-buffer (10 mM BisTris, 0.1 M MgCU, pH 6.5) containing 5 % (v/v) sterile 
filtered formaldehyde and the SPBs were fixed at RT for 15 min. The fixation was 
stopped by dilution of the SPBs in 5 ml Bt-Mg-buffer. Meanwhile, glass tubes were 
prepared which contained adapters on which a cover slip could be placed. The glass 
tube was filled with some Bt-Mg-buffer, so that the cover slip was covered and 5 ml 
Bt-Mg-buffer containing the fixed SPBs were added. The tube was spun in a HB 6  
Beckman rotor at 4 °C and 11,000 rpm for 12 min. The supernatant was aspirated off 
until 5 mm above the cover slip. The cover slip was taken out of the glass tube and was 
placed with the SPB-containing side on a drop of blocking buffer (PBS containing 
1 % (w/v) BSA and 100 mM lysine) for 10 min. The cover slip was moved to a new
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drop of blocking buffer and the incubation step was repeated. Afterwards, the cover 
slip was put head up on parafilm (American National Can, Chicago, USA). A drop of 
primary antibody diluted in blocking buffer (anti-Bbplp and anti-Mps2p at dilution: 
1:5) was placed on the cover slip. The SPBs were incubated for 1 h, before the 
antibody was aspirated off and the SPBs were washed 6  times with blocking buffer. 
This was done by placing a drop of blocking buffer on the cover slip and aspirating it 
off again. The secondary antibody (12 nm gold, goat anti-rabbit, dilution 1:40) was 
applied in a drop of blocking buffer for 1 h. Afterwards, the SPBs were washed 6  times 
with PBS. To cross-link the antibodies, the SPBs were incubated in a drop of PBS 
containing 1 % (v/v) glutaraldehyde at RT for 10 min. The SPBs were washed three 
times in H2O before they were contrasted in 2  % (v/v) osmium tretroxide in H2O in the 
fume hood for 15 min. The SPBs were washed again twice with a drop of H2O, before 
they were de-hydrated with drops of 95 % (v/v) ethanol and 100 % ethanol. Finally, a 
drop of Spurr-resin was placed on the cover slip and SPBs were soaked for 1 h. The 
Spurr-resin was taken off and three gelatin EM capsules (Polysciences, Warrington, 
USA) filled with Spurr-resin were placed on the cover slip. After polymerisation of the 
Spurr-resin at 65 °C for 8  h, the glass cover slip was carefully removed with the help of 
tweezers. Since the layer of SPBs in the Spurr-resin is very thin, sections were cut (see 
2.2.34.3), which contained a small line of SPBs. The SPBs were contrasted as 
described in 2.2.34.4.
2.2.34.3 Sectioning of samples
Sectioning of samples was provided by Margaret O’Prey (Technical Services, Beatson 
Institute, Glasgow). Ultra thin sections of samples were cut at 70 nm with the 
microtone using a diamond knife. The sections were floated of the knife into H2O. 
Sections were transferred onto microscopy grids (300-mash grid, copper/rhodium; slot 
grid, cooper/palladium; both 0  3.05 mm; TAAB, Aldermasten, UK) which had been 
coated with 0.6 % (v/v) formvar (TAAB, Aldermasten, UK).
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2.2.34.4 Post-embedding staining of samples
2.2.34.4.1 Staining with uranyl acetate
The samples were contrasted by post-embedding staining in a methanolic solution of 
uranyl acetate. Therefore, the microscopy grids were incubated in the dark for 5 min in 
a sterile filtered solution of 2 % (w/v) uranyl acetate in 70 % (v/v) methanol (Stempak 
and Ward, 1964). Each grid was taken up with a pair of tweezers and was secured with 
an elastic band. The grid remained on the pair of tweezers for the following steps. The 
grids were washed by moving them through about 10 drops of 70 % (v/v) methanol, 
which had been prepared in a multi-well porcelain dish. The grids were dried for at 
least 15 min, before they were stained with lead citrate (see below).
2.2.34.4.2 Staining with lead citrate
Reynolds’ lead citrate stain (1963) was prepared as follows. CC>2-free water was made 
by autoclaving double-distilled water in a screw-capped bottle and sealing the flask 
while still very hot. 1.33 g of lead nitrate and 1.76 g of sodium citrate were mixed with 
30 ml C02-free water by shaking. The milky solution turned clear after 5 to 7 ml of 
NaOH were added. The pH of the solution was between pH 12.0 and pH 12.1. A CO2- 
free staining chamber was prepared by placing NaOH pellets on a wet piece of filter 
paper in a petri dish. A drop of lead citrate was placed in the middle of the petri dish 
and the grids were floated in lead citrate for 5 min. Each grid was taken up with a pair 
of tweezers and was placed in a drop of water. Afterwards, each grid was washed, still 
on the tweezers, under the constant flow of water from a squeeze bottle for about 
1 min. The grids were dried for at least 15 min.
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3. Results
3.1 Functional epitope tags of BBP1
The construction of functional epitope tags for Bbplp was a prerequisite for the 
localisation and immunoprecipitation of the protein. Strains expressing BBP1 fused to 
triple HA, triple Myc, protein A or single GFP were obtained as described in Material 
and Methods. The tags were generated by PCR (see 2.2.1.4) with primers BBP1-S2 and 
BBP1-S3 (see 2.1.6) using the modules pYMl, pYM4, pYM8 and pYM12 (Knop et 
al., 1999) (see 2.2.16). The PCR products were analysed by gel-electrophoresis (see 
2.2.4.1). As expected the DNA fragments were 1922 bp for 3HA, 1943 bp for 3Myc, 
2225 bp for TEV-ProA-7HIS and 2562 bp for GFP (Figure 6A). After ethanol 
precipitation (see 2.2.2), the fragments were transformed into the yeast strains YPH499 
(HA: YCS3; TEV-ProA-7HIS: YCS4; Myc: YCS5) or ESM357 (GFP: YCS6) and 
were selected for the kanMX6 marker (Wach et al., 1994). The proper integration of 
constructs at the C-terminus of BBP1 was tested by colony-PCR (see 2.2.1.2) using the 
BBP1 -B primer and the KAN2 primer, which binds in the kanamycin gene. The PCR 
products confirmed the correct chromosomal integration of the modules (Figure 6B). 
The expression of the gene-fusions was tested by Western blotting (see 2.2.13) using 
anti-HA, anti-Myc and anti-ProA antibodies (Figure 6C). The sizes of the fusion- 
proteins were about 54 kD for Bbplp-3HA, 57 kD for Bbplp-3Myc and 64 kD for 
Bbplp-TEV-ProA-7HIS. The expression of BBP1-GFP was analysed by fluorescence 
microscopy (see 2.2.33.1). Since BBP1 is an essential gene (see 3.4.1) the protein- 
fusions were functional when they allowed the normal growth of the haploid yeast 
strains YPH499 and ESM357.
A Bbplp-9Myc fusion protein was constructed as described above using the pYM6 
module. It was only partially functional, since cells grew more slowly and contained 
elongated buds. This strain was not used for further experiments.
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Figure 6\ Epitope tagging o f  BB P I . (A) Cassettes for 3HA, 3Myc, TEV-ProA and 
GFP tagging of BBPI  were amplified by PCR with primers BB P/-S2  and BBPI-S3 
and the PCR products were cheeked by agarose gel-electrophoresis. (B) Insertion of 
tags into the chromosome was monitored by colony PCR using primers which prime 
in the selection marker (kanamycin) and downstream from the stop codon of  B B P I . 
(C) Expression o f  BBPI-3HA, BBPI-3Myc  and BBPI-TEV-ProA  was controlled by 
Western blotting with antibodies recognising the specific epitope tags.
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3.2 Antibodies specific for Bbplp
Polyclonal Antibodies recognising Bbplp were raised against Bbplp-GST fusion 
proteins for identification of Bbplp by Western blotting and for immunolabelling 
localisation of Bbplp.
BBPI-GST and N-BBP1-GST fusions were obtained by cloning the ORF and the N- 
terminus of BBPI into the pGEX-5X-l plasmid (pCSl and pCS7-l, see 2.1.7). After 
transformation of the plasmids into the E. coli strain BL21 (DE3) pLysS, the best 
conditions for the expression of the gene-fusions were established as 0.5 mM IPTG for 
2 h at 37 °C (see 2.2.25.1). Longer induction caused severe degradation of the fusion- 
protein and lower concentration of IPTG did not provide sufficient induction. 
Expression of full length BBPI-GST caused inclusion bodies and the protein was 
insoluble. The N-terminal Bbplp-GST fusion protein was soluble and could be 
purified by binding to glutathione sepharose as described in 2.2.25.1. The purified 
protein was used for the immunisation of a rabbit (see 2.2.23). A course of four 
immunisations was sufficient to obtain serum that recognised protein bands at about 
45 kD in a Western blot of total yeast extract of cells overexpressing Bbplp (YCS18-1; 
GAL1-BBP1, Figure 7A). After affinity purification of the antibodies (see 2.2.23.3), the 
fraction of antibodies eluted with glycine/EGTA produced a strong signal at about 
45 kD in a Western blot of total yeast extract of GAL1 -BBPI cells (Figure 7B). The 
antibodies did not show a signal in Western blots using total yeast extract of wild type 
cells (data not shown). The antibodies recognised Bbplp in Western blots of extracts 
from nuclei and SPBs and they were specific since only one single band was visible at 
about 45 kD (Figure 7C). Therefore, the antibodies specifically recognise Bbplp and 
show a signal in Western blots containing sufficient amounts of protein. The antibodies 
were stored at -  20 °C and were used at a dilution of 1:200 for Western blotting.
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Figure 7: Antibodies which specifically recognise Bbplp . (A)  Western blots 
containing cell extract o f  cells overexpressing BBPI  were probed with different 
dilutions o f  serum of the immunised rabbit. The rabbit serum contained antibodies 
recognising a protein band corresponding to the molecular weight of B b p lp  (about 
45kD, indicated by arrow) which was not recognised by the pre-immunserum (first 
lane). (B) The immunopurified serum eluted with glycin/KGTA recognised protein 
bands at about 45kD in Western blots containing cell extract of cells overexpressing 
BB PI . (C) The immunopurified serum recognised a single protein band just below 
45kl) at a dilution o f  1:200 in Western blots containing isolated nuclei (lane 1) or 
isolated SPBs (lane 2).
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3.3 Cellular localisation of Bbplp
Bbplp was found as an interacting protein of Spc29p (S. Elliott, published in Schramm 
et al., 2000), a component of the central plaque of the SPB (Adams and Kilmartin, 
1999; Elliott et al., 1999). This interaction with Spc29p could take place at the SPB 
and therefore Bbplp or a pool of Bbplp might be localised at the SPB as well. To 
prove this hypothesis the localisation of Bbplp in the cell was determined by direct 
fluorescence, indirect immunofluorescence and immunolabelling electron microscopy.
3.3.1 Localisation of Bbplp using GFP fusions
GFP has been used successfully to visualise various SPB components in yeast. 
Especially products of gene fusions of SPC42 and SPC72 with GFP show a very 
distinct dot-like staining by fluorescence microscopy which represents the SPB (Chen 
et al., 1998; Schutz and Winey, 1998). Cells expressing BBPI fused to GFP (YCS6, 
see 3.1, see 2.2.16) were grown in liquid culture to early logarithmic phase, were 
harvested by centrifugation and investigated by fluorescence microscopy (see 2.2.33.1). 
To be able to observe a GFP-signal by fluorescent microscopy, the cells had to be 
washed in water to remove the YPD-medium which obstructed the documentation of 
the weak Bbplp-GFP signal. The Bbplp-GFP signal exhibited a single dot-like 
staining in unbudded cells and double dot-like staining in budded cells (Figure 8A). 
This is consistent with GFP signals observed for other SPB components. However, 
compared to the signals obtained for the SPB components Spc42p, SpcllOp or Spc72p 
the Bbplp-GFP signal was much weaker. In addition, dot-like staining could also 
represent staining of kinetochores which cluster near the SPB (Goh and Kilmartin, 
1993; Goshima and Yanagida, 2000; Hyland et al., 1999). Thus, Bbplp is localised in 
distinct dot-like patterns which could indicate a localisation of Bbplp at the SPB.
3.3.2 Localisation of Bbplp at the SPB by indirect immunofluorescence
To investigate if the signal obtained by direct fluorescence microscopy represented a 
localisation of Bbplp at the SPB, Bbplp had to be co-localised with known SPB 
components by indirect immunofluorescence (see 2.2.33.2). For this experiment 
Bbplp-3Myc was detected using mouse monoclonal 9E10 antibodies against the Myc-
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tag of the protein. The SPB was marked with polyclonal antibodies (rabbit) against the 
outer plaque component Spc72p (Knop and Schiebel, 1998). The DNA was stained by 
DAPI and the blue staining roughly represented the area of the nucleus. Bbplp-3Myc 
(YCS5) cells were grown to OD6oo=0.8 and were fixed according to the 
methanol/acetone method (see 2.2.33.2.2). As secondary antibodies, goat-anti-mouse 
CY3 and goat-anti-rabbit CY2 antibodies were used (see 2.1.10). The wild type control 
(YPH499) sample showed some unspecific background staining for the anti-Myc/anti- 
mouse CY3 antibody combination (Figure 8, B1 and B2). However, the staining of 
Bbplp-3Myc cells was distinctly different from the control strain (Figure 8, compare 
B1 and B2 with B3 and B4). The red coloured CY3 signal which represented Bbplp 
was consistent with the dot-like pattern obtained in the GFP localisation experiment 
(compare Figure 8 A with Figure 8, B3 and B4) and co-localised with the green 
Spc72p signal (Figure 8, B3 and B4). Both, Spc72p and Bbplp signals were in 
proximity to the blue staining for chromatin (Figure 8B). Due to co-localisation with 
the known SPB component Spc72p, Bbplp is a component of the SPB.
3.3.3 Localisation of Bbplp at the periphery of the central plaque by 
immunolabelling electron microscopy
To investigate which substructure of the SPB, Bbplp associates with, isolated SPBs, 
nuclei and whole yeast cells were investigated by immunolabelling electron 
microscopy. YCS5 (Bbplp-3Myc) cells were prepared for pre-embedding labelling 
(see 2.2.34.2.1). The optimal fixation for cells was determined as 3.5 % formaldehyde 
for 40 min. The primary antibody (Boehringer anti-Myc antibody) was used in a 
dilution of 1:500 and the secondary antibody which was coupled to ultra small gold 
particles (goat anti-mouse nanogold) was pre-absorbed with spheroblasts to reduce 
non-specific binding (see 2.2.34.2.1). The ultra-small gold particles were silver- 
enhanced by the Danscher method (see 2.2.34.2.1). After ultra-thin serial sectioning of 
Spurr embedded cells (see 2.2.34.3) the sections were placed onto microscopy grids 
and were stained with uranyl acetate and lead citrate (see 2.2.34.4). In 10 cases a gold 
signal representing Bbplp was observed close to the central plaque (Figure 9A). As a 
control YPH499 cells were treated identically and the cells did not show any gold 
staining at the SPB (data not shown).
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In the experiment described above, the morphology of yeast cells and of SPBs was not 
perfectly conserved. This was due to the harsh treatment of cells during spheroblasting 
and due to incubation of cells with detergent to allow the penetration of antibodies into 
the cell. Therefore, the localisation was repeated using isolated nuclei and isolated 
SPBs. Since the cell walls and most of the cytoplasmic material and in case of isolated 
SPBs, partially the nuclear envelope, had been removed by the isolation, antibodies 
had easier and better access to the SPB. Therefore, samples could be treated less 
harshly and the structure of SPBs was less affected by this procedure.
The isolated nuclei (see 2.2.31) were prepared for electron microscopy as described in 
Material and Methods (see 2.2.34.2.2). Anti-Bbplp antibodies were used at a dilution 
of 1:5 and the secondary antibody coupled to ultra small gold particles was pre­
absorbed with isolated nuclei and the dilution was adjusted accordingly. The ultra­
small gold particles were silver-enhanced by the Danscher method (see 2.2.34.2.1). 
About 40 % of all 64 nuclei investigated showed labelling at the SPB (Figure 9B). The 
gold particles representing Bbplp were found near the periphery of the central plaque 
(n=20). In cases in which the half-bridge was visible, the signal was close to the site 
where the half-bridge connects to the central plaque periphery (n=3). In three cases the 
gold particle stained the inner plaque. The control nuclei which had been incubated 
with the secondary antibody, did not show any SPB staining. Only, two out of 
45 control nuclei investigated had staining at the nuclear envelope but not at the SPB.
The localisation of Bbplp at the central plaque periphery was further confirmed using 
isolated SPBs (see 2.2.32). SPBs were fixed in 5 % formaldehyde (see 2.2.34.2.3). The 
anti-Bbplp antibody was used at a dilution of 1:5 and the goat-anti-rabbit antibody 
coupled to 12 nm gold was used at a dilution of 1:1000. About 55 % of 60 SPBs 
investigated had staining at the side of the central plaque (Figure 9C). Side-by-side 
SPBs connected via the bridge structure were observed to have signals where the 
bridge connects to the central plaque or 180° opposite, on the other side of the central 
plaque (n=5) (Figure 9C).
Taken together, Bbplp was shown to be a component of the SPB with a localisation at 
the central plaque periphery.
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Bbp1p-3Myc anti-Spc72p DAPI
Figure 8: B bp lp  is localised at the SPB. (A) Cells expressing B B P I -GFP were 
investigated by fluorescence microscopy and dot-like signals typical for SPB staining 
were observed. (B) Indirect immunofluorescence of wild type cells (panel I and 2) and 
cells expressing Bbplp-3M yc (panel 3 and 4). B bplp-3M yc was localised using mouse 
monoclonal anti-Myc antibodies (9E10). The SPB was labelled with antibodies against 
the outer plaque component Spc72p (rabbit anti-Spc72p) and the DNA was visualised 
by DAPI staining. The specific dot-like signal for B b p lp  which was not present in the 
wild type control co-localised with the Spc72p staining of SPBs. Bars (A and B), 5 jam.
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Figure 9: B bplp  is associated with the central plaque periphery. Immunolabelling 
electron microscopy of BBPl-3Myc  cells (A), isolated nuclei (B) or isolated SPBs (C) 
using mouse monoclonal anti-Myc antibodies (A) or immunopurified rabbit an ti-B bplp  
antibodies (B and C). The secondary antibodies were conjugated to ultra small gold (A 
and B) or to 12 nm gold particles (C). Ultra small gold particles were silver enhanced. 
Gold staining represents B bplp  (large arrows). Note: in a few cases (n=3) gold staining 
was found close to the inner plaque of the SPB (B, bottom right micrograph). B: bridge, 
CP: central plaque, HB: half bridge, IP: inner plaque, MT: microtubules, NE: nuclear 
envelope, OP: outer plaque; Bars (A-C), 0.25 pm.
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3.4 The cellular role of Bbplp
The following experiments were designed to reveal the functions of Bbplp at the SPB 
and to elucidate its role in cellular processes.
3.4.1 BBP1 is essential
To determine if BBPI is an essential gene YCS1, a diploid yeast strain in which one 
chromosomal copy of BBPI was replaced with the HIS3 marker gene was constructed 
(see 2.2.17). YCS1 was forced by sub-optimal growth conditions to undergo meioses 
and transform cells into tetrads (see 2.2.17). The four spores of each tetrad were 
separated by microscopic dissection onto non-selective YPD-plates and were incubated 
for growth at 23 °C. Two spores should harbour wild type copies of BBPI while the 
other two spores should contain the HIS3 marker gene instead. Two out of four spores 
managed to grow on non-selective plates (Figure 10A). These two spores did not 
contain the HIS3 marker gene, since the colonies could not grow after replication on 
selective plates lacking histidine (data not shown). Therefore, spores which did not 
contain BBPI were unable to grow into colonies.
In addition, YCS1 was transformed with BBPI on a single copy t/7M3-based vector 
and the strain was analysed by microscopic dissection (data not shown). All four spores 
could grow on non-selective plates. If colonies grown up from four sister spores were 
replica plated on 5-FOA plates the URA3-based BBPI plasmid was lost (see 2.2.20) 
and only two colonies could grow. Cells of these colonies harboured the chromosomal 
wild type copy of BBPI. Thus, cells lacking Bbplp were unable to grow and BBPI is 
an essential gene.
3.4.2 Overexpression of BBP1 inhibits cell growth
A yeast strain overexpressing BBPI was constructed by placing BBPI under the 
control of the GAL1-promoter (pCS9) and transforming the p425-GAL1-BBP1 plasmid 
into wild type (YPH499) yeast cells. The resulting strain, YCS18, was streaked out on 
2 % raffinose/2 % galactose plates for induction of the GAL1 -promoter. Induction of 
the GAL1 -promoter can cause an overproduction of up to 1500-fold (Mumberg et al.,
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1994). Some small colonies of the strain containing the p425-GAL 1-BBPI plasmid 
were able to grow (Figure 10B, sector 1). Compared to the normally growing wild type 
strain (Figure 10B, sector 2), containing the p425-GAZJ control plasmid, growth was 
strongly inhibited. The effect of BBPI overexpression was not as harmful for cells as 
overexpression of SPC42 coding for a component of the IL2 which was used as a 
control (Figure 10B, sector 3). Overexpression of SPC42 is known to be toxic and cells 
overexpressing Spc42p contain disc-shaped polymers associated with the SPB at the 
outer nuclear membrane (Bullitt et al., 1997; Donaldson and Kilmartin, 1996). BBPI 
overexpression was toxic, however, slightly less than compared to SPC42.
In a second experiment, YCS18 cells were grown in liquid culture, for two days in SC- 
Leu medium containing 2 % raffinose to deplete glucose. Then, cells were harvested 
and transferred into SC-Leu medium containing 2 % raffinose and 2 % galactose for 
induction of the GAL1 -promoter. The control strain containing the p425-GA£J plasmid 
was treated accordingly. Cells were harvested shortly before induction (0 h) and 3 h, 
6 h, 8 h, 24 h and 48 h after induction for Western (see 2.2.13) and FACS analysis (see 
2.2.15). Western blotting using anti-Bbplp antibodies (Figure 10C) showed that Bbplp 
was highly enriched in cells overexpressing Bbplp (Figure 10C, S2) compared to non­
induced cells (0 h) and cells containing the empty p425-GALi plasmid (Figure 10C, 
SI). However, the anti-Bbplp antibody did not show a signal for wild type levels of 
Bbplp in Western blots as described in 3.2 before. Samples of the control strain 
(YPH499 p425-GALZ) and of YCS18 (GAL1-BBP1) cells of all time points were 
analysed by FACS (data not shown). There was no significant difference in the DNA 
content of cells highly overexpressing BBPI compared to wild type cells. Furthermore, 
cells overexpressing BBPI did not have any unusual phenotypes as investigated by 
light microscopy (data not shown). Immunofluorscence microcopy showed high levels 
of Bbplp in the cytoplasm and the nucleus (data not shown). Cells overexpressing 
Bbplp for 3 h were investigated by morphological electron microscopy and did not 
display any SPB defects (data not shown).
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Figure 10. BBPI  is an essential gene and its overexpression is toxic. (A) Sporeanalysis 
o f  YCSI (BBPI/Abbpl::H1S3MX4).  Two out of four .spores (SI. S2, S3, S4) lacked 
BBPI  and were unable to grow into colonies. Four tetrades were dissected (lane 1-4) 
(B) Cells containing p425 -GALl-BBPI  and p425-GALI -SPC42  were unable to grow 
on plates containing 2% Raffinose and 2% Galactose. The control cells containing 
p425-GALl  were able to grow. (C) Overexpression o f  BBPI  under the GAP/  promotor 
in liquid culture. Cells containing p425-GALl-BBPI or  p425-GALI  were grown in 2 % 
Raffinose/2% Galactose medium and samples were taken at several time points after 
induction as indicated. Cell extracts were analysed by Western blotting with polyclonal 
rabbit an ti-B bp lp  antibodies; strain SI: YPFI499 containing p425-GALI:  strain S2: 
YPH499 containing p425-GALI-BBPI.
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3.4.3 Analysis of temperature sensitive mutants of BBP1
Since overexpression of BBPI neither caused a distinct arrest in the cell cycle nor an 
obvious alteration in the phenotype, conditional lethal mutants of BBPI were 
constructed as a tool to further investigate the function of Bbplp.
3.4.3.1 Temperature sensitive mutants of BBP1
The function of Bbplp was determined by the analysis of yeast strains carrying a 
mutated BBPI gene. Conditional lethal mutants of BBPI were constructed using PCR 
based techniques (see 2.2.18). Primers were designed to bind to the regions 167 bp 
upstream of start {BBPI-M l) and 138 bp downstream of stop {BBPI-M2) of BBPI, 
therefore, including the complete ORF of BBPI. Firstly, the optimal PCR conditions 
for the amplification of the BBPI containing fragment were determined as standard 
PCR conditions (see 2.2.1.1) with 2.5 mM MgCb (template pCS14). For the mutagenic 
PCR these optimal conditions were changed as described in 2.2.1.3. PCR fragments 
obtained from reactions with 0.08 mM ATP and 1 mM MnCl2 or 0.2 mM ATP and 
1.5 mM MnCb were selected. The ORF of BBPI contains two Hpdl restriction sites at 
297 bp and 1327 bp downstream from start. This Hpal-fragment was cut out of BBPI 
which had been cloned into a single-copy TRP1 -based vector (pCS17, pRS414-BBPI). 
The /f/?0 l-restricted vector and the PCR fragments obtained by mutagenic PCR were 
transformed into YCS17 {BBPI shuffle strain, see 2.2.17) and the transformants were 
selected for growth on plates lacking histidine and tryptophan. Due to homologues 
recombination the //pal-fragment was ligated into the cut pRS414-BBPI vector. About 
25,000 transformants were obtained. The pRS316 plasmid carrying a wild type copy of 
BBPI was counter selected on 5-FOA plates (see 2.2.20) and afterwards colonies were 
replica plated on SC-His-Trp plates (see 2.2.19) and tested for failure to grow at 
different temperatures. As a result, 25 potentially temperature sensitive mutants were 
obtained. From these mutants, 17 of the pRS414-M>/?i plasmids could be isolated by 
plasmid rescue (see 2.2.10.2) and were amplified in E. coli. After re-transformation 
into the BBPI shuffle strain 7 plasmids still caused a conditional lethal phenotype. 
Three strains with different restrictive temperatures were selected and the mutated
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genes were integrated into the chromosomal TRP1 locus. The mutations were 
confirmed by sequencing (see 2.2.14). Thus, the following strains were obtained:
YCS64 (bbpl-1) restrictive temperature: 35 °C
missense mutations: N97S, H135R, N234D, D243E 
YCS65 (bbpl-3) restrictive temperature: 37 °C
missense mutations: M55T, N92D, E128D, N144M, I152K, 
I155R, L168I, V208D, E211G, K221R 
YCS66 (bbpl-2) restrictive temperature: 33 °C
missense mutations: T66P, S106N, M230S
3.4.3.2 Suppression of conditional mutants of BBP1 by other SPB components
All three conditional lethal mutants of BBPI (bbpl-1, bbpl-2, bbpl-3) were tested for 
rescue of growth by overexpression of other SPB components and SPB associated 
proteins. Suppression of temperature sensitive mutants might be explained by the 
ability of the overexpressed protein to function downstream of the mutated protein or 
by its ability to take over or assist with the function of the mutated protein. Therefore, 
growth of the mutant strain at the restrictive temperature due to overexpression of 
another gene indicates a possible interaction or functional analogy of proteins. In this 
experiment various known SPB components were tested (Table VIIII). Firstly, all three 
mutants grew like wild type cells when additional copies of BBPI were reintroduced. 
Overexpression of SPC42 coding for an IL2/central plaque component improved the 
growth of YCS64 and YCS66 strains very slightly. High gene dosage of SPC34, 
coding for a SPB component with unknown function (Wigge et al., 1998), allowed 
bbpl -2 to grow well at 33 °C and slightly at 35 °C. This effect was not observed in the 
case of bbpl-1 and bbpl-3. An increase in the growth defect of bbpl-1 and bbpl-3 was 
recorded for the mild overexpression of the half-bridge component KAR1 (see 3.6). 
Such an effect has been described before for conditional lethal mutants of CDC31 
(Vallen et al., 1994) and SPC29 (Elliott et al., 1999). Additional copies of SPC19, 
SPC24, SPC25, SPC29, SPC72, SPC97, SPC98, SPC105, STU2, CDC31, TUB1, 
TUB4, CMD1, and CNM67 did not affect the growth of the mutant strains.
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Table VIIIT. Effect of high gene dosage of indicated genes on 
mutants in BBPI (bbpl-1, bbpl-2 and bbpl-3)
YCS64 (bbpl-1) Temperature in °C
gene plasmid plasmid name 30 33 35 37
BBPI pRS425 pCS14-2 + + + + + + + + + + + +
SPC19 pRS425 pSM535-6 + + + + + -
SPC24 pRS425 pSM541-3 + + + + +
SPC25 pRS425 pSM538-l + + + + +
SPC29 pRS425 pSE3-6 + + + + +
SPC34 pRS425 pSElO + + + + +
SPC42 pRS425 pSE17-2 + + + + + +
SPC72 pRS426 pSM458-l + + + + +
SPC97 pRS425 pMKll-15 + + + + +
SPC98 pRS425 pSM271 + + + + +
SPC105 pRS425 pSM544-l + + + + +
CNM67 pRS425 pSM568-l + + + + +
STU2 pRS425 pSM603-l + + + + +
KAR1 pRS315 pSM39-2 + + + -
CDC31 pRS425 pSM234-l + + + + +
TUB1 pRS425 pSM553-3 + + + + +
TUB4 pRS426 pSM347-4 + + + + +
CMD1 pRS426 pSM292-3 + + + + +
pRS315 + + + + +
pRS425 + + + + +
pRS426 + + + + +
YCS65 (bbpl-3) Temperature in °C
gene plasmid plasmid name 30 33 35 37
BBPI pRS425 pCS14-2 + + + + + + + + + + + +
SPC19 pRS425 pSM535-6 + + + + + + + +
SPC24 pRS425 pSM541-3 + + + + + + + +
SPC25 pRS425 pSM538-l + + + + + + + +
SPC29 pRS425 pSE3-6 + + + + + + + +
SPC34 pRS425 pSElO + + + + + + + +
SPC42 pRS425 pSE17-2 + + + + + + + +
SPC72 pRS426 pSM458-l + + + + + + + +
SPC97 pRS425 pMKll-15 + + + + + + + +
SPC98 pRS425 pSM271 + + + + + + + +
SPC105 pRS425 pSM544-l + + + + + + + +
CNM67 pRS425 pSM568-l + + + + + + + +
STU2 pRS425 pSM603-l + + + + + + + +
KAR1 pRS315 pSM39-2 + + + + + + +
CDC31 pRS425 pSM234-l + + + + + + + +
TUB1 pRS425 pSM553-3 + + + + + + + +
TUB4 pRS426 pSM347-4 + + + + + + + +
CMD1 pRS426 pSM292-3 + + + + + + + +
pRS315 + + + + + + + +
pRS425 + + + + + + + +
pRS426 + + + + + + + + -
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Table M ill  continued
YCS66 (bbpl-2) Temperature in °C
gene plasmid plasmid name 30 33 35 37
BBPI pRS425 pCS14-2 + + + + + + + + + + + +
SPC19 pRS425 pSM535-6 + + + - - -
SPC24 pRS425 pSM541-3 + + + - -
SPC25 pRS425 pSM538-l + + + - -
SPC29 pRS425 pSE3-6 + + + - -
SPC34 pRS425 pSElO + + + ++ -
SPC42 pRS425 pSE17-2 + + + +
SPC72 pRS426 pSM458-l + + + -
SPC97 pRS425 pMKll-15 + + + -
SPC98 pRS425 pSM271 + + + -
SPC105 pRS425 pSM544-l + + + -
CNM67 pRS425 pSM568-l + + + -
STU2 pRS425 pSM603-l + + + -
KAR1 pRS315 pSM39-2 + + + -
CDC31 pRS425 pSM234-l + + + -
TUB1 pRS425 pSM553-3 + + + -
TUB4 pRS426 pSM347-4 + + + -
CMD1 pRS426 pSM292-3 + + + -
pRS315 + + + -
pRS425 + + + -
pRS426 + + + -
BBPI complements the temperature dependent phenotype of mutants in 
BBPI. High gene dosage of SPC42 rescues growth in bbpl-1 and 
bbpl-2 cells. SPC34 is a high gene dosage suppresser of bbpl-2 cells. 
KAR1 on a centromer based plasmid has a negative effect on bbpl-1 
and bbpl-3 cells. Strains were transformed with the indicated plasmids 
and cells were grown on plates for 3 d at the indicated temperatures. 
Wild type like growth is indicated by (+++) and slight growth by (+). 
(-) indicates no growth of strains at this temperature.
RESULTS 122
3.4.3.3 The temperature sensitive mutant bbp1-1 arrests in G2 and is defective 
in chromosome segregation and proper spindle formation
The conditional lethal mutant bbpl-1 (YCS64) was investigated throughout the cell 
cycle by FACS analysis and indirect immunofluorescence. Bbpl -1 cells and wild type 
cells were grown in liquid culture at 23 °C, the permissive temperature of bbpl -1 cells, 
to an OD6oo=0.3. The cultures were arrested with a-factor in Gi-phase of the cell cycle 
(t=0) (see 2.2.21). After a-factor was removed by washing with YPD-medium the 
cells progressed synchronously through the cell cycle. Simultaneously, the cells were 
shifted to 37 °C, the restrictive temperature of bbpl-1 cells. Samples of bbpl-1 and 
control cells were taken at t=0 and every 30 min after release from Gi-arrest for 3 h.
Most wild type and bbpl-1 cells were arrested in Gi-phase before release from a -  
factor arrest (t=0) as indicated by the In DNA content seen in the FACS analysis 
(Figure 11 A). DNA replication was completed in both strains 1.0 h after release from 
a-factor arrest with cells now harbouring a 2n DNA content. Wild type cells 
underwent mitosis and separated their chromosomes between time points t=l h and 
t=1.5 h returning to single cells with In DNA content (Figure 11 A, Diagram 1). In 
contrast, bbpl-1 cells arrested with a G2 DNA content and did not complete mitosis 
(Figure 11 A, Diagram 2).
SPB duplication (anti-Spc72p antibodies), spindle formation (anit-tubulin antibodies) 
and chromosome segregation (DNA stained with DAPI) were monitored throughout 
the cell cycle by immunofluorescence microscopy (see 2.2.33.2). The percentages of 
different morphological phenotypes of bbpl-1 and wild type cells of the time-course 
samples were counted and are displayed in Table X. Wild type cells duplicated their 
SPBs, formed a mitotic spindle and separated their chromosomes (Figure 11, B1 and 
B2; Table X). Bbpl-1 cells instead, showed various defects in mitosis (Figure 11, B3- 
B6; Table X). At 1.5 h after release, about 40 % of bbpl-1 cells contained only one 
anti-Spc72p staining representing the SPB or two SPBs close together. This suggested 
that cells failed to duplicate their SPB or had disintegrated a non-functional SPB 
(Figure 11, B3). About 60 % of bbpl-1 cells duplicated their SPB but displayed major 
mitotic spindle defects (Figure 11, B4-B6). If a mitotic spindle was visible it was an
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asymmetrical spindle consisting of a large bundle of microtubules emerging from one 
SPB and only a few microtubules were nucleated by the other SPB (Figure 11, B4). 
The majority of cells with two spindle pole bodies (40 %) did not have a mitotic 
spindle. In these cells, one SPB was associated with a large array of microtubules and 
the other SPB only nucleated some, which seemed to be cytoplasmic microtubules 
(Figure 11, B5 and B6). Both SPBs always seemed to nucleate cytoplasmic 
microtubules which might explain why the positioning of the SPBs in the mitotic cells 
was normal. Most likely as an effect of the spindle defects, 99 % of bbpl -1 cells failed 
to separate their chromosomes (Figure 11, B4-B6). The DAPI staining region always 
remained with the SPB that was able to nucleate the majority of micro tubules. 
Interestingly, this functional SPB remained in the mother cell which could be identified 
as such because it still contained the mating projectile (shmoo) from the a-factor 
arrest. To summarise, immunofluorescence microscopy revealed that bbpl-1 cells were 
defective in SPB duplication, spindle formation and DNA separation.
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Figure 11. Mutants in BBPI  are defective in spindle formation and chrom osome 
segregation. Wild type and bbpl -1  cells were arrested with a -fac to r  in G, o f  the cell 
cylce. Cells were released from the arrest (t=0) and continued synchronously through 
the cell cycle. At the same time, cells were shifted to the the non-permissive 
temperature (37 °C). (A) The DNA content o f  wild type and bbpl-1  cells was followed 
over time by flow cytometry. (B) Wild type (B1 and B2) and bbp l -1  (B3-B6) cells were 
analysed 1.5 h after shift to 37 °C by indirect immunofluorescence with affinity-purified 
rabbit anti-Spc72p and monoclonal mouse anti-tubulin antibodies. The DNA was 
stained with DAPI. The anti-Spc72p (red), anti-tubulin (green) and DAPI (blue) signals 
were merged. Bar 5 pm.
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3.4.3A  The bbp1-1 cells are defective in inner plaque formation
As shown in the immunofluorescence experiment 40 % of bbpl-1 cells contained only 
one SPB at time points when wild type cells had already duplicated their SPBs and all 
bbpl-1 cells with two SPBs, contained one SPB that was defective in microtubule 
nucleation. Therefore, it was assumed that bbpl-1 cells fail to properly duplicate their 
SPB. To investigate the defects in duplication and especially, of the non-functional 
SPB, bbpl -1 cells were examined by electron microscopy. Furthermore, components of 
the central and inner plaque of the SPB where tagged with GFP and the assembly of 
the new SPB was studied in bbpl-1 cells by direct fluorescence microscopy.
3.4.3.4.1 Analysis of bbp1-1 cells by morphological electron microscopy
Cultures of wild type and bbpl -1 cells were synchronised in the cell cycle as described 
in 4.3.2 and samples were prepared for electron microscopy (see 2.2.34.1) at time- 
points t=l h, t=1.25 h and t=1.5 h after shift to the non-permissive temperature. This 
time range was chosen according to the immunofluorescence experiment (see 3.4.3.3) 
which suggested that complications in SPB duplication occur in this time interval. 
Bbpl-1 cells were able to perform initial steps of SPB duplication just like wild type 
cells. In Gi-cells (t=0.45 h) the enlarged satellite/duplication plaque was visible at the 
end of the half-bridge (n=20) (Figure 12A). The duplication plaque was still connected 
with the mother SPB via the half bridge (Figure 12A). Wild type cells then formed 
side-by-side SPBs (t=1.25 h) and the newly formed SPB was able to nucleate nuclear 
micro tubules (Figure 12B, two serial sections). This step of SPB duplication was not 
observed in bbpl-1 cells. Here, a second SPB could be seen still connected to the 
mother SPB via the bridge, as expected for side-by-side SPBs, but the new SPB did not 
have an inner plaque and did not nucleate nuclear microtubules (n=25) (Figure 12C, 
two serial sections). This suggested that the insertion of the duplication plaque is 
delayed or defective in bbpl-1 cells. After 1.5 h only one normal looking SPB was 
observed in most serial sections through bbpl -1 cells (n=50). Only in n=2 cases a small 
structure was seen which nucleated some nuclear and cytoplasmic microtubules and 
was located opposite a normally looking SPB (Figure 12, D and E; serial sections). 
These structures were very difficult to identify in serial sections of whole cells. Mainly,
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because they only nucleated very few microtubules and they were only slightly larger 
than nuclear pores. Therefore, it was difficult not to mistake the small second SPB for 
a nuclear pore. This might explain why a second SPB was not identified in 60 % of 
cells as would have been expected from the immunofluorescence experiment (60 % of 
cells contained two SPB signals at t=1.5 h by immunofluorescence, compare 3.4.3.3). 
When a second SPB was detected in bbpl-1 cells no proper spindle was seen 
connecting the two SPBs as normally the case for wild type cells (Figure 12, compare 
D and E with F). The few nuclear microtubules organised by the smaller SPB failed to 
connect to the microtubules of the other SPB. Although the small SPB nucleated fewer 
microtubules than normal, it must have developed some inner plaque structure, which 
nucleated microtubules via the y-tubulin binding complex.
SPB1
Figure 12: Mutants in BBPI  are defective in SPB duplication. Synchronised wild type 
(B and F) and bbpl-1  (A, C, D, E) cells were prepared for morphological EM 1 h (A), 
1.25 h (B) and 1.5 h (D -F) after they had been shifted to 37°C (t=0). The mother SPB 
consists of an outer (OP), central (CP) and inner (IP) plaque. The 1 , ' cation plaque 
(DP) is associated with the distal tip of the half-bridge (HB). Microtubules (MT) form 
functional mitotic spindles (MS) only in wild type cells. (A) Five micrographs of bbpl-1  
cells show the functional mother SPB with a normal duplication plaque. (B) Two serial 
sections through wild type side-by-side SPBs. (C) Tw o serial sections through bbpl -1  
cells. The duplication plaque (SPB2) is not properly inserted in the nuclear envelope 
(NE) and does not connect nuclear microtubules (MT). (D and E) Two serial sections 
through two nuclei of bbpl-1  cells. SPB1 shows wild type morphology while SPB2 is 
smaller and associates with fewer nuclear microtubules. (F) Four serial sections through 
wild type cells. SPB1 and SPB2 form a mitotic spindle. Bars (A-F), 0.25 pm.
54
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3.4.3.4.2 Analysis using GFP-tagged outer and central plaque components
To further investigate the defects of the smaller second SPB, bbpl-1 strains were 
constructed which expressed SPC42-GFP or SPC110-GFP gene fusions. Spc42p is a 
SPB component which localises to the cytoplasmic side of the central plaque (Rout and 
Kilmartin, 1991). The inner plaque component SpcllOp assembles into the SPB from 
the nuclear side (Kilmartin and Goh, 1996; Rout and Kilmartin, 1990) after the 
duplication plaque was inserted into the nuclear envelope (Adams and Kilmartin, 
1999). The strains were arrested with a-factor and at t=1.5 h after release and shift to 
37 °C, cells were analysed by fluorescence microscopy (Figure 13, A and B). GFP 
signals representing the inner (SPC110, Figure 13A) or central (SPC42, Figure 13B) 
plaque structures of SPBs were counted (Table XI). About 46 % of bbpl-1 SPC42- 
GFP cells had one and 54 % had two central plaque signals. For the strain containing a 
GFP marker for the inner-plaque it was observed that 84 % of cells had only one, while 
16 % had two signals. In addition, the indirect immunofluorescence experiment (see
3.4.3.3) using antibodies against the outer plaque component Spc72p showed that 40 % 
of cells had one outer plaque staining and 60 % had two signals (Table X). Taken 
together, about 54 % to 60 % of cells contained two SPBs. But, only about one third of 
these duplicated SPBs had assembled an inner plaque structure. Interestingly, if two 
GFP signals were observed one was always fainter than the other one. This supported 
the finding by electron microscopy that one SPB was smaller than normal (Figure 12, 
C and D).
Taken together, bbpl-1 cells displayed a defect in SPB duplication. The new SPB was 
smaller and could only with 30 % probability assemble an inner plaque. Small size and 
lack of an inner plaque structure lead to failure in microtubule nucleation, spindle 
formation and chromosome segregation.
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DAPI
Figure 13: The majority o f  bbp l-1  cells fails to assemble an inner plaque. Bbpl -1  cells 
containing (A) SPCJ10-GFP  or (B ) SPC42-GFP  were synchronised with a-fae tor. 1.5 h 
after release and shift to the non-permissive temperature (37 °C) cells were fixed with 
paraformaldehyde and DNA was stained with DAPI. The cells were analysed by 
fluorescence microscopy and 54 % o f  large budded bbpl-1  SPC42-GFP  cells contained 
two SPB signals while only 16 % of bbpl-1  SPC110-GFP  cells with two SPB signals 
were detected (see Table XI).
Table XI:  The majority of bbpl -1  cells fails to assemble an inner plaque
phenotype
bbpl-1 
SPC42-  GFP
bbp1-1 
SPC110-G  FP
counts in % counts in %
&
on
e 
SP
B 1
46
0
84
<P 25 48
<P
tw
o 
SP
B
s 22
54
8
16
(oP 9 1
total 57 100 57 100
Only about 54 % bbpl-1  cells contain two SPBs at the restricitve temperature. Only 
1/3 of  the duplicated SPBs contain an inner plaque structure. Bbpl-1  cells containing 
SPC42-GFP  (central plaque) or SPC110-GFP  (inner plaque) were prepared as described 
in Figure 13 (see directly above). 57 cells were counted at 1.5 h after release from a-  
factor and shift to the non-permissive temperature (37 °C). The SPB is indicated as a dot. 
The DAPI staining region is drawn as a dotted circle.
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3.4.4 Two-hybrid analysis of BBP1 with components of the y-tubulin 
complex
Since BBP1 was originally identified as a high gene dosage suppresser of mutants in 
SPC98, the possible interaction of Bbplp with Spc98p, a component of the y-tubulin 
complex, was further investigated by two-hybrid analysis (see 2.2.28). BBP1 fused to 
the LexA DNA-binding domain or to the GAL4 activation domain did not show 
positive interactions in any combination with two-hybrid vectors containing SPC98, 
SPC97 or TUB4, genes coding for the three components of the yeast y-tubulin 
complex. Furthermore, BBP1 did not interact with TUB4 in the yeast two-hybrid 
system in a strain background slightly overexpressing SPC97 or SPC98. Taken 
together, the two-hybrid system did not indicate any interaction of Bbplp with 
components of the yeast y-tubulin complex.
3.5 Bbplp interacts with Bfrlp genetically
It had been reported by Xue et al. (1996) that Bbplp interacts with Bfrlp in the yeast 
two-hybrid system. To investigate if Bfrlp could be interacting with Bbblp the 
following experiments were designed.
3.5.1 Two-hybrid interactions of Bfrlp
BFRl and BBP1 were analysed in the yeast two-hybrid. Apart from BBP1, genes 
coding for SPB components like SPC29, KAR1 and CDC31 were tested for interaction 
with BFRl. In addition, cdc31-16 that causes CDC31 to be independent of KAR1 was 
investigated (Vallen et al., 1994). The genes were cloned into the yeast two-hybrid 
vectors pEG202 or pMM5 and pACTII or pMM6. The plasmids were transformed into 
YPH500 or SGY37 cells and two-hybrid vectors were combined by mating of yeast 
cells with opposite mating type. The resulting diploid cells were tested for interaction 
of proteins encoded by the two-hybrid vectors by X-Gal overlay assay (see 2.2.28). 
Blue colour indicated the interaction of proteins and could be seen for Bfrlp/Bbplp, 
Bfrlp/Spc29p and Bfrlp/Cdc31p only in the combination with Bfrlp fused to the 
GAL4 domain (Figure 14A). Bfrlp in the LexA vector pMM5, did not show these
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interactions. Bfrlp did not show any interaction with Cdc31-16p, Karlp or itself. As 
controls, interactions with the empty control plasmids were measured. All controls 
were negative, apart from Cdc31p with pMM6. However, the activation of the reporter 
gene was much weaker than seen for the Bfrlp/Cdc31p interaction. It was therefore 
concluded, that Bfrlp interacts with Bbplp, Spc29p and Cdc31p in the yeast two- 
hybrid system.
3.5.2 BFR1 is not a high gene dosage suppresser of conditional lethal 
mutants of BBP1
To further investigate if Bfrlp could interact with Bbplp, conditional lethal mutants in 
BBP1 were transformed with the pRS415 plasmid containing BFRl under the ADH- 
promotor (pCS84). Transformants were checked for growth at the restrictive 
temperature. High gene dosage of BFRl did not suppress the growth defect of the 
mutants (data not shown).
3.5.3 Bfrl p and Bbp1 p do not co-precipitate
Proteins that interact with each other often form stable complexes which can be 
enriched by immunoprecipitation (Elliott et al., 1999; Knop and Schiebel, 1997). If 
Bfrlp and Bbblp interacted with each other it might be possible to precipitate the two 
proteins together. Wild type cells and cells expressing Bfrlp-3HA-tag were lysed under 
optimal extraction conditions for Bbplp (100 mM NaCl, 1 % (v/v) Triton-X-100, see
2.2.22.3) and were incubated with anti-HA antibodies coupled to sepharose beads (see 
see 2.2.24 and 2.2.25.3). Immunoprecipitates were analysed by Western blotting using 
mouse monoclonal anti-HA and rabbit polyclonal anti-Bbplp antibodies (see 2.2.13). 
Bfrlp-3HA had been precipitated and the control did not show any unspecific binding 
of Bfrlp-3HA to the sepharose beads. However, Bbplp was not co-precipitated (data 
not shown).
3.5.4 Bfrl p is localised in the cytoplasm and at the nuclear envelope
It proved to be difficult to establish a direct interaction of Bbplp and Bfrlp. However, 
a localisation of Bfrlp in proximity to Bbplp at the SPB could confirm the possibility
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of an interaction of the proteins, even if this interaction might not be direct but via 
other proteins. Bfrlp was localised by indirect immunofluorescence. Cells expressing 
BFRl-9Myc were prepared for immunofluorescence microscopy and were incubated 
with antibodies recognising the Myc epitope of the protein (see 2.2.33.2). The red 
CY3-signal of the secondary antibody representing Bfrlp showed cytoplasmic staining 
with a slight increase of the signal intensity around the DAPI stained DNA region 
(Figure 14B). As such, Bfrlp might be a cytoplasmic protein that is enriched at or 
around the nuclear envelope where it could potentially interact with Bbplp.
3.6 Bbplp interacts with the half-bridge component Karlp
As described above (see 3.4.3.2), KAR1, on a centromere-based plasmid, increased the 
growth defect of bbpl-1 and bbpl-2 cells (Table VHII, Figure 15A). This finding was 
especially interesting, since this was also the case for other conditional lethal mutants 
of SPB components like spc29 and cdc31 (Elliott et al., 1999; Vallen et al., 1994) 
which are also defective in SPB duplication. The bbpl-1 mutant displayed a defect in 
proper SPB duplication (see 3.4.3.3 and 3.4.3.4) and Bbplp was in some cases 
localised close to the half-bridge (see 3.3). An interaction with the half-bridge 
component Karlp seemed likely and could be established using the yeast two-hybrid 
system (Figure 15B). KAR1 in a yeast two-hybrid vector containing the Gal4 activation 
domain interacted with BBP1 fused to the LexA DNA-binding domain and activated 
the reporter gene. However, no positive signal was seen for the combination of BBP1 
fused to Gal4 with KAR1 fused to LexA. Taken together, Bbplp interacts genetically 
with Karlp by negative suppression and in the yeast two-hybrid system.
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Figure 14. The non-essential BFR1  codes for a cytoplasmic protein that is enriched at 
the nuclear envelope and interacts with SPB components. (A) B fr lp  interacts with the 
SPB components B bplp , Cdc31p and Spc29p in the yeast two-hybrid system, as 
indicated by the blue colour. Note: LexA-Cdc31p is slightly selfactivating. (B) 
Fluorescence microscopy o f  wild type cells (B I ) and cells expressing B fr lp -3M yc (B2 
and B3). Cells were incubated with mouse monoclonal anti-Myc antibodies and DNA 
was stained with DAPI. (C) Sporeanalysis o f  YCS56 (BFRl/AbfrI: :HIS3MX4).  All 
four spores can grow into colonies and two out o f  four spores harbour a copy o f  the 
H I  S3 gene.
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Figure 15: BBPI  interacts with KARL  (A) KAR1 on a centromer-based plasmid 
increases the growth defect of bbpl -1  cells. Strains were incubated for 3 d at 33 °C, a 
semi-permissive temperature for bbpl-1 .  (B) B b p lp  and K a r lp  interact in the yeast two- 
hybrid system as indicated by the blue colour.
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3.7 Bbplp forms a complex with Mps2p
So far in this study, Spc34p and Karlp were identified as proteins which interact with 
Bbplp (see 3.4.3.2). Experiments that led to the finding of these interactions were 
designed to look specifically for interactions of Bbplp with known SPB components. 
To identify novel proteins that directly interact with Bbplp, Bbplp-containing 
complexes were enriched by affinity chromatography.
3.7.1 Affinity precipitation of Bbplp and identification of Mps2p
Bbplp-ProA was enriched from cells carrying a functional gene fusion of BBPI and 
protein A. Wild type cells and cells expressing BBPI -ProA were lysed under optimal 
extraction conditions (see 2.2.23.3) and were incubated with IgG-sepharose beads to 
which protein A binds with high affinity (Knop and Schiebel, 1997). After several 
washing steps, proteins were eluted from the sepharose columns. The eluates were 
analysed on an 8 to 18 % SDS-PAGE gradient gel and proteins were stained according 
to Fairbanks (see 2.2.5.2.2). 15 g of cells were lysed to identify the bands of 45, 46 and 
60 kD (Figure 16A). The binding of these proteins was dependent on the expression of 
BBPI-ProA, since they were not among the proteins of BBPI wild type cells that 
bound non-specifically to IgG-spharose (Figure 16A). The precipitates were analysed 
by Western blotting (see 2.2.13). The band at 60 kD was identified as Bbpl-ProA 
using anti-rabbit antibodies (data not shown) proving the immunoprecipitation of 
Bbplp. However the known SPB components Karlp, SpcllOp, Camlp, Tub4p, 
Spc97p and Spc98p were not present in the precipitate (data not shown).
Since two of the three protein bands remained unidentified, these protein bands were 
analysed by MALDI-MS in collaboration with Anna and Andrej Shevchenko at the 
EMBL, Heidelberg. The identification of proteins from yeast by MALDI-MS has been 
possible since the completion of the yeast genome sequence. Each protein band was 
digested with trypsin and the resulting peptide masses were determined by MALDI-MS 
(see 2.2.26). As expected, the protein band at 60 kD was identified as Bbplp-ProA. 
The bands at 45 and 46 kD were identified as a duplet band of Mps2p (Figure 16B).
RESULTS 137
A
1 2
66 —
—*
HP f t
<-Bbp1p-ProA
45 — ^ZMps2p
B
10 - Trypsin
Figure 16: Mps2p affinity purifies with Bbplp-ProA . (A) Bbplp-ProA  was enriched 
from lysates expressing B bplp-ProA  by affinity purification using IgG sepharose beads 
(lane 2). The duplet band at about 45 kD was identified as Mps2p by MALD1 (matrix- 
assisted laser desorption/ionisation) and was not present in the control lane (lane 1) 
which represents proteins that bound unspecifically to IgG sepharose. (B) Identification 
of Mps2p as B b p lp  interacting protein by MALDI. The mass spectrum acquired using 
0.5 pi o f  the in gel digest o f  the 45 and 46 kD bands revealed 10 peptide ions, which 
matched the calculated masses of protonated tryptic peptides originating from M ps2p 
with mass accuracy better than 75 p.p.m (designated with filled triangles). These 
peptides covered about 30 % o f  the sequence o f  Mps2p. Ions that originated from the 
HCCA matrix ( ‘Matrix’) and intensive ions o f  autolysis products o f  trypsin ( ‘T rypsin ’ ) 
are also designated in the spectrum. The inset presents an isotopically resolved cluster 
of the peptide ion with m/z 1591.740 [mass resolution of  the instrument was better than 
6500 (full width at half-maximum)].
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At the time, MPS2 was called MMC1 (Mitotic mutability control 1) according to the 
MIPS (Munich, Germany) database. Data had been submitted suggesting a defect of 
MMC1 mutants in mitosis. These data were published (Munoz-Centeno et al., 1999) 
revealing that MMC1 is MPS2. MPS2 had been identified in 1991 in a screen for 
mutants with a defect in spindle formation (Winey et al., 1991). Only at this later time 
point MPS2 was allocated its DNA sequence in the database. MPS2 functions in SPB 
duplication (Winey et al., 1991) which is consistent with an interaction of Bbplp and 
Mps2p since mutants in bbpl also show SPB duplication defects.
3.7.2 Verification of the MALDI-MS results by co-immunoprecipitation
The interaction of Bbplp and Mps2p was verified by immunoprecipitation. The strains 
either expressed MPS2-3HA BBPl-3Myc or MPS2 BBPl-3Myc (control strain). Cells 
were lysed under the same conditions as in 3.7.1. Figure 17A (lane 1-4) shows Western 
blots of total yeast extract of these strains probed with anti-HA and anti-Myc 
antibodies. Cell lysates were incubated with anti-HA antibodies coupled to protein A 
sepharose and the precipitated proteins were analysed by SDS-PAGE (see 2.2.4.2) and 
Western blotting (see 2.2.13) using anti-HA and anti-Myc antibodies. Indeed, Bbplp- 
3Myc was co-immunoprecipitated with Mps2p-3HA (Figure 17A, lane 6 and 8). This 
precipitation was specific, since it was not observed when the MPS2 BBPl-3Myc 
extract was used (Figure 17A, lane 5 and 7). Similarly, Mps2p-3Myc was co- 
immunoprecipitated with Bbplp-3HA but not with Bbplp using anti-HA antibodies 
(data not shown). This suggests that Bbplp interacts with Mps2p and that both proteins 
are part of a common complex.
3.7.3 Bbplp and Mps2p interact in the yeast two-hybrid system
The interaction of Bbplp and Mps2p could also be verified using the yeast two-hybrid 
system (Figure 17B). MPS2 and BBPI were fused to the Gal4 or LexA domains. Both 
proteins interacted with each other in the two combinations. The plasmids combined 
with the empty vector controls were negative. Mps2p and Bbplp were both able to 
interact with themselves and might therefore have the potential to form dimers.
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Figure 17: B b p lp  and M ps2p form a complex. (A) B b p lp  co-purifies with M ps2-3HA 
by immunoprecipitation. Lysates o f  cells expressing BBPI-3Myc MPS2  (lane 1, 3, 5 
and 7) or BBPI-3Myc MPS2-3HA (lane 2, 4, 6, 8) were analysed by Western blotting 
(lane 1-4) with the indicated antibodies or were incubated with anti-HA antibodies 
coupled to protein A sepharose beads for immunopurification (lane 5-8). Precipitated 
proteins were analysed by Western blotting with mouse monoclonal anti-HA (I2C A 5) 
antibodies (lane 5 and 6) or anti-Myc (9L10) antibodies (lane 7 and 8). (B) B b p lp  and 
Mps2p interact in the yeast two-hybrid system as indicated by the blue colour. B b p lp  
and Mps2p also interact with themselves.
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3.7.4 M PS2 is a suppresser of temperature sensitive mutants of BBP1
Further genetic studies were undertaken to confirm the existence of the Bbplp/Mps2p 
complex. Temperature sensitive mutants of BBPI (bbpl-1, bbpl-2) were transformed 
with MPS2 on a multi-copy plasmid and transformants were incubated at the restrictive 
temperature. High gene dosage of MPS2 rescued the growth of bbpl-1 (Figure 18A, 
sector 2) and bbpl -2 cells (data not shown). Cells containing the control plasmid could 
not grow at the restrictive temperature (Figure 18A, sector 1). This experiment 
indicated that MPS2 was able to functionally support or substitute the defective bbpl.
3.7.5 BBP1 is a suppresser of temperature sensitive mutants of M PS2
Temperature sensitive mutants for MPS2 were constructed and investigated for high 
gene dosage suppression by BBPI.
3.7.5.1 Temperature sensitive mutants of MPS2
Temperature sensitive mutants of MPS2 were constructed in a similar way to 
conditional lethal mutants of BBPI (see 3.4.3.1 and 2.2.18). The PCR conditions 
optimised for the mutagenic PCR of BBPI proved to be suitable for the amplification 
of MPS2 from plasmid pCS71 with primers MPS2-M l and MPS2-M2. The primers 
were designed to amplify a part of MPS2 ranging from 146 bp downstream of start to 
194 bp upstream of stop. The shuffle strain of MPS2 (Amps2::HIS3, pRS316-MPS2; 
ESM780) was transformed with the isolated MPS2 fragment obtained by mutagenic 
PCR and with pRS414-AMPS2 lacking the Bsu36l/Ndel fragment (283 to 912 bp 
downstream of start). Homologous recombination occurred between the 5’- and 3’- 
terminal regions of pRS414-AMP52 and the mutated PCR fragment. Recombination 
resulted in circularisation of the pRS414 plasmid which was selected for by growth on 
medium lacking tryptophan. Temperature sensitive alleles were selected as described 
for BBPI (see 3.4.3.1). After integration into the LEU  locus, two temperature sensitive 
mutants of MPS2 were obtained:
ESM786 (jmps2-2) restrictive temperature: 35 °C
missense mutations: I258V, S259Y
RESULTS 141
ESM787 (imps2-42) restrictive temperature: 37 °C
missense mutation: L191S
In addition, a conditional lethal mutant (mps2-l) from M. Winey’s lab was used for the 
following experiment (see 3.7.1).
3.7.5.2 Suppression of temperature sensitive mutants of MPS2
All three conditional lethal mutants of MPS2 were tested for high gene dosage 
suppression of BBPI. Mps2-1, mps2-2 and mps2-42 were transformed with pRS426- 
BBP1 (pCS4) and were checked for growth at the restrictive temperature. Mps2-2 
(Figure 18B, sector 3) and mps2-42 (data not shown) containing the pRS426-BBPI 
plasmid were able to grow at the restrictive temperature. In contrast, the conditional 
lethal phenotype of mps2-l was not rescued by high gene dosage of BBPI (Figure 18C, 
sector 3). This could indicate that the defect of mps2-l mutants is more severe than that 
of mps2-2 and mps2-42 and could not be rescued by high gene dosage of BBPL It 
could also indicate dual or multiple functions of MPS2. Interestingly, mps2-l cells 
flocculate when grown in liquid culture while mps2-2 and mps2-42 cells do not form 
cell clumps.
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Figure IS: MPS2 is a high gene dosage suppresser o f  bbpl -1  cells and BBPI  is a high 
gene dosage suppresser o f  mps2-2 but not mps2-l  cells. (A) B b p l - I  mutant cells were 
unable to grow at the restrictive temperature (35°C) containing pRS425. 
Complementation was observed by pRS425 -BBP I . MPS2  on pRS425 rescued the growth 
defect of b b p l - 1 . (B) Similarly, mps2-2 cells were unable to grow at the restrictive 
temperature (35°C) containing pRS425. Complementation was observed by pRS425- 
MPS2. BBPI  on pRS425 rescued the growth defect o f  mps2-2 cells. (C) Instead, mps2-l  
cells were not rescued by high gene dosage of  BBPI.
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3.7.6 Bbpl p binds directly to Mps2p
Bbplp and Mps2p interacted in the yeast two-hybrid system and showed a genetic 
interaction in the suppression experiment. Furthermore, both proteins were co­
precipitated. All these experiment were performed in a yeast strain background and 
therefore, additional proteins were present which might have mediated the interaction 
of Bbplp and Mps2p. To investigate if this had been the case, the interaction of 
bacterial expressed Bbp2p and Mps2p was tested in an in-vitro binding experiment 
(see 2.2.27). Full length GST-Bbplp, N-terminal GST-Bbplp1'237 and C-terminal GST-
909Bbplp ' (pGEX-5X vector system) were purified from E. coli and immobilised to 
glutathione sepharose (see 2.2.25.1). The different beads were then incubated with cell 
extract from E. coli expressing His6-Mps2p1'307 (pET vector system) which lacked the 
membrane spanning region. After several washing steps, the proteins were eluted (see 
2.2.27) and analysed by SDS-PAGE, Coomassie Blue staining (Figure 19, A l) and 
Western blotting with anti-GST (Figure 19, A2) and anti-His (Figure 19, A3) 
antibodies. His6-Mps2p1'307 bound to immobilised full length GST-Bbplp 
(Figure 19A, lane 3), but not to the GST control beads (Figure 19A, lane 9). It 
interacted with similar efficiency with the C-terminal portion of Bbplp (Figure 19A, 
lane 5), as with the full length Bbplp (Figure 19A, lane 3). When His6-Mps2p1"307 was 
incubated with the N-terminal part of Bbplp a faint protein band corresponding in size
1 3 0 7to His6-Mps2p ' was observed in some experiments (Figure 19A, lane 7). This band 
was not recognised by anti-His antibodies (Figure 19, A3, lane 7). It may represent a 
Bbplp degradation product. Alternatively, His6-Mps2p1'307 might have bound weakly 
to the N-terminal part of Bbplp, but the low amount of His6-Mps2p1'307 was not 
detected by the antibodies which recognised His6 rather poorly. It should also be 
pointed out that the N- and C-terminal constructs of Bbplp overlap by 36 aa which 
may be part of the binding region. Taken together, Mps2p interacts in vitro with the C- 
terminal half of Bbplp. Since this experiment was carried out using bacterial expressed 
proteins this interaction was not assisted by additional yeast proteins and the 
interaction can be considered direct.
Figure 19: Binding of recombinant Bbplp to Mps2p. (A) Bbplp binds directly to 
Mps2p. GST-Bbplp (lane 1 and 3), GST-C-Bbplp202 385 (lane 4 and 5), GST-N-Bbplp1' 
237 (lane 6 and 7) and GST (lane 8 and 9) bound to glutathione sepharose were 
incubated with (lane 3, 5, 7 and 9) or without (lane 1, 4, 6 and 8) His6-N-Mps2p1'307 
(lane 2). The GST-Bbplp derivates and associated proteins were eluted with sample 
buffer. The eluate was analysed by Coomassie Blue staining (Al) and by 
immunoblotting with anti-GST (A2) or anti-His (A3) antibodies. Protein bands (lane 2, 
3, 5 and 7) corresponding in size to His6-N-Mps21'307 are marked with an asterisk. (B) In 
bbpl-1 cells Bbplp and Mps2p form a complex at the permissive and the restrictive 
temperature. Bbpl-1 cells were incubated for 3 h at 23 °C (lane I and 3) or 37 °C (lane 
2 and 4). Lysates of cells were incubated with protein A sepharose beads coupled to 
rabbit anti-Mps2p antibodies and eluates were analysed by immunoblotting with rabbit 
anti-Bbplp (lane 1 and 2) or rabbit anti-Mps2p (lane 3 and 4) antibodies.
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3.7.7 Stability of the Bbp1p/Mps2p complex
Conditional lethal mutants in BBPI were unable to duplicate their SPB properly. This 
defect could be due to Bbplp and Mps2p failing to interact. To address if the 
Bbplp/Mps2p complex was affected in BBPI mutants, co-precipitation of Bbplp and 
Mps2p was tested in bbpl -1 cells incubated at the restrictive temperature. Bbpl -1 cells 
were grown in liquid culture at 23 °C to OD6oo=0.3. The culture was divided equally 
and incubated at the permissive (23 °C) and the restrictive temperature (37 °C) for up 
to 3 h. This incubation time was sufficient to arrest more than 95 % of bbpl-1 cells in 
G2 . Cells of both cultures were lysed under optimal extraction conditions for Bbplp 
(see 2.2.22.3) and the cell extract was incubated with sepharose beads coupled to anti- 
Mps2p antibodies (see 2.2.24). The precipitated proteins were analysed by SDS-PAGE 
(see 2.2.4.2) and Western blotting (see 2.2.13) with antibodies against Bbplp and 
Mps2p. Mps2p was precipitated in slightly larger amounts in the culture incubated at 
the restrictive temperature (Figure 19B, lane 4) than at the permissive temperature 
(Figure 19B, lane 3). Bbplp was co-precipitated under both conditions (Figure 19B, 
lane 1 and 2). Bbplp showed slightly higher amounts in the precipitate of bbpl-1 cells 
(Figure 19B, compare lane 1 with lane 2) which is most likely a consequence of the 
higher amount of Mps2p in the precipitate. To summarise, Bbplp and Mps2p still 
formed a complex in bbpl -1 cells.
3.8 Characterisation of Mps2p
As mentioned above mps2-l displayed a SPB duplication defect, such as the newly 
formed SPB was non-functional (Winey et al., 1991). In addition, Mps2p directly 
interacted with Bbplp (see 3.7.6) which was shown to be a SPB component (see 3.3). 
Taken together, it seemed likely that Mps2p itself is associated with the SPB. The 
following experiments were undertaken to support this hypothesis and to further study 
the function of MPS2.
RESULTS 146
3.8.1 Mps2p is localised at the SPB
Mps2p was localised by direct fluorescence microscopy, by indirect 
immunofluorescence microscopy and by immuno electron microscopy.
3.8.1.1 Localisation by direct fluorescence microscopy
As described for Bbplp (see 3.3.1), GFP fused to MPS2 was used as a reporter for the 
cellular localisation of Mps2p. Cells were prepared according to Material and Methods 
(see 2.2.33.1) and were investigated by fluorescence microscopy. The Mps2p-GFP 
signal was stronger than the Bbplp-GFP signal, but still weaker than signals obtained 
for the central plaque component Spc42p or the outer plaque component Spc72p. 
Single cells usually contained one dot-like signal per cell (Figure 20, A l) whereas 
budded cells displayed two signals, which could represent the duplicated SPBs 
(Figure 20, A2). Thus, cells expressing MPS2-GFP exhibited typical SPB like staining.
3.8.1.2 Localisation by indirect immunofluorescence
Wild type cells and cells expressing fully functional epitope tagged Mps2p-3Myc were 
prepared for indirect immunofluorescence as described in 2.2.33.2 (compare to 3.3.2). 
Mouse monoclonal anti-Myc antibodies were used for the localisation of Mps2p-3Myc 
and antibodies against the outer plaque component Spc72p were employed to mark the 
SPB. The signals for Mps2p (red) and Spc72p (green) were merged (yellow) and co­
localised (Figure 20, B3-B5). However, the signals did not overlap completely (red and 
green still visible in merge) which might indicate that Mps2p could be localised with a 
different substructure of the SPB than Spc72p. As a control, wild type cells were 
incubated with the same set of antibodies. Non-specific staining of cells by the anti- 
Myc antibody was not observed (Figure 20, B1 and B2). As speculated, Mps2p is a 
component of the SPB.
Figure 20: Mps2p is localised at the SPB. (A) Cells expressing MPS2-GFP were 
investigated by immunofluorescence microscopy and single (Al) or double (A2) dot­
like signals, typical for SPB components, were observed. (B) Indirect 
immunofluorescence of wild type cells (lane 1 and 2) and cells expressing MPS2-3MYC 
(lane 3-5). Mps2p-3Myc was localised using mouse monclonal anti-Myc antibodies 
(9E10). The SPB was labelled with antibodies against the outer plaque component 
Spc72p (rabbit anti-Spc72p) and the DNA was visualised with DAPI. The dot-like 
signal for Mps2p-3Myc (red), which was not present in the wild type control, co­
localised (green+red=yellow) with the Spc72p staining of the SPB (green). Note that 
Mps2p and Spc72p signals do not completely overlap (red and green still visible). (C) 
Mps2p is localised at the central plaque periphery (C1-C3) and near the outer plaque 
(C4-C6). Immunolabelling electron microscopy of isolated SPBs using immunopurified 
rabbit anti-Mps2p antibodies (C1-C6). The secondary antibodies were conjugated to 
12nm gold particles. Gold staining represents Mps2p (large arrows). B: bridge, CP: 
central plaque, HB: half bridge, IP: inner plaque, MT: microtubules, NE: nuclear 
envelope, OP: outer plaque; Bars (A-B), 5 pm. Bar (C), 0.25 pm.
Phase _ _  phase
contrast contrast
1 2
anti Myc 
-Mps2p anti Spc72p merged
c
Figure 20.  See facing page for figure legend.
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3.8.1.3 Localisation by immunolabelling electron microscopy
To determine the localisation of Mps2p at the SPB in more detail, isolated SPBs (see 
2.2.32) were prepared for electron microscopy (see 2.2.34.2.3). The SPBs were 
incubated with anti-Mps2p antibodies. The secondary antibody was a goat anti-rabbit 
antibody coupled to 12 nm gold particles. As control, SPBs were incubated only with 
the secondary antibody. The SPBs were embedded in Spurr resin, sectioned and 
contrasted with uranyl acetate and lead citrate (see 2.2.34.3 and 2.2.34.4). About 40 % 
of all SPBs investigated (n=40) had gold staining at the SPB (Figure 20C). In single 
SPBs, gold staining was observed at the side of the central plaque (n=9; Figure 20, C l- 
C3). This localisation was very similar to that of Bbplp (Figure 9). In addition, gold 
particles close to the outer plaque were seen for single (n=2, Figure 20, C4), side-by- 
side (n=2, Figure 20, C6) and duplicated SPBs connected via mitotic spindle 
mircotubules (n=l, Figure 20, C5). Staining at the outer plaque had not been observed 
for Bbplp. In some sections, the half-bridge was visible and the Mps2p staining was 
either opposite of (Figure 20, C5) or at the half-bridge (Figure 20, C3). The control 
SPBs did not show any staining (data not shown). Taken together, Mps2p is localised 
at the side of the central plaque and/or near the outer plaque.
3.8.2 Immunoprecipitation of Mps2p
When Mps2p was co-precipitated with Bbplp no other protein had been identified as 
part of the complex. The immunoprecipitation of Mps2p could possibly reveal other 
components of the Bbplp/Mps2p-complex. Wild type cells and cells expressing fully 
functional epitope tagged Mps2p-3HA were lysed under extraction conditions which 
were suitable for the isolation of the Bbplp/Mps2p complex (see 2.2.22.3). Cell lysates 
were incubated with anti-HA antibodies immobilised to protein A sepharose beads (see 
2.2.25.3). The purified proteins were firstly analysed by Western blotting (see 2.2.13). 
Mps2p-3HA and Bbplp were present in the enriched protein fraction but not in the 
control, indicating that the immunoprecipitation was successful. The blots were also 
tested for the precipitation of other known SPB components. However, Spc42p, 
Spc72p, Cnm67p, Karlp, calmodulin and SpcllOp were not present in the precipitate. 
Consequently, the immunoprecipitate was analysed by SDS-PAGE (see 2.2.4.2) and
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Fairbanks staining (see 2.2.5.22). Protein bands at 45 kD, 34 kD and 32 kD were 
excised from the gel and analysed by mass spectroscopy (see 2.2.26). The proteins at 
45 and 32 kD were identified as Bbplp. The band at 34 kD represented the 40S 
ribosomal protein Rps3p (data not shown). Therefore, Rps3p could potentially interact 
with Mps2p. However, it is known that ribosomal proteins are frequently found as 
contaminants of immunoprecipitates and this interaction was not further investigated.
3.8.3 Analysis of Am ps2  cells
3.8.3.1 Some Amps2 cells are viable
A diploid strain was constructed which only carried one functional allele of MPS2 
while the other gene was disrupted by the HIS3 marker (Amps2/MPS2::HIS3). Cells of 
this strain were sporulated and the spores were analysed by microscopic dissection (see
2.2.17). The separated spores were incubated at 23 °C on YPD plates. After 3 d, two 
out of four spores resulting from one single tetrad had grown into colonies. Cells of 
these colonies did not contain the HIS3 marker, since the cells were not able to grow 
on selective medium (data not shown). Using a light microscope, micro-colonies could 
be seen in the areas where the other two spores were placed (data not shown). 
Therefore, hjnps2 spores were able to germinate. When the plates had been incubated 
for one week, small colonies became visible, but only 60 % of Amps2 spores were able 
to grow into colonies (Figure 21). For these colonies the disruption of MPS2 by the 
HIS3 marker was confirmed by colony PCR. The Amps2 cells were temperature 
sensitive since they were unable to grow at temperatures higher than 23 °C. 
Interestingly, Amps2 cells were only partially complemented by MPS2 since Amps2 
pRS316-MPS2 cells were not able to grow at 37 °C. This might indicate that 
chromosome miss-segregation occurred during meiosis. In a further experiment, the 
shuffle strain of MPS2 (Amps2::HIS3, pRS316-MPS2; ESM780) was incubated on 5- 
FOA plates to select against the L7M3-based MPS2 plasmid. No growth of the Amps2 
cells was observed. However, 5-FOA is slightly toxic even for wild type cells. To 
summarise, some Amps2 cells were able to grow from spores into colonies on YPD 
plates but Amps2 cells were unable to grow on 5-FOA. Cells that managed to grow
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must have been suppressed by other proteins which can partially take over functions of 
Mps2p.
3.8.3.2 Phenotype of cells lacking MPS2
To gain more information about the cellular function of Mps2p, the deletion strain was 
analysed by immunofluorescence (see 2.2.33.2). Cells lacking MPS2 were grown in 
liquid culture at 23 °C for 3 d to obtain efficient amount of cell material. Microtubules 
were visualised using anti-tubulin antibodies. The SPB was labelled using antibodies 
recognising the outer plaque component Spc72p and the chromatin positioning was 
monitored by DAPI staining.
Cells with wild type morphology including all stages of the cell cycle could be 
documented (Figure 22, 1 to 4). Early Gi cells with one SPB (Figure 22,1) and small 
budded cells with two SPBs connected by a short spindle (Figure 22, 2) were present in 
the culture. Large budded cells in late anaphase (Figure 22,3) and telophase 
(Figure 22, 4) containing two SPBs and separated DNA were also observed.
On the other hand, various abnormal mutant phenotypes were documented (Figure 22, 
5 to 10). Firstly, the shape of some mutant cells was different from wild type. Cells had 
elongated buds and/or were multi-budded. Cells displaying unusual morphology also 
showed abnormalities in chromosome segregation, microtubule distribution and SPB 
content (Figure 22, 7 to 10). Cells lacking MPS2 could contain up to four SPBs 
(Figure 22, 7 to 10). Some of these SPBs did not connect to microtubules (Figure 22, 7 
and 10) or nucleated very few microtubules (Figure 22, 9) Other SPBs nucleated an 
aster-like array of microtubules (Figure 22, 6 and 8) and some SPBs were connected by 
spindle-like structures (Figure 22, 5, 7 and 8). Most of these cells were unable to 
segregate their chromosomes (Figure 22, 6, 7, 9 and 10) and one main DAPI staining 
region was observed in these cells, even when they had a multi-budded phenotype. In 
some cases, the DNA was partially separated (Figure 22, 5 and 8). Taken together, the 
MPS2 deletion strains displayed various phenotypes reaching from wild type 
appearance to highly defective cells.
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Figure 21. Cells lacking MPS2 show a severe growth defect. Spore analysis of YCS75 
(MPS2/Amps2::HIS3MX4) reveals that some spores lacking MPS2 are able to grow into 
colonies. Six tetrades (lane 1-6) were dissected into four spores (SI, S2, S3, S4) and 
were incubated at 23 °C for one week.
Figure 22: Cells lacking MPS2 display wild type (1-4) and mutant phenotypes (5-10). 
Amps2 cells were grown for 3 d at 23 °C and were prepared for indirect 
immunofluorescence microscopy using rabbit anti-Spc72p to visualise the SPB and 
monoclonal mouse anti-tubulin antibodies. The DNA was stained with DAPI. The anti- 
Spc72p (red), anti-tubulin (green) and DAPI (blue) signals were merged. Bar, 5 jam.
DAPI anti-Spc72p anti-tubulin
Figure 22: See facing page for figure legend.
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3.8.3.3 BBP1 is unable to suppress the deletion of MPS2
If BBP1 was the gene that suppressed Amps2, high gene dosage of BBP1 should have a 
positive effect on the growth of the deletion strain. The MPS2 shuffle strain (see
2.2.17), a strain lacking the chromosomal copy of MPS2 but containing a wild type 
copy of MSP2 on a centromere-based URA3-plasmid was transformed with BBP1 on a 
multi-copy vector. As positive control pRS425-MPS2 and as negative control pRS425 
were transformed into the shuffle strain. Cells were counter selected for pRS316-MPS2 
on 5-FOA medium (see 2.2.20). Cells containing pRS425-BBP1 or the empty vector 
control were unable to grow (data not shown). Cells containing the additional copies of 
MPS2 grew like wild type cells. It cannot be excluded that Bbplp takes over functions 
of Mps2p in the deletion strain but it does not have the potential to be the main protein 
supporting the growth of Amps2 cells.
3.8.3A  Multi-copy suppression screen
To identify the gene or genes responsible for the survival of the MPS2 deletion, a 
screen for high gene dosage suppression of bjnps2 was carried out. The MPS2 shuffle 
strain (see 2.2.17) was transformed with the yeast multi-copy library in plasmid YEpl3 
and transformants were selected on SC-His-Leu-Ura selective medium. About 
50,000 transformants were replica plated (see 2.2.19) onto 5-FOA plates to counter 
select for the pRS316-MPS2 plasmid (see 2.2.20). Altogether, 33 colonies were able to 
grow and thereof 18 YEpl3 plasmids could be isolated and amplified in E. coli (see
2.2.10.2). These plasmids still allowed the growth of tsmps2 cells. The inserts of all 
plasmids were sequenced (see 2.2.14) and 15 contained a fragment from 
chromosome VII carrying RPL7A, SNR39, SNR39B, MPS2, YGL074c and HSF1. The 
complementation of Amps2 by wild type MPS2 was expected and indicated that the 
library was functional. All other three plasmids contained a fragment of 
chromosome II. The inserts varied slightly in size but all coded for SEC66, SMY2 and 
UMP1. SEC66, codes for a glycoprotein which is part of an integral endoplasmic 
reticulum membrane protein complex that is required for translocation of presecretory 
proteins (Brodsky and Schekman, 1993; Feldheim et al., 1993; Kurihara and Silver, 
1993). Not much is known about SMY2, a gene that suppresses myosin 2 defects (Lillie
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and Brown, 1994). UMP1 is the gene for the 20S proteasome maturation factor (Ramos 
et al., 1998). All three genes were amplified by PCR and were cloned into pRS425. 
The subcloned SEC66, SMY2 and UMP1 were transformed into the MPS2 shuffle 
strain. As controls, the MPS2 shuffle strain containing pRS425-MPS2, pRS425 or 
clone 61 (pCS85), one of the YEp plasmids isolated in the screen containing the 
chromosome II fragment, were used. All transformants grew at 23 °C on plates lacking 
leucine (Figure 23B). Cells containing pRS425-UMP1, pRS425-SEC66 and pRS425 
were unable to grow on 5-FOA medium (Figure 23, C and D). High gene dosage of 
SMY2 rescued the growth of Amps2 cells on 5-FOA medium in the same manner as 
clone 61. Cells containing the clone 61 or the pRS425-SMY2 plasmids grew at 23 °C 
and 30 °C (Figure 23, C and D). However, these strains were unable to grow at higher 
temperatures. Therefore, high gene dosage of SMY2 was able to suppress the growth 
defect of cells lacking Mps2p significantly.
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Figure 23: SMY2  is a high gene dosage suppresser of  Amps2. Clone 61, isolated in a 
multi copy suppresser screen o f  Amps2  codes for the ORFs o f  U M PE SEC66  and 
SMY2. (A) The shuffle strain o f  MPS2  containing the indicated plasmids is able to 
grow on SC-Leu plates at 23 °C. (B and C) MPS2  complements the growth defect o f  
Amps2  cells. The C7?Ai-based A/F\S2-plasmid was counter-selected on 5-FOA plates. 
High gene dosage o f  clone 61 and SMY2  mediates growth o f  Am p s l  cells at 23 °C and 
30 °C while UMPI  and SEC66  fail to do so.
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3.9 Connections between the nuclear pore component 
Pom152p and the SPB
It had been shown by Chial et al. (1998) that the deletion of POM152 coding for an 
abundant but nonessential nuclear pore component suppresses defects associated with 
mutations in NDC1. Ndclp is a shared component of nuclear pores and SPBs and 
mutations in NDC1 cause a SPB duplication defect (Winey et al., 1993). Since mutants 
in BBP1, MPS2 and SPC29, are defective in SPB duplication, the effect of the deletion 
of POM 125 in these mutant strains was tested.
3.9.1 Deletion of POM 152 in temperature sensitive mutants of SP C 29 , 
BBP1 and M PS2
POM152 was deleted in bbpl-1, bbpl-2, mps2-2 and spc29-2 mutants using the 
KanMX disruption cassette (Knop et al., 1999). The deletion of POM 152 was selected 
for on kanamycin plates. Transformants of bbpl-1 and bbpl-2 strains were then replica 
plated on SC-His-Trp plates to ensure that the deletion of BBP1 and the integration of 
the bbpl-1 and bbpl-2 alleles were still present (Appendix 1). Accordingly, 
transformants of the mps2-2 strain were selected on SC-His-Leu medium, to control 
the deletion of MPS2 and the integration of mps2-2 (Appendix 1). Spc29-2 cells were 
only tested for the disruption of POM152 by growth on kanamycin selective plates 
since the spc29-2 mutant allele was directly integrated into the wild type gene 
(Appendix 1). The deletion of POM152 was additionally proven by colony PCR (see 
2.2.1.2). All four strains grew at the permissive temperature. Bbpl-1 Apoml52, bbpl-2 
Apoml52 and mps2-2 Apoml52 were all able to grow at the restrictive temperature 
apart from spc29-2 Apoml52 (Figure 24A). When a wild type copy of POM 152 was 
re-introduced into bbpl-1 Apoml52 (Figure 24A), cells regained temperature 
sensitivity. This proved that deletion of POM152 had the same ‘positive’ effect on 
bbpl-1, bbpl-2 and mps2-2 cells as on mutants in NDC1.
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3.9.2 A fraction of the Pom152p pool is localised in proximity to the SPB
So far, Poml52p had only been described as a component of nuclear pores although 
the originial publication shows Poml52p staining at the SPB by immunoelectron 
microscopy (Wozniak et al., 1994). In this study, the localisation of Poml52p in 
relation to the SPB was investigated by immunofluorescence (see 2.2.33.2). Poml52p- 
6HA was visualised using anti-HA antibodies and the SPB was marked with antibodies 
against the outer plaque component Spc72p. The staining pattern obtained from the 
anti-HA antibodies could be seen along the nuclear envelope and it was either dot-like 
or covered larger areas continuously (Figure 24B). In all cells investigated, a Poml52p 
signal was always located proximal to the SPB signal (Figure 24B, white arrows). This 
localisation was seen for SPBs containing single or duplicated SPBs.
3.9.3 Co-precipitation of Pom152p and Tdh3p
Genetic evidence suggested that Poml52p might be involved in SPB duplication 
(Chial et al., 1998; this study). It had been shown by immunoprecipitation, that 
Poml52p interacts directly with the nuclear pore proteins Nic96p and Nupl88p (Fabre 
and Hurt, 1997; Nehrbass et al., 1996). However, SPB components were not identified 
in the precipitation. To exclude the possibility that further interactors of Poml52p had 
remained undiscovered, the immunoprecipitation of Poml52p was repeated. Wild type 
cells and cells expressing Poml52p-6HA were lysed under conditions optimal for the 
extraction of Bbplp and Mps2p (see 2.2.22.3). Poml52p-6HA was enriched by 
immunoprecipitation using anti-HA antibodies immobilised to protein A sepharose 
beads (see 2.2.25.3). Western blot analysis (see 2.2.13) showed that Bbplp and Mps2p 
were not present in the precipitate of Poml52p-6HA (data not shown).
The precipitates were also analysed by SDS-PAGE (see 2.2.4.2). In the Coomassie 
Blue stained gradient gel 5 unique protein bands were visible in the lane representing 
the Poml52p-6HA precipitation. The bands at 170 kD, 165 kD and 155 kD were 
identified by MALDI-MS (see 2.2.26) as Poml52p-6HA. This indicated that 
Poml52p-6HA had been slightly degraded during the experiment. The band at 66 kD 
did not contain enough material for identification by mass spectroscopy. The band at
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37 kD was identified as Tdh3p, one of the three yeast glyceraldehyd 3-phosphate 
dehydrogenases (data not shown). Neither Nic96p nor Nupl88p were precipitated 
under these conditions or they might not have been identified due to low amounts (data 
not shown). Taken together, no interaction with known SPB components could be 
detected.
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Figure 24. The nuclear pore component P om l52p  might have functions at the SPB. (A) 
Deletion o f  POM 152 rescued the growth defect of  mutants in BBP1 and MPS2 hut not 
SPC29  at the non-permissive temperature. U' POM 152 was re-introduced into the b b p l -  
I Apom 152  strain, cells regained temperature sensitivity and were unable to grow at the 
non-permissive temperature. (B) Indirect imm unofluorescence microscopy of  cells 
expressing POM152-6HA.  Pom l52p-6H A  (red) was localised at the nuclear envelope 
using mouse monelonal anti-HA antibodies (12CA5). The SPB was labelled with 
antibodies against the outer plaque component Spc72p (rabbit anti-Spc72p. green). The 
merge shows that a pool o f  Pom l52p  is always localised close to the dot-like signal for 
Spc72p representing the SPB. Bar, 2.5 pm.
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3.10 The Spc24p/Spc25p/Ndc80p sub-complex
I. LeMasson (CEA/Saclay, France) identified SPC24 in a two-hybrid screen with 
MPS2 as bait. In collaboration with I. LeMasson, the possible interaction of Mps2p 
with Spc24p, a putative SPB component of unknown function was investigated. In our 
laboratory, this genetic interaction was followed up by immunoprecipitation (see
2.2.25.3). Mps2p was precipitated in cells expressing fully functional Spc24p-3HA 
using antibodies recognising Mps2p directly. Mps2p but not Spc24p-3HA was 
precipitated. In addition, Spc24p-3HA was precipitated using anti-HA antibodies 
coupled to sepharose beads. Spc24p-3HA, but not Mps2p were detected in the 
precipitate. Therefore, the two-hybrid interaction could not be supported by 
immunoprecipitation (data not shown).
Although Mps2p could not be detected in the precipitation of Spc24p-3HA, two unique 
bands, not present in the control precipitate were observed. Using MALDI-MS (see 
2.2.26) the band of 70 kD was identified as Ndc80p which is a shared component of 
SPBs and centromeres (Wigge et al., 1998). The band at 34 kD could not be identified 
due to low protein content. Shortly after, C. Janke in our laboratory, identified Ndc80p 
and Spc24p in a immunoprecipitation of Spc25p-3HA. This indicated that Spc24p 
might be part of a complex with Spc25p and Ndc80p. To verify this result, Spc25p- 
3HA and Ndc80p-6HA were precipitated using anti-HA antibodies (Figure 25). In both 
precipitates Spc24p could be detected using antibodies against Spc24p (Figure 25, lane 
5 and 6). Spc24p was not present in the wild type control (Figure 25, lane 4). 
Therefore, Spc24p, Spc25p and Ndc80p are part of a common complex.
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Figure 25: The SPB associated proteins Ndc8()p. Spc24p and Spc25p form a novel 
complex. Spc24p (lane 5 and 6) co-precipitates with Spc25p-3HA (lane 2) and Ndc80p- 
6HA (lane 3). Lysates o f  wild type cells (lane l and 4) and cells expressing Spc25p- 
3HA (lane 2 and 5) or Ndc80p-6HA (lane 3 and 6) were incubated with anti-HA 
sepharose beads. The eluate was analysed by western blotting using mouse monoclonal 
anti-HA (lane 1-3) or rabbit polyclonal anti-Spc24p (lane 4-5) antibodies.
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3.11 Hsc82p
3.11.1 Co-precipitation of Hsc82p and Mps2p in temperature sensitive 
mutants of BBP1
It was shown in earlier in this study (see 3.7.7) that Bbplp and Mps2p form a complex 
in bbpl-1 cells at the restrictive temperature. In this experiment Mps2p was 
precipitated from lysates of bbpl-1 cells which had been incubated at 23 °C and 37 °C 
prior to precipitation. When the precipitates were analysed by SDS-PAGE (see 2.2.4.2) 
and Coomassie Blue staining (see 2.2.5.2.1), a very strong protein band at about 82 kD 
was observed in the precipitate of cells which had been incubated at 37 °C 
(Figure 26A). This protein band was identified by mass spectroscopy (see 2.2.26), as 
the constitutively expressed heat shock protein Hsc82p, a member of the HSP90 heat 
shock family. It is known that heat shock proteins are often precipitated by 
immunoprecipitation due to their ability to bind and fold proteins. However, it had 
been shown recently, that Hsp90 is a core component of the centrosome of Drosophila 
(Lange et al., 2000). Furthermore, in budding yeast, mutants in the heat shock 
transcription factor HSF1 are defective in HSP90 expression and they have a defect in 
SPB duplication (Zarzov et al., 1997). Therefore, the relation of HSC82 with MPS2 
and BBP1 was further investigated.
3.11.2 Geldanamycin Assay
Geldanamycin is a member of the benzoquinoid ansamycins, a class of naturally 
occuring antibiotics (DeBoer et al., 1970). Geldanamycin is known to bind to Hsp90 
thereby blocking the interaction of substrates with Hsp90 (Whitesell et al., 1992). 
Morano et al. (1999) showed recently, that a mutant of hsfl-583, which is defective in 
cell cycle progression, is highly sensitive to geldanamycin. In an adaption of this 
experiment (see 2.2.30), the sensitivity of hsfl-82 (mutant defective in SPB 
duplication) and of mutants of MPS2 and BBP1 to geldanamycin was tested. In 
addition, cdc37, mpsl and cdc28 cells were investigated for geldanamycin sensitivity. 
These are mutants in kinases, which act in the yeast cell cycles and all three mutants 
fail to duplicate their SPB (Schutz et al., 1997; Winey et a l, 1991; Zarzov et al.,
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1997). Geldanamycin and the control (DMSO) were applied to top agar layers 
containing the different strains and plates were incubated at 23 °C and 30 °C. Hsfl-82, 
mpsl-1 and cdc28-109 were highly sensitive to geldanamycin even at the permissive 
temperature as seen by the inhibition of cell growth (Figure 26, C1-C3). Mutants of 
BBP1, MPS2 and CDC37 were not effected by geldanamycin (Figure 26, C4-C11) at 
the permissive or semi-permissive temperature (data not shown).
3.11.3 H SC82  is a suppresser of a temperature sensitive mutant allele of 
M PS2
Mutants of BBP1 (bbpl-1 and bbpl-2) and MPS2 (mps2-l, mps2-2 and mps2-42) were 
tested for suppression by high gene dosage of HSC82. Only mps2-42 cells were able to 
grow at the restrictive temperature due to overexpression of HSC82 (Figure 26B, 
sector 3). Bbpl-1 , bbpl-2, mps2-l and mps2-2 did not benefit from high gene dosage 
of HSC82.
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Figure 26: HSC82 genetically interacts with MPS2.  (A) Hsc82p and B b p lp  co ­
precipitate with Mps2p when bbpl-1  cells were incubated at the restrictive temperature. 
Bbpl-1  cells were incubated for 3 h at 23 °C (lane 2) or 37 °C (lane 1). Lysates o f  cells 
were incubated with protein A sepharose beads coupled to rabbit anti-Mps2p antibodies 
and eluates were analysed by SDS-PAGE and Fairbanks staining. The band at about 
82kl) (lane 1), which was not present in the control (lane 2), was identified as Hsc82p 
by MALD1-MS. (B) HSC82 is a high gene dosage suppresser o f  mps2-42  cells grown at 
the restrictive temperature. MPS2  complements the growth defect o f  mps2-42  cells 
while cells containing the empty control plasmid were unable to survive at 37 °C. (C) 
Mutants in HSFP MPSI  and CD C28  are affected by the Hsp90 inhibitor geldanamycin. 
10 pi o f  DM SO or 2 mM geldanamycin in DM SO were applied to the top agar layer 
containing cells of the indicated strains. Plates were incubated for 3 d at the permissive 
temperature.
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4. Discussion
4.1 Bbplp is a SPB component
The SPB is a multi-layered protein complex which functions in the nucleation and 
organisation of microtubules. In this study, Bbplp was proven to be a novel component 
of the SPB. Firstly, Bbplp was localised at the SPB using several microscopy 
techniques. Bbplp was shown to localise to the SPB by fluorescence microscopy using 
Bbplp fused to GFP. This result was also obtained by Wigge et al. (1998) who 
identified Bbplp as a novel SPB component in the MALDI analysis of isolated SPBs. 
Furthermore, Bbplp was co-localised with the known SPB component Spc72p by 
indirect immunofluorescence (this study). Bbplp was present at the SPB throughout 
the cell cycle. These findings showed that Bbplp is a component of SPBs. More 
detailed localisation studies using immunolabelling microscopy revealed the 
localisation of Bbplp at the periphery of the central plaque (Figure 27A). This result 
was obtained in independent experiments using either anti-Myc antibodies to visualise 
Bbplp-3Myc fusion proteins in whole cells or anti-Bbplp antibodies to locate Bbplp 
at SPBs of isolated nuclei or at isolated SPBs. Micrographs of SPBs containing a half­
bridge showed gold staining representing Bbplp either where the half-bridge connects 
to the central plaque or directly opposite. This particular localisation was also observed 
if a bridge linked two side-by-side SPBs. Here, Bbplp might connect the SPB with the 
bridge-structure via its interaction with the central plaque component Spc29p and the 
half-bridge component Karlp (see below). Since staining in proximity to the central 
plaque was observed when no bridge structure was visible, Bbplp might be localised 
in a ring around the central plaque and not just at the site of bridge attachment or 
opposite (Figure 27B). In some cases staining was observed on the nuclear side of the 
SPB in proximity to the inner plaque. This however could be an artefact created by the 
distance of the gold particle from the protein itself caused by the length of the 
secondary and primary antibody. Otherwise, it could indicate that Bbplp interacts with 
nuclear proteins on the nuclear face of the SPB. A localisation of Bbplp throughout the 
central plaque itself could not be excluded by these experiments since such a pool of 
Bbplp would hardly be accessible for the primary antibody.
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Figure 27 : Model for the localisation o f  the B bplp /M ps2p  complex at the central 
plaque periphery. B b p lp  interacts with the central plaque component Spc29p 
(Schramm et al., 2000) which itself interacts with Spc42p and Spcl 1 Op (Adams and 
Kilmartin, 1999; Elliot et a l ., 1999). B b p lp  further interacts with the half-bridge 
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(A) Two dimensional layered organisation of  the budding yeast SPB. (B) Three 
dimensional horizontal cut through the central core of the SPB.
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The layers of the SPB are held together horizontally and vertically by the interaction of 
proteins within the layers. In this study, Bbplp could be shown to interact with SPB 
proteins that are known to localise in vicinity of Bbplp. In addition interactions with 
other SPB components and non-SPB components were observed (summarised in 
Figure 28).
Bbplp was originally identified in two independent genetic screens. Firstly, as a high 
gene dosage suppresser of spc98 conditional lethal mutants (S. Geissler, unpublished 
data) and secondly, as a suppresser of spc29 conditional lethal mutants (S. Elliott, 
published in Schramm et al., 2000). An interaction of Bbplp with the central plaque 
component Spc29p is now well established. Bbplp and Spc29p interact in the yeast 
two-hybrid system and by in vitro binding (S. Elliott, Schramm et a l , 2000). These 
findings suggest that Bbplp and Spc29p interact directly. However, high gene dosage 
of SPC29 could not rescue conditional lethal mutants in BBP1. Considering the fact 
that BBP1 overexpression can rescue spc29 conditional lethal mutants, this may 
indicate that Bbplp functions later in the cell cycle than Spc29p.
No further evidence could be found for an interaction of Bbplp with Spc98p, a protein 
of the y-tubulin complex. High gene dosage of SPC98 did not rescue mutants in BBP1. 
Spc98p was not present in immunoprecipitates of Bbplp and both proteins did not 
show a positive signal in the yeast two-hybrid system. Therefore, it is unlikely that 
Bbplp interacts with Spc98p. Furthermore, Bbplp did not interact with the other two 
components of the budding yeast y-tubulin complex, Spc97p and Tub4p, in the two- 
hybrid system. Spc97p and Tub4p as well as Cnm67p and Spc72p, which are outer 
plaque components, were not present in immunoprecipitates of Bbplp.
In contrast, high gene dosage of SPC42 a gene coding for an intermediate layer 
component suppressed bbpl-1 and bbpl-2 mutants. This genetic interaction could not 
be further established neither in the yeast two-hybrid system nor in affinity purification 
experiments. Nevertheless, the localisation of Bbplp in proximity to the central plaque 
indicates the possibility of an interaction of the proteins. It may be that Bbplp and 
Spc42p interact only temporarily during SPB duplication.
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Furthermore, a genetic interaction between BBP1 and SPC34 was established. Spc34p 
was identified as a novel SPB component by Wigge et al. (1998). High gene dosage of 
SPC34 suppresses the temperature dependent growth defect of bbpl-2 cells. This 
findings are supported by the interaction of BBP1 and SPC34 in the yeast two-hybrid 
system (C. Janke, unpublished data). Since the cellular role of Spc34p is as yet 
unknown, further data are needed to allow conclusions about the function of this 
interaction.
Interestingly, Bbplp interacted with the half-bridge component Karlp in the yeast two- 
hybrid system. When additional copies of KAR1 on a centromere-based plasmid were 
introduced into mutants in BBP1 they caused an increase in the growth defect. Such an 
effect of KAR1 deletion was recognised before for mutants in CDC31 (Vallen et al., 
1994) and SPC29 (Elliott et al., 1999) which are both defective in SPB duplication 
(Adams and Kilmartin, 1999; Baum et al., 1986a; Elliott et al., 1999). How this effect 
occurs is not understood but it is an additional hint for functional similarities between 
Bbplp and Spc29p and possibly Cdc31p, the yeast centrin.
4.2 Bbplp forms a complex with Mps2p
Affinity enrichment of Bbplp-ProA revealed the co-precipitation of a duplet protein 
band of about 45 kD which was identified as Mps2p by MALDI-MS analysis. This 
indicated a potential complex formation of Bbplp with Mps2p. The interaction of 
Bbplp and Mps2p was further proven in the yeast two-hybrid system and in 
immunoprecipitation experiments. Mps2p was co-precipitated with Bbplp-3HA and 
vice versa, Bbplp was co-precipitated with Mps2p-3HA.
The interaction between Bbplp and Mps2p was direct and not mediated by other yeast 
proteins as shown in an in vitro binding experiment. Bacterial expressed N-terminal 
Mps2p which lacked the putative transmembrane segment (311-327 aa), bound to 
bacterial expressed full length or C-terminal Bbplp. The N-terminal Mps2p construct 
contained the two potential coiled-coil domains (150-225 aa, 230-270 aa; Lupas et al., 
1991) of the protein. The C-terminal construct of Bbplp also contained the putative
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coiled-coil segment (320-360 aa; Lupas et al., 1991). It could therefore be possible that 
Bbplp and Mps2p interact via their coiled-coil domains.
MPS2 was first discovered in a screen for monopolar spindle mutants (Winey et al., 
1991). The mutants were shown to display a defect in late SPB duplication which 
caused the formation of monopolar spindles (Winey et al., 1991). The MPS2 gene was 
also isolated in a genetic screen with mutants in CIN5 (Munoz-Centeno et al., 1999). 
CIN5 codes for a protein of the proteasome required for G2/M transition (Ghislain et 
al., 1993). Mutants in CIN5 arrest with unsegregated chromosomes and it is assumed 
that proteolysis by the proteasome which is required for cells to enter anaphase is 
impaired. High gene dosage of MPS2 inhibits growth of the cin5 mutant at the 
semipermissive temperature of 30 °C. Mps2p contains 3 putative Cdc28p 
phosphorylation sites (Songyang et al., 1994) and four potential destruction box 
sequences (Glotzer et al., 1991) which could target the protein for destruction by the 
proteasome (Munoz-Centeno et al., 1999). Therefore, Mps2p might be a substrate of 
the proteasome and its inefficient degradation might limit cell division (Munoz- 
Centeno et al., 1999). Bbplp and Mps2p co-immunoprecipitate in bbpl-1 mutants 
which had been incubated for 3 h at the non-permissive temperature. The formation of 
the complex is therefore not impaired in these mutants. Mutants in BBP1 arrest in G2 
and it could also be possible that the complex has to be disconnected or degraded for 
cell cycle progression. However possible degradation of Mps2p by the proteasome is 
still only hypothetical especially since Munoz-Centeno et al. (1999) showed that the 
concentration of Mps2p is nearly constant throughout the cell cycle except a slight 
decrease in Gi-S transition.
4.3 Mps2p is a component of SPBs
The finding that Bbplp and Mps2p form a complex was followed up by the 
localisation of Mps2p. As expected Mps2p showed a localisation similar to Bbplp. 
Mps2p-GFP displayed a typical SPB staining pattern and Mps2p localised close to 
Spc72p, a component of the outer plaque. As seen in the merged images, signals for 
Mps2p-3Myc and Spc72p overlapped (yellow) but not entirely (red and green). 
Therefore, Spc72p and Mps2p did not completely associate with the same SPB
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substructures. This could be confirmed by immunolabelling microscopy using isolated 
SPBs. The gold signal representing Mps2p was mostly localised at the central plaque 
periphery, a localisation also seen for Bbplp. Mps2p could be seen where the half­
bridge connects to the central plaque or at the central plaque itself when no half-bridge 
was visible. This indicates that Mps2p like Bbplp is localised in a ring like pattern at 
the level of the central plaque (Figure 27). In addition, gold staining was found at the 
outer plaque, where Spc72p is localised. Again, this could be an artefact created by the 
primary and secondary antibody but one micrograph showed staining of up to 3 gold 
particles which could indicate that this localisation is relevant. Munoz-Centeno et al. 
(1999) also localised Mps2p at SPBs by immunolabelling microscopy using whole 
cells expressing Mps2p-9Myc. In addition to the SPB staining, they observed staining 
for Mps2p at the nuclear envelope by immunofluorescence microscopy. Interestingly, 
Mps2p was also identified by Wigge et a l (1998) in the MALDI analysis of isolated 
SPBs but Mps2p was not further investigated in this publication. Taken together, 
Mps2p is a component of the SPB.
4.4 The Bbp1p/Mps2p complex functions in SPB duplication
Morphological electron microscopy studies of temperature sensitive mutants in BBP1 
showed that mutants are defective in late SPB duplication. Early steps like the 
enlargement of the satellite into a duplication plaque were normal in bbpl-1 mutants 
but subsequent insertion of the duplication plaque into the nuclear envelope and 
formation of a functional inner plaque seemed to be defective. This was concluded 
because two fully functional SPBs were not observed in bbpl-1 cells. If two side-by- 
side SPBs were investigated, one of the two SPBs connected via the bridge always 
lacked a complete inner plaque structure. If two separated SPBs were observed one 
SPB nucleated an apparently normal amount of microtubules while the other SPB 
nucleated non or only a few nuclear microtubules. Defects in inner plaque assembly 
possibly causing this microtubule nucleation defect were proven by direct fluorescence 
microscopy using SPB proteins fused to GFP as markers for the central and inner 
plaque structure. Only with 30 % probability contained both of the duplicated SPBs an 
inner plaque structure. GFP and immunofluorescence studies also showed that about 
50 % of cells contained only one SPB. It was concluded that possibly the non­
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functional SPB was disintegrated in most bbpl -1 cells. Disintegration of the novel and 
defective SPB has been postulated for mutants in spc29 and spcl 10 (Adams and 
Kilmartin, 1999; Sundberg and Davis, 1997). The defects in SPB duplication observed 
in bbpl -1 cells caused cells to fail in the formation of a functional spindle and in the 
separation of chromosomes. Therefore, mutant cells arrested in G2 probably due to the 
spindle checkpoint which monitors unattached chromosomes.
The phenotype observed in bbpl -1 mutants is nearly identical to that of mps2-l cells. 
Mutants in MPS2 are defective in late SPB duplication (Winey et al., 1991). After 4 h 
at the restrictive temperature about half of the mutant cells contain duplicated SPBs but 
the nascent SPB is not inserted into the nuclear envelope. The functional SPB 
nucleates nuclear and cytoplasmic microtubules while the second SPB only nucleates 
cytoplasmic microtubules. The smaller SPB-like structure was not found to connect to 
nuclear microtubules but was in some cases able to move away from the functional 
SPB probably via cytoplasmic microtubules. As consequence the two SPBs are not 
connected via a mitotic spindle and the cells arrest in G2 with a monopolar spindle and 
unsegregated DNA (Winey et al., 1991). The similarity between the two mutant 
phenotypes and the direct interaction of Bbplp and Mps2p suggests that the Bbplp and 
Mps2p function together in a complex in late SPB duplication.
A defect in SPB duplication was also observed for mutants in SPC29 (Adams and 
Kilmartin, 1999; Elliott et al., 1999). Most spc29 mutant cells (66 %) contain only one 
SPB at the restrictive temperature. In about 30 % of cells a second SPB is visible 
which is smaller in size and only able to nucleate few microtubules. High gene dosage 
of BBP1 is able to suppress this defect in spc29-2 and spc29-3 mutants (S. Elliott, 
published in Schramm et al., 2000) indicating a functional similarity of both proteins. 
Overexpression of MPS2 instead did not rescue spc29 mutants (S. Elliott, 
unpublished). Spc29p did not show an interaction with Mps2p in the yeast two-hybrid 
system or by immunoprecipitation as shown for Spc29p and Bbplp. Taken together, 
Spc29p has a role in SPB duplication and Spc29p might partially execute this function 
by interacting with the Bbplp/Mps2p complex via Bbplp.
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That Bbplp and Mps2p function together as a complex was further confirmed by the 
ability of each protein to suppress the mutant phenotype of the other protein. High gene 
dosage of MPS2 was able to suppress the growth defect of bbpl-1 and bbpl-2 cells and 
overexpression oiBBPl rescued the mps2-2 and mps2-42 mutants. The only exception 
was that mps2-l cells were not rescued by high gene dosage of BBPl. Importantly, 
only the mutation of the mps2-l allele (E39K) is not located in the predicted coiled- 
coil domain of Mps2p. If Bbplp and Mps2p interacted via the coiled-coil region, 
Bbplp might not be able to suppress mutations outside this region.
4.5 Functional similarities between the Bbp1p/Mps2p complex 
and Ndrfp
Ndclp is a protein with functions in late steps of SPB duplication that is localised at 
nuclear pores and at SPBs. In more detail, a pool of Ndclp co-localises with Spc42p by 
immunofluorescence microscopy and it was shown by immunolabelling microscopy 
that Ndclp is located at the central plaque periphery (Chial et al., 1998). The 
localisation of Ndclp at the SPB is therefore identical to the localisation observed for 
Mps2p and Bbplp. Furthermore, the phenotype of mutants in NDC1 is similar to that 
observed in mps2, bbpl and spc29 cells (Adams and Kilmartin, 1999; Elliott et al., 
1999; Thomas and Botstein, 1986; Winey e ta l., 1991,1993; this study). When mutants 
in NDC1 contain two SPBs, one is normal in form and nucleates cytoplasmic and 
nuclear microtubules while the second SPB is smaller in size and only attaches to 
cytoplasmic microtubules. The defective SPB can move away from the mother SPB 
but it does not acquire its share of chromosomes which all remain connected to the 
functional spindle pole body. Ndclp is not only a component of SPBs it also localises 
to nuclear pores but ndcl cells are actually not defective in nuclear pore function 
(Chial et al., 1998). The fission yeast homologue of Ndclp is Cutllp, a nuclear 
envelope protein and which is most likely to function as an anchor protein for the 
fission yeast SPB at the nuclear envelope in cell division (West et al., 1998). Like 
Ndclp, Cutllp also localises to nuclear pores (West et al., 1998). It has been proposed 
that Ndclp and C utllp  are not only homologous in their sequence but also in their 
function with a role in the anchorage and/or insertion of SPBs and nuclear pores into
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the nuclear envelope. It was shown by Chial et al. (1998) that deletion of the nuclear 
pore component Poml52p rescues the cold sensitive growth defect of ndcl mutants. 
The mechanism of this phenomenon is not clear but wild type Poml52p seems to be 
antagonistic to the ndclp mutant form. Furthermore, deletion of POM152 in mutants of 
BBP1 and MPS2 also rescued the growth of mutant cells at the non-permissive 
temperature (this study, Figure 28). Deletion of POM152 however had no positive 
effect on the growth of spc29 mutant cells. This finding emphasises the functional 
similarity of Bbplp and Mps2p with Ndclp. Considering the localisation of Ndclp at 
the central plaque and the similarity of the mutant phenotypes of ndcl, bbpl and mps2, 
Ndclp might be functionally similar to Bbpl and Mps2p. All three proteins might be 
involved in processes leading to the insertion of the duplication plaque into the nuclear 
envelope.
Interestingly, there is evidence that Poml52p might also be a shared component of 
nuclear pores and SPBs. Firstly, the original publication about the localisation of 
Poml52p (Wozniak et al., 1994) contains micrographs which show localisation of 
Poml52p at the side of the central plaque of the SPB but the authors only commented 
on the localisation of Poml52p at nuclear pores. Secondly, Poml52p was identified by 
MALDI analysis of isolated SPBs (Wigge et al., 1998) but was classified as 
contaminant. Finally, it was shown in this study by immunofluorescence microscopy 
that a pool of Poml52p was always present near SPBs. Taken together Poml52p might 
be a candidate for a protein which is shared by nuclear pores and SPBs, like Ndclp.
In this study Poml52p was co-precipitated with Tdh3p, the budding yeast GAPDH 
(Figure 28). The relevance of this interaction was not further investigated. However, 
recently a MALDI analysis of highly enriched nuclear pores also identified Tdh3p as a 
potential nuclear pore component (Rout et al., 2000) but the authors classified the 
protein as a contaminant. It might be interesting to consider a potential function of 
Tdh3p at nuclear pores or SPBs since the protein is known to have complex functions
other than in glycolysis. Mammalian GAPDH is a membrane bound protein (Wooster
2+and Wrigglesworth, 1976) with a Ca dependent membrane fusion activity (Morero et 
al., 1985). Furthermore, GAPDH can bind to the C-terminal region of a-tubulin 
(Kumagai and Sakai, 1983; Volker and Knull, 1997) and can cause tubulin
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polymerisation and microtubule bundling (Huitorel and Pantaloni, 1985). GAPDH is 
known to be phosphorylated by a number of kinases including protein kinase C (Reiss 
et al., 1996) and it has RNA binding activity (Ryazanov, 1985; Singh and Green, 
1993). In yeast, TDH3 was also isolated as a high gene dosage suppresser of mutations 
in SEC61 (Esnault et al., 1993) (Figure 28). Trimeric Sec61p forms the pore of the ER 
translocon but it is as yet unknown by which mechanism Tdh3p might be able to 
restore translocon activity. Speculating about the function of Tdh3p at the SPB, Tdh3p 
may interact with Poml52p to mediate steps in duplication plaque insertion or in inner 
plaque assembly.
4.6 Analysis of the Amps2 deletion strain
BBP1 was regarded to be an essential gene since cells, which lacked a functional copy 
of BBP1, could not survive. In contrast, some cells lacking MPS2 could grow very 
slowly at 23 °C but the majority of these cells displayed various severe mutant 
phenotypes. Cells were large and multi-budded and displayed defects in spindle 
formation and chromosome segregation. Interestingly, these cells could contain up to 
4 SPBs. If the cellular defects in these cells were caused by malfunction of SPBs is not 
known since mutant cells have not yet been investigated by electron microscopy. 
FACS analysis of the Amps2 strain showed that cells had In, 2n or 4n DNA contents 
(Munoz-Centeno et al., 1999). High gene dosage of BBP1 did not restore wild type 
growth in cells lacking MPS2. Therefore, it was unlikely that BBP1 could be the main 
suppresser that mediated the slow growth of the deletion strain. A screen designed to 
identify high gene dosage suppressers of the mps2 deletion strain identified one single 
candidate, SMY2 (Figure 28). Overexpression of SMY2 allowed cells lacking MPS2 to 
grow at temperatures up to 30 °C. At 23 °C, cells with additional gene copies of SMY2 
grew with similar kinetics as wild type. The morphology of these cells was normal 
apart from the elongated form of the bud and the positioning of the bud at the side of 
the mother cell. This however could be a side effect of SMY2 overexpression and 
should be followed up in future work.
The cellular role of Smy2p is as yet unknown but there are various hints for its putative 
function. SMY2 had been identified in a screen for high gene dosage suppressers of
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mutants in MY02. MY02  encodes the yeast unconventional class V myosin, an actin 
associated motor protein which is involved in vesicle and organelle transport to the 
bud. Overexpression of SMY2 can also suppress mutations in several other genes like 
sec22, betl and seel6 (Lillie and Brown, 1994) (Figure 28). The wild type products of 
these genes are involved in vesicular transport and vesicle fusion or vesicle formation 
(Espenshade et al., 1995; Gimeno et al., 1995; Newman et al., 1990, 1992a, 1992b). 
Myo2p is also involved in directing the astral microtubules into the bud via an 
interaction with Kar9p (Yin et al., 2000), thereby aligning the mitotic spindle. How 
could possible functions of Smy2p be related to functions of Mps2p? It might be that 
Mps2p has additional functions which are not closely related to its function at the SPB. 
The mps2-l mutant is not rescued by overexpression of BBP1 and indeed, mps2-l cells 
show an additional defect not observed in mps2-2 and mps2-42 mutants. If mps2-l 
cells are grown in liquid culture cells floculate, which means that cells form clumps 
and sediment on the bottom of the flask. This phenotype is usually observed in mutants 
defective in cell wall formation. Cell wall formation is a process dependent on 
vesicular transport along the actin cytoskeleton and on vesicle fusion at the location of 
growth. Mps2p and Smy2p could possibly be involved in these processes but this is 
still to be proven. However to rescue the MPS2 deletion mutant, Smy2p might have to 
compensate for functions of Mps2p directly at the SPB or at the nuclear envelope. This 
role of Smy2p remains to be determined in future work.
It was shown recently that the potential S. pombe homologue of SMY2, mpd2+, 
suppresses the conditional lethal phenotype of mutants in CDC7 (Cullen et al., 2000). 
Cdc7p is a protein kinase which is essential for initiating septum formation a process 
required in fission yeast for cytokinesis (Fankhauser and Simanis, 1994). Cdc7p, like 
its budding yeast homologue Cdcl5p, is localised at the SPB in mitosis (Sohrmann et 
al., 1998; Xu et al., 2000). In late anaphase Cdc7p localises to only one SPB 
(Sohrmann et al., 1998) while it was shown for budding yeast that a portion of Cdcl5p 
is found at the mother-bud neck at the end of telophase (Xu et al., 2000). While Cdc7p 
is involved in the exit from mitosis by signalling the onset of septum formation 
(Sohrmann et al., 1998), Cdcl5p is part of the mitotic exit network required for 
degradation of B-type cyclins at the end of mitosis in budding yeast (Jaspersen et al.,
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1998; Surana et al., 1993). So far, it has not been investigated if high gene dosage of 
SMY2 can rescue mutants in CDC15 in budding yeast as indicated by the findings in 
fission yeast. However, if this was the case then Smy2p might have the potential to 
interact with Cdcl5p and Mps2p at the SPB.
4.7 Bfrlp interacts with SPB components in the two-hybrid 
system
Bfrlp was shown to interact genetically with Bbplp in the yeast two-hybrid system 
(Xue et al., 1996; this study). The interaction of Bfrlp with other SPB components was 
also checked in the yeast two-hybrid system and Bfrlp was shown to interact with the 
half-bridge component Cdc31p and the central plaque protein Spc29p (this study). 
Localisation of Bfrlp by immunofluorescence microscopy revealed that the protein is 
cytoplasmic with a slight concentration at the nuclear envelope. An exclusive 
localisation or concentration at the SPB was not observed. About the function of Bfrlp 
can only be speculated despite several publications on the protein. Bfrlp was first 
identified in a screen for proteins that mediate resistance against the drug Brefeldin A 
(BFA) (Jackson and Kepes, 1994). Wild type yeast cells are resistant against the drug 
but if cells carry the erg6 mutation they become sensitive ((Graham et al., 1993; Shah 
and Klausner, 1993; Vogel et al., 1993). In yeast, BFA binds to complexes of Sec7p 
and Arflp-GDP thereby trapping the small G-protein of the Arf-family with its 
potential guanine nucleotide exchange factor Sec7p. As consequence Arflp stays in the 
inactive GDP-bound form and COPI coat vesicle can not be assembled (Peyroche et 
al., 1999). Transport to the Golgi and retrograde transport to the ER ceases and the 
Golgi disassembles and redistributes to the ER. Overexpression of BFR1 causes 
complete resistance to BFA by an unknown mechanism (Jackson and Kepes, 1994). In 
addition, overexpression of BFR1 partially suppresses the growth defect of mutants in 
SEC17 a yeast gene coding for the homologue of the mammalian a-SNAP involved in 
vesicle targeting and/or fusion, respectively (Clary et al., 1990; Griff et al., 1992). This 
indicates that Bfrlp might have functions in vesicular transport. Interestingly, Smy2p 
the suppresser of the mps2 deletion strain was also implicated in having functions in 
vesicular transport or fusion (see above).
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More recently, Bfrlp was isolated in a complex with Scpl60p, a potential member of 
the vigilin family that mainly associates with polyribosomes. Another component of 
the Scpl60p complex isolated is Pablp, a poly(A) binding protein (Lang and 
Fridovich-Keil, 2000). Scpl60p can bind to ribohomopolymers and rRNA but not to 
tRNA (Weber et al., 1997) and it localises to the cytoplasm with enrichment around 
the nuclear envelope and possibly the ER (Lang and Fridovich-Keil, 2000) a 
localisation similar to Bfrlp (this study). Deletion of SCP160 in yeast is not lethal but 
results in various phenotypes including increased DNA content, missegregation of 
genetic markers during sporulation and abnormal cell morphology, including increased 
size and irregular shape (Wintersberger et al., 1995). A deletion strain of BFR1 is 
viable (Jackson and Kepes, 1994; this study) and shows similar phenotypes (Jackson 
and Kepes, 1994). Cells are enlarged in size and some cells are elongated and/or form 
multiple buds. About 20 % of cells show defects in nuclear segregation creating 
anucleate and polyploid cells (Jackson and Kepes, 1994). Therefore, Bfrlp and 
Scpl60p show similar localisation and deletion phenotypes. Interestingly, Mps2p was 
co-purified with the ribosomal protein Rps3p (this study). Ribosomal proteins are often 
found to contaminate immunoprecipitates. On the other hand, this result could be an 
indication for the possibility of the interaction of Mps2p with ribosomes. However, 
more data are needed to confirm SPB ribosome interactions. In addition, interactions of 
Bfrlp with proteins involved in SPB duplication (Bbplp, Cdc31p, Spc29p) still have 
to be connected to Bfrlp function in BFA-resistance, vesicular transport and as part of 
the Scpl60p complex which binds to polyribosomes.
4.8 HSC82 might have functions at the SPB
In Drosophila, the chaperone Hsp90 is a core component of the centrosome (Lange et 
al., 2000). Hsp90 localises to the centrosome throughout the cell cycle and its 
localisation is not microtubule dependent. Mutations in Hsp90 or treatment with Hsp90 
inhibitors result in abnormal centrosome separation and maturation. As consequence 
aberrant spindles are formed and chromosomal separation is impaired. Therefore, 
Hsp90 seems to be essential to ensure proper centrosome functions (Lange et al., 
2000). Other functions of Hsp90 include the promotion of protein folding (Wiech et 
al., 1992), keeping proteins in a folding compatible state for other chaperones
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(Freeman and Morimoto, 1996) and the prevention of protein unfolding and 
aggregation (Miyata and Yahara, 1992).
In budding yeast two isoforms of Hsp90, the constitutively expressed Hsc82p and the 
highly inducible Hsp82p are present and expression of one of the two isoforms is 
essential (Borkovich et al., 1989). So far, it is unknown whether Hsp90 is also a 
component of the yeast SPB. In this study, the constitutively expressed isoform HSC82 
was found to co-precipitate with the Bbplp/Mps2p complex in mutant cells incubated 
at the restrictive temperature but not at the permissive temperature. The relevance of 
this interaction for the function of the complex in SPB duplication is not known. 
Interestingly, mutants in HSF1, a gene coding for a transcription factor of Hsp90 are 
defective in spindle pole body duplication (Zarzov et al., 1997). This duplication defect 
might be due to direct functions of Hsflp at the SPB but could also be due to the defect 
of hsfl mutants in the synthesis of Hsp90. The latter might be more likely since high 
gene dosage of HSC82 can restore the defects in hsfl mutants (Zarzov et al., 1997). It 
was tested whether high gene dosage could also restore growth in bbpl and mps2 
mutants also defective in SPB duplication. Here, high gene dosage of HSC82 
suppressed cells carrying the mps2-42 mutant allele only while growth of mps2-l, 
mps2-2 and all bbpl mutants was not improved. It was shown by Morano et al. (1999) 
that cells containing only the truncated form of HSF1 [1-583] are very sensitive to the 
drug geldanamycin, an inhibitor of Hsp90. Other mutants which show defects in SPB 
duplication were tested for sensitivity to geldanamycin at the permissive and semi- 
permissive temperature. Of those strains tested, wild type strains and mutants in BBP1, 
MPS2 and CDC37 did not show reduced growth by treatment with geldanamycin. The 
cdc37-l mutant was tested since mutant cells arrest with side-by-side SPBs. Of these 
SPBs, the novel SPB has a reduced outer plaque or lacks the outer plaque completely. 
In contrast, the hsfl -82, mpsl-1 and cdc28-109 mutants were unable to grow on plates 
treated with geldanamycin. The cdc28-109 is an allele of CDC28 that shows mixed G l­
and G2- arrest after transfer of an asynchronous culture to the restrictive temperature 
(Zarzov et al., 1997). Interestingly, depletion of Hsp90 from yeast cells also results in 
cell cycle arrest at both Gi/S- and G^M-phase (Morano et al., 1999) suggesting a 
complex requirement for Hsp90 function at important time points of Cdc28p/cyclin
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activity. Mpslp has functions at early and late stages in SPB duplication (Schutz et al., 
1997; Schutz and Winey, 1998) and it is part of the spindle checkpoint with signalling 
activity via Madlp (Hardwick et al., 1996). Mutants in MPS1 have been shown to be 
co-lethal with mutations in HSC82 (Jones et al., 1999). This genetic interaction and the 
effect of geldanamycin on mpsl-1 could indicate a function of Hsp90 either in SPB 
duplication or in checkpoint signalling, since Hsp90 was shown to be part of various 
signalling cascades. Taken together, these findings indicate effects of Hsp90 function 
on proteins implicated in SPB duplication.
4.9 A novel protein complex of SPB associated proteins
Ivan LeMasson (Saclay, Paris, France) found a genetic interaction of Mps2p with 
Spc24p in the yeast two-hybrid system (personal communication). This genetic 
interaction has lately been reported in a publication about interactions of coiled-coil 
proteins (Newman et al., 2000). Spc24p was first identified as a novel SPB component 
by MALDI-MS analysis of isolated SPBs and Spc24p was localised at the nuclear side 
of SPBs by immunolabelling electron microscopy (Wigge et al., 1998).
The potential interaction of Mps2p and Spc24p was investigated by co- 
immunoprecipitation, but purification of Mps2p or Spc24p with each other was 
unsuccessful. However, MALDI analysis of the precipitate of Spc24p-3HA revealed 
the co-precipitation of Ndc80p. Vice versa, Spc24p could be co-precipitated with 
Ndc80p-6HA, which indicated that Spc24p and Ndc80p might form a complex. This 
assumption is further supported by the known genetic interaction of Ndc80p and 
Spc24p in the yeast two-hybrid system (Cho et al., 1998).
Ndc80p, is a protein which localises close to the nuclear side of the SPB, a localisation 
also shown for Spc24p and Spc25p (Rout and Kilmartin, 1990; Wigge et al., 1998). 
The staining pattern of Ndc80p-GFP at the nuclear side of the SPB is punctuated which 
is characteristic for centromere staining. Centromeres are known to cluster near the 
nuclear side of the SPB (Goh and Kilmartin, 1993; Goshima and Yanagida, 2000; He 
et al., 2000; Hyland et al., 1999; Jin et a l, 2000). Ndc80p is a homologue of the 
human HEC protein (Wigge et al., 1998) which is localised at human kinetochores.
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Furthermore, NDC80 is synthetical lethal with CTF19 (Hyland et al., 1999) a gene 
coding for a kinetochore component, which was shown to localise to the nuclear phase 
of SPBs (Hyland et al., 1999). Taken together, this indicates that Ndc80p is a potential 
component of kinetochores (Rout and Kilmartin, 1990; Wigge et al., 1998; Zheng et 
al., 1999).
C. Janke in our laboratory investigated Spc25p a protein that potentially interacts with 
Spc24p (see above). Precipitation of Spc25p-3HA enriched a complex containing the 
Spc24p/Ndc80p-complex and Nuf2p, a protein that is localised at SPBs (Osborne et 
al., 1994). The cellular localisation of the complex consisting of Spc24p, Spc25p, 
Ndc80p and Nuf2p was further investigated in a collaboration of our laboratory with 
the group of J. Lechner (Heidelberg). CHIP analysis proved the association of all 
proteins with centromere DNA. This association was dependent on NdclOp a core 
kinetochore component (Janke et al., in press).
Mutants in NDC80 contain two morphological normal SPBs and cells are able to form 
an anaphase spindle of wild type morphology but fail to segregate duplicated 
chromosomes (Wigge et al., 1998). This mutant phenotype taken together with the 
localisation of Ndc80p at the kinetochore led to the conclusion that mutants in NDC80 
are unable to attach microtubules to kinetochores, a task which might usually be 
fulfilled by the functional complex.
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5. Conclusion
Bbplp and Mps2p form a novel complex that functions in SPB duplication. The 
interaction of both proteins is direct and not mediated by other proteins. The complex 
is localised most likely in a ring-like structure around the central plaque periphery of 
the SPB thereby possibly anchoring the SPB in the nuclear envelope and connecting 
the central plaque to the half-bridge. This is supported by the interaction of Bbplp with 
Spc29p a component of the central plaque of the SPB and by the interaction with 
Karlp which is a component of the half-bridge. Bbplp also shows genetic interaction 
with other SPB components like Spc34p and Spc42p. Furthermore, Bbplp interacts 
with Bfrlp, a protein which is localised in the cytoplasm and at the nuclear envelope. 
Bfrlp is a protein of unknown function which mediates Brefeldin A resistance and 
associates with polyribosomes. Mutants in BBP1 and MPS2 display similar defects in 
SPB duplication which result in impaired mitosis and G2 arrest. This phenotype can be 
rescued by deletion of POM 152, a gene coding for a nuclear pore component, as 
observed before for mutations in NDC1. Mutants in NDC1 show nearly identical 
defects as bbpl and mps2 mutants and the proteins might have similar functions. A 
pool of Poml52p was shown to always be present in the proximity of SPBs and the 
protein might have direct function at the SPB. Cells lacking MPS2, which show 
various defects in spindle formation, SPB content and chromosomal segregation can 
not be rescued by high gene dosage of BBP1 but by SMY2. Smy2p is a protein which 
might be involved in membrane fusion and/or vesicular transport. The mechanism of 
rescue has to be investigated further. This study also provides evidence that Hsp90 
might have functions in SPB duplication. Hsc82p was found in the Bbpl/Mps2p 
complex in mutants oiBBPl. Furthermore, high gene dosage of Hsc82p suppressed the 
mps2-42 mutant. Inhibition of Hsp90 was lethal for mutants in HSF1, MPS1 and 
CDC28 which are all defective in SPB duplication. In addition to the Bbplp/Mps2p- 
complex, a complex consisting of the SPB associated proteins Spc24p, Ndc80p and 
Spc25p was isolated. This complex might mediate the attachment of microtubules at 
kinetochores and is therefore essential for the formation of a functional mitotic spindle.
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